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Summary 
Background: Several studies suggested association between consanguinity and risk of 
developing Type 2 Diabetes (T2D). 
Aim: To examine mechanisms by which consanguinity might increase the risk of T2D in a 
Saudi population.  
Methodology: 362 adult male participants were recruited, 179 were T2D patients and 183 
healthy participants were siblings of recruited patients.  Severity was assessed in patients by 
recording age at diagnosis.  Diabetes risk in healthy subjects was inspected by measuring their 
body mass index (BMI), fasting blood glucose (FBG), and waist circumference. Extended 
pedigrees were constructed to calculate inbreeding coefficients. 23 Single Nucleotide 
Polymorphisms (SNPs) incurring higher risk of T2D were genotyped. All subjects were 
interviewed to complete food frequency and physical activity questionnaires to provide 
information on environmental variation between participants.  
Results: 
Significant inverse association was detected between inbreeding coefficients and age at 
diagnosis accounting for environmental covariates (β: -0.572 P-value: 0.012).  In 42 families, 
we were able to recruit 2 healthy siblings from each. Pearson’s correlation coefficient of FBG 
between siblings was 0.317 (P= 0.04). Correlations between siblings’ FBG increased with 
increased range of consanguinity suggesting a stronger genetic influence leading to lower 
variation of FBG between siblings. The effect of consanguinity on variation of FBG was further 
assessed by fitting a regression line and controlling for difference in age, calorific intake, and 
level of physical activity (β: -0.118 P-value: 0.024).  
No significant associations were detected between number of loci identical for risk alleles and 
age at diagnosis, BMI, FBG or waist circumference. An association of marginal significant was 
detected  between age at diagnosis and total number of risk alleles when accounting for parental 
history of diabetes and inbreeding coefficients (β:-0.399 P: 0.052). 
Conclusion: Study’s findings suggest consanguinity might increase risk of T2D by earlier 
development of the disease, and by strengthening possible genetic effect on FBG.  
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Glossary 
Allele: one of a number of alternative forms of the same gene occupying a given position in a 
chromosome.  
Additive effect: when the combined effects of alleles on the phenotype at different loci are equal 
to the sum of their individual effects. 
Consanguinity: the property of being descended from a common ancestor.    
Consanguineous marriage: marriage between individuals who share a common ancestor.  
DNA: Deoxyribonucleic Acid a long linear polymer found in the nucleus of a cell, formed from 
nucleotides and shaped like a double helix; responsible for the transmission of genetic 
information. 
Dominant: production of the same phenotype whether its alleles are identical or dissimilar. 
Dominance: a deviation from additive allelic effects on phenotype within the same locus.  
Gene: a segment of DNA. 
Genotype: the specific pair of alleles at a single locus in a diploid organism that determines a 
specific trait of an individual, such as ‘Aa’ or ‘aa’. 
Gluconeogenesis: the process of glucose synthesis.   
Hardy-Weinberg equilibrium: a state in which genotype frequencies and proportions remain 
constant from generation to generation. 
Heritability: proportion of population phenotypic variation attributable to  variation in genetic 
components. 
Heterozygote: having different copies of alleles at a locus. 
Homeostasis: the ability of a system or living organism to adjust its internal environment to 
maintain a stable equilibrium. 
Homozygote: having an identical copy of alleles at a locus. 
Inbreeding: mating of related individuals. 
Khat:  Catha edulis or Khat is a plant with stimulating amphetamine-like characteristics. 
Locus: the specific location of a gene or DNA sequence on a chromosome. 
Metabolism: the complete set of chemical reactions that occur in living cells. 
XVII 
 
Monogenic: a condition in which inheritance of mutation in a single gene is responsible for 
development of a phenotype.  
Mutation: changes in the DNA sequence of a cell's genome which may be caused by internal 
and external factors. 
Nucleotide:  the basic building unit of nucleic acids such as DNA and RNA.  Nucleotides can be 
Adenine (A), Guanine (G), Thymine (T), or Cytosine (C). 
Phenotype: the visible or measurable (i.e. expressed) characteristics of an organism. 
Polygenic: a condition in which many more than one gene contribute to development of a 
phenotype.   
Primers: synthetic sequence of nucleotides serve as the starting point of DNA synthesis during 
the PCR process. 
Recessive: production of a phenotype when its alleles are identical.  
Selection: certain traits or alleles of a species which may be favoured in certain environments.    
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Abbreviations 
ATP: Adenosine Triphosphate. 
BMI: Body Mass Index. 
CI: Confidence Intervals. 
CNF : Canadian Nutrient File. 
DNA: Deoxyribonucleic Acid. 
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T2D: Type 2 Diabetes. 
USDA: National Nutrient Database for Standard Reference. 
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WHO: World Health Organization.
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1Chapter One: Introduction 
1.1 Background 
     Saudi Arabia has a high prevalence of type 2 diabetes. Several epidemiological 
investigations have suggested multiple factors contributing to the high level of the disease such 
as obesity, overweight, and reduced level of physical activity. However, type 2 diabetes is a 
complex disease and not solely dependent on environmental factors. Genetic factors have been 
reported by several studies indicating that inheriting certain type 2 diabetes risk alleles could 
increase the risk of developing the disease.  
     Several genetic variants have been suggested to increase risk of type 2 diabetes with different 
levels of effect. Most of detected variants are presumed to act additively. However, several 
epidemiological investigations were able to find an association between consanguinity and risk 
of developing type 2 diabetes. This might suggest a possible recessive effect increasing the risk 
of developing type 2 diabetes.  
     Saudi Arabia has a high prevalence of consanguinity compared to western societies. Almost 
half of marriages in Saudi Arabia are arranged between related individuals. Higher 
consanguinity levels are likely to increase overall homozygosity of the Saudi Arabian 
population. Increased homozygosity might increase the power to detect recessive effect whether 
on monogenic illnesses or even more complex diseases such as type 2 diabetes.   
1.2 Research Problem 
     Despite the global increase of type 2 diabetes prevalence, there are several epidemiological 
investigations suggesting that certain populations could be at higher risk of developing the 
disease compared to others. This is clearly apparent in societies where individuals from different 
ethnicities, but sharing similar environment, have different levels of risk of developing type 2 
diabetes. This might indicate that certain populations might be genetically more susceptible to 
type 2 diabetes compared to others.  Genetic susceptibility could be driven by several factors 
influencing genetic structure of populations such as inbreeding.  
1.3 Research aims and objectives 
     The current thesis is interested in investigating the mechanism by which consanguinity might 
increase risk of type 2 diabetes. Several Genome Wide Association Studies (GWAS) revealed 
multiple alleles incurring higher risk of the disease. However, these studies were mainly 
conducted in Western and East Asian and populations with low level of consanguinity.  
     This study hypothesized that increased level of consanguinity in the Saudi Arabian 
population has lead to increased overall homozygosity. In recessive effects, inheriting identical 
copies of the risk alleles increases the risk of developing a disease while those with 
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heterozygote genotypes are at lower risk of developing the disease. The study argues that with 
increased overall homozygosity in the Saudi Arabian population, there could be a chance to 
observe a cumulative recessive effect due to inheriting multiple loci identical for type 2 diabetes 
risk alleles.  
The main objectives of this study are: 
- To investigate the association between levels of consanguinity and number of detected 
type 2 diabetes risk alleles.  
- To investigate possible cumulative recessive effect of measured alleles on earlier age at 
diagnosis of the disease.  
- To assess cumulative recessive effect of measured alleles on continuous traits related to 
type 2 diabetes such as BMI, FBG and waist circumference.    
1.4 Significance of this study 
     There is a limited research related to investigating non-additive genetic effect on 
development of type 2 diabetes. Although several studies have suggested synergism between 
consanguinity and type 2 diabetes, this investigation is the first to explore mechanisms linking 
between consanguinity and type 2 diabetes. Unlike other studies assessing this association, we 
utilized extended pedigrees to measure level of consanguinity. Additionally, this study is the 
first to measure SNPs related to type 2 diabetes in Saudi Arabian population. Giving lack of 
genotyping infrastructures in Saudi Arabia, this study provides a comprehensive guide on, 
solutions, logistics and methods of genotyping SNPs in a Saudi Arabian subjects which could be 
utilized for similar investigations.   
1.5 Thesis structure 
     This thesis is composed of seven chapters and appendices. The current chapter provides an 
overview of the study and how main research questions were formulated. The second chapter is 
a literature review which covered several points to illustrates nature of type 2 diabetes, type 2 
diabetes in Saudi Arabia, assessment of genetic risk factors of type 2 diabetes, population 
genetics of type 2 diabetes and genetic structure of Saudi Arabian population. The third chapter 
is related to generation of research hypotheses and main questions while the fourth chapter is a 
detailed illustrate of methods used to answer research questions. The fifth chapter is composed 
of descriptive and analytic sections where the main research questions were answered. The sixth 
chapter comprise a discussion of the study’s main findings, strengths and weaknesses of the 
current research and gained experiences. The final chapter is a summary, recommendations and 
conclusions of this investigation.  
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2 Chapter Two: Background 
2.1 Type 2 diabetes 
2.1.1 Epidemiology of type 2 diabetes 
       Type 2 diabetes is one of the most common chronic conditions. There are about 347 million 
patients in the globe (1)  where  90% of them are type 2 diabetes patients (2). This number is 
projected to increase in 2030 to 438 million patients (3). In 2004, 4.8 million people died due to 
the complications of the disease (2).  
     Formerly known as Non-Insulin Dependent Diabetes Mellitus (NIDDM), the disease is more 
prevalent in certain localities of the world.  According to the International Diabetes Federation 
(IDF), Diabetes has the highest prevalence in Middle East and North African region (Prevalence 
10.9%) followed by  the North American and Caribbean regions (10.2%). Other parts of Africa 
have a much lower prevalence of diabetes (4.3%) (4). This variation in prevalence is largely 
explained by the variation in genetic and environmental backgrounds.   
     Monogenic and immune-mediated forms of diabetes are more likely to occur in younger ages 
(5). Type 2 diabetes is considered a disease of ageing where older populations are at more risk 
of getting the disease. One study conducted in the US reported that the total rates of diabetes 
increased with age, from 2.0% at age 20-44 years to 17.7% at age 65-74 years (6). However, 
although type 2 diabetes is still a disease of ageing, the number of children becoming diagnosed 
with the disease is progressively increasing (5).  
     Type 2 diabetes is equally prevalent in males and females. Nevertheless, men are more likely 
to acquire the disease in middle age than women (7). One study reported that females are more 
likely to experience symptoms related to type 2 diabetes than males. However, the 
complications of type 2 diabetes are very similar in both  males and females, except for 
cataracts, which have been reported as being higher in females  (odds ratio (OR) and 95% 
confidence intervals (CI) 1.47 (1.04, 2.08 ))(8).  
    The risk of developing type 2 diabetes stems from the presence of predisposing genetic 
influences and certain environmental conditions. The genetic risk is clearly apparent from the 
familial pattern of the disease (9, 10) and from concordance rates in twins (11, 12). A parental 
history of diabetes increases the risk of type 2 diabetes in offspring. The odds of having type 2 
diabetes when there is paternal diabetes are 3.5 ( 95% CI: 2.3-5.23)  and 3.4 (95% CI:2.3-4.9) in 
the case of maternal diabetes.  The risk of getting the disease increases when both parents are 
affected by type 2 diabetes. The odds of having the disease when both parents are affected by 
type 2 diabetes increases to 6.1 (95% CI: 2.9-13.0) (13).  
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     Despite the obvious genetic influence on type 2 development, environmental factors are 
similarly significant contributors (12). The presence of genetic influence of the disease might 
actually be augmented or prevented by other environmental factors. The westernized life style 
and decreased physical activity are major environmental contributors to the development of type 
2 diabetes. These environmental changes can mean that obesity is more likely to occur, which 
creates a higher risk of the disease occurring (10).   
        There is an obvious association between obesity and the risk of developing type 2 diabetes. 
A higher BMI  is an important risk factor (14, 15). A longitudinal cohort study reported an 
increase in the risk of type 2 diabetes in men who experience a substantial weight gain (>10%) 
compared to those who had a stable weight (Relative Risk [RR] 1.61 [95% CI 1.01-2.56]) after 
adjustment for age, and initial BMI. It has been suggested that the increased duration of high 
BMI can increase the risk of type 2 diabetes (16). Central obesity in particular may pose a 
higher risk for developing type 2 diabetes (10) (15, 17). Central obesity plays a major rule in 
dyslipidemia and in increasing resistance to insulin (18-20). Insulin resistance can in turn 
eventually lead to the development of type 2 diabetes (5).  
     It has also been suggested that a low birth weight may increase the risk of type 2 diabetes in 
later life. A systematic review was conducted to assess the association between type 2 diabetes 
and birth weight. It was found that birth weight is inversely associated with type 2 diabetes. The 
pooled odds ratio for type 2 diabetes was 0.75 (95% CI, 0.70-0.81) per kilogram, after 
adjustment for age and sex. Adjustment for socioeconomic status did not appear to change the 
association (21).  
      In addition to the previously mentioned risk factors, essential hypertension has been 
suggested as a risk factor for type 2 diabetes. The relative risk of metabolic syndromes 
(including type 2 diabetes) increases to 1.55 (95% CI 1.21; 1.99) in individuals with 
prehypertension when compared with normotensive subjects  (22). This implies that 
hypertension may have an effect on insulin sensitivity and thus increase the risk of the disease 
(23). Ethnicity is another risk factor for type 2 diabetes as non-Caucasians are at higher risk of 
developing the disease (24). Psychological and socioeconomic conditions have also been 
suggested as associated factors (25, 26). 
     Several clinical scenarios can be experienced before the development of type 2 diabetes. An 
elevated blood sugar level caused by the inability of the body to metabolize sugar can form a 
prediabetes stage. This stage includes Impaired Glucose Tolerance (IGT) and Impaired Fasting 
Glucose (IFG). Individuals who exhibit this stage are at higher risk of developing of type 2 
diabetes. A similar example is gestational diabetes, a condition where some women develop 
high levels of blood glucose during pregnancy which is associated with  increase the risk of type 
2 diabetes after pregnancy (27).  
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2.1.2 Pathophysiology of type 2 diabetes 
    The WHO defines type 2 diabetes as being a chronic illness where the body is unable to use 
the insulin it produces effectively (2). Insulin is a hormone produced by the pancreas. The 
pancreas is an endocrine and exocrine organ located in the upper left quadrant of the abdomen. 
The endocrine part of the pancreas is called the Islets of Langerhans and it contains both alpha 
and beta cells. Alpha cells are responsible for the production of glucagon and beta cells are 
responsible for insulin production (28). While insulin secretion is stimulated by high level of 
blood sugar, known as hyperglycemia, glucagon is secreted when there is a low level of blood 
sugar, known as hypoglycemia. 
     Hyperglycemia usually occurs after ingestion of food, especially food rich in carbohydrates 
(28). An enzyme called glucokinase is responsible for sensing the high level of glucose in the 
blood and sending signals to  the pancreas to produce insulin (29). A high level of blood amino 
acids after absorption of protein-rich meal will also stimulate the secretion of insulin. Other 
digestive hormones, particularly glucose-dependent insulinotropic peptides, and 
parasympathetic nervous stimuli after eating food can also contribute to the induction of insulin 
secretion (30). 
     Glucose is used by body cells for energy production. Insulin is combined with membrane 
receptors and increases the permeability of cell membrane to facilitate the movement of glucose 
into the cell. Insulin reduces blood glucose, whether by increasing the utilization of glucose for 
energy production or increasing the storage rate of glucose as glycogen in the liver and skeletal 
muscles. Insulin also induces the utilization of glucose to produce amino acids, essential for 
protein production, and the production of fatty acids, which are later used in adipose tissue to 
form triglycerides (30). In addition to aiding in building protein and triglycerides, it also inhibits 
their degradation.   
     In type 2 diabetes patients, insulin is not being used effectively. Ineffective use can be due to 
resistance against insulin actions in peripheral tissues (5, 31, 32), or because of the deficiency of 
the insulin receptors of cell membranes (28).  Increased insulin resistance and elevated levels of 
blood sugar will ultimately force the pancreas to produce more insulin as a compensatory 
mechanism, which may result in hyperinsulinemia (33). Hyperinsulinemia might be further 
augmented by the inability of the liver to uptake and degrade circulating insulin (5). Type 2 
diabetes patients may suffer from defective responses to blood sugar (5) which can be caused by 
a lack of in glucokinase (29). A reduction in quantitative and qualitative aspects of insulin can 
eventually lead to an increase in the rate of hepatic gluconeogenesis and thus to more 
hyperglycemia (5, 31). 
     Abnormalities in insulin function or secretion can lead to several pathological consequences. 
Cells may not be able to utilize the available blood glucose. A lack of insulin can increase the 
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degradation of triglycerides, and this may result in increased levels of blood fatty acids, which 
are an alternative source of energy. Protein degradation may also increase, leading to the 
wasting of muscles (30).   
 2.1.3 Clinical presentation 
     There are several clinical presentations of type 2 diabetes. In certain cases, it can be 
asymptomatic and patients are only diagnosed by routine blood glucose measurements. Younger 
cases are more likely to experience a faster development of diabetes and faster appearance of its 
symptoms, perhaps over days or a   few weeks.  In older cases, type 2 diabetes can be subtle and 
might take months before it can be clinically presented (34).  
    When a normal level of blood glucose exists, the kidneys prevent the passage of glucose into 
the urine. In patients with diabetes, the elevated level of blood glucose will render the kidneys 
unable to maintain the urine in a glucose-free condition. The excretion of glucose through urine 
will increase the volume of urine and the frequency of voiding, creating a condition known as 
polyuria. Due to the high output of body fluids which pass through the urinary system, the body 
will eventually suffer dehydration, and increased sensations of thirst and dryness in the mouth, 
clinically known as polydipsia (35). To compensate for the loss of fluids, patients with diabetes 
drink higher amounts of water. Due to frequent fluid loss and dehydration, some patients may 
experience constipation (34).  
      Hyperglycemia and increased urinary output will cause further disturbances. The increased 
level of sugar in the urine will facilitate the occurrence of Candidiasis, leading to pruritus vulvae 
and balanitis (35). A high loss of body fluids may cause disturbances in the chemical 
environment of the body. This alteration of the chemical balance might lead to nervous 
disturbance, especially in the peripheral nerves, leading to tingling sensations in the hands and 
feet. A chemical imbalance may lead to weakening of the immune system, giving rise to a 
higher incidence of infections (34). 
     Since the body is unable to utilize blood glucose, storage of lipid may be utilized as an 
alternative energy source. This may lead to marked weight loss, even if the person has a good 
appetite. High levels of glucose will also have an effect on vision ability. Elevated levels of 
blood glucose may cause a disturbance to the focusing ability of the lens, rendering the vision 
hazy or blurred (34).  
         Some cases with diabetes might present by other symptoms caused by the long-term 
complications of diabetes. Chronic hyperglycemia eventually causes vascular changes where 
capillaries get thicker. The process of oxygen and nutrient exchange will be affected by changes 
in vascular nature, leading to less or diminished supplies reaching other parts of the body (28). 
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Furthermore, hyperglycemia increases the chance of atherosclerotic changes, leading to a 
decreased blood supply to several organs.  
    A delay in the diagnosis of type 2 diabetes may lead to macrovascular and microvascular 
complications being present at the time of diagnosis. Some cases can be complicated by 
coronary heart disease (36), cerebrovascular accidents, or peripheral vascular disease (5). Some 
studies suggest that increased levels of glycated haemoglobin HbA(1c) and fasting blood 
glucose are associated with increased risks of developing coronary heart disease (5, 37). In 
addition, vascular changes can also affect the kidneys, leading to diabetic nephropathy and renal 
failure (5).  
    A common complication of diabetes is retinopathy. Retinal blood vessels can become 
occluded due to the occurrence of vascular changes, leading to weakness of vision or blindness. 
After 20 years of diabetes, 60% of patients with diabetes are more likely to develop varying 
degrees of retinopathy (38). The risk of diabetic retinopathy is associated with longer duration 
of diabetes (38) and elevated levels of glycated haemoglobin (39, 40). 
      Macrovascular and microvascular complications are considered the leading cause of 
morbidity and mortality in patients with diabetes (38). This may have a significant impact on 
life expectancy, leading to an approximate reduction of 10 years (5). Nevertheless, patients with 
diabetes have different tendencies towards developing these complications. Some patients with 
diabetes do not develop any complications at all. This variation in the incidence of 
complications suggests that an elevated blood sugar level is not sufficient to cause these 
complications and in fact other factors have to be maintained to cause the illness (38). 
2.1.4 Diagnosis of type 2 diabetes 
      To confirm the diagnosis of type 2 diabetes, blood glucose level need to be investigated. 
WHO has established diagnostic criteria for diabetes. FPG  ≥ 7mmol/l (126mg/dl) or 2-hours 
blood glucose ≥ 11.1mmol/l (200mg/dl) are considered diagnostic criteria (41). An FPG test 
should be preceded by no caloric intake occurring for 8 hours before performing the test and 
should be repeated to further confirm the diagnosis (5).   
    Glycated haemoglobin (HbA1c) is used to measure the effectiveness of diabetes therapy. 
Recently, it has being recommended as a diagnostic test for diabetes. A HbA1c of 6.5% is 
recommended as a cut-off point for diagnosing diabetes. Despite this, a level below 6.5% does 
not rule out diabetes and blood glucose can be investigated through alternative tests (42). 
Although HbA1c is recommended for diagnosing type 2 diabetes, it might not be as feasible in 
certain parts of the world as other laboratory measures of glucose (43). 
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2.1.5 Management of type 2 diabetes 
     Management of type 2 diabetes is a comprehensive process whereby undertaking one 
measure is unlikely to provide meticulous control of the disease. This process is not solely 
dependent on pharmacological agents. Lifestyle changes can be a significant step in providing a 
better prognosis for the disease. Regular exercise can be a key intervention which can reduce 
body weight and central obesity and consequently reduce insulin resistance (44). Having low-
glycemic index food is essential for better glycemic control (45). Health education is a vital tool 
in drawing the attention of patients with diabetes toward the importance of these lifestyle 
changes.   
      Depending on the progress of diabetes, pharmacological agents vary between oral glycemic 
control agents or those for the administration of insulin. Oral glycemic control drugs act in 
various different ways. There are insulin sensitizers which aim to increase the action of insulin, 
whether it appears in the liver as biguanides or peripherally as thiazolidinediones. Other drugs 
as such as sulfonylureas, repaglidine and nateglinide increase the secretion of insulin. Alpha-
glucosidase inhibitors reduce the absorption of carbohydrate in the intestine and thus reduce the 
blood glucose level (5). Other pharmacological agents such as Orlistat and Sibutramine (35) 
may assist in weight reduction.  The failure of previously mentioned management strategies will 
indicate the use of insulin.  
     In addition to conventional lifestyle changes and pharmacological agents, other surgical 
options have been introduced to control type 2 diabetes. Bariatric surgeries have different 
procedures depending on surgical intervention applied to the stomach. These procedures have 
different forms such as applying adjustable gastric bands, gastric bypass which involves the 
diversion of food flow from the stomach or sleeve gastrectomy which involves removal of parts 
of the stomach. All these procedure have a shared effect on reducing the level of BMI, blood 
glucose and induce the remission of type 2 diabetes in varying magnitudes(46).  
    One study compared the level of BMI, fasting blood glucose and haemoglobin A1c between 
two groups composed of morbidly obese type 2 diabetes patients. The first group included 
patients who underwent sleeve gastrectomy and the second group had a conventional medical 
therapy. There was a significant drop over an 18 month period from the beginning of applying 
interventions in both groups. In the first group means of BMI, fasting blood glucose and 
haemoglobin A1c dropped from 41.3 (SD: 6.0), 166.6 (SD: 68.1) mg/dL, and 7.9% (SD: 2.1%), 
respectively at baseline to 28.3 (SD: 5.4), 96.2 (SD: 29.4) mg/dL, and 6.0% (SD: 1.5%), 
respectively after 18 months. The second group did not exhibit any significant changes 
comparing between levels at baseline and after 18 months (47). Additionally, similar studies 
provided similar supporting evidence providing a stronger control of diabetes compared to 
medical therapy (48, 49). 
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    Despite the significant effect of Bariatric surgery on enhancing diabetes control, it has several 
drawbacks. Introducing patients to surgical procedures might expose those patients to operative 
complications such as risk of infections. Additionally, risk of malnutrition might occur where 
certain nutrients will no longer be absorbed from the stomach which might mandate taking 
additional supplements (50). 
2.1.6 Prevention of type 2 diabetes 
      Identifying individuals who are at higher risk of diabetes is an important element of the 
primary prevention of type 2 diabetes. Despite the genetic determinants, risk of  type 2 diabetes 
can be reduced by undertaking a healthy lifestyle and balanced diet. A longitudinal cohort study 
investigated the effect of dietary pattern on increasing the risk of type 2 diabetes among Finnish 
subjects during a 23-year follow-up period. The study found that subjects who were engaged in 
the consumption of high calorific food items (such as potatoes and butter) were at higher risk of 
developing the disease compared with the group who reported higher consumption of fruits and 
vegetables [1.49 (95% CI: 1.11 - 2.00] (51).  
      One systematic review studied published randomised controlled trials which investigated the 
effect on the population of increased exercise and a healthier diet with regard to increased the 
risk of developing type 2 diabetes . This revealed that combined physical activity and balanced 
diet had a favourable effect on reducing the risk of type 2 diabetes  (RR: 0.63, 95% CI: 0.49 to 
0.79) (52). Another study implied that exercise might have a role in increasing insulin action 
(53).  
      The multi-factorial nature of type 2 diabetes indicates the importance of recognizing 
lifestyle risk factors in prevention of the disease in addition to the genetic risk. The ratios of 
developing the disease vary between 3.4 and 6.1 based on family history of type 2 diabetes (13). 
Additionally, reported odds ratios of SNPs incurring higher risk of type 2 diabetes varied 
between 1.07 and 1.7. However, despite the obvious genetic risk, we cannot neglect the effect of 
lifestyle on causation of type 2 diabetes. This influence is apparent by observing increased risk 
of type 2 diabetes due to dieting patterns rich with calorific value [RR 1.49] (51) or reduced risk 
due to healthier lifestyle and exercise [RR: 0.63] (52). 
Several factors increased the difficultly of comparing the magnitude of risk of genetic factors 
with lifestyle factors. Firstly, genetic risk of type 2 diabetes is usually measured using 
retrospective methods where lifestyle factors could be measured prospectively. Therefore, 
different estimates of risk such as relative risk and odds ratios were reported. Usually, odds 
ratios are calculated for genetic risk factors where relative risks were calculated for lifestyle 
factors. Finally, in comparison with investigating the genetic effects, being able to control 
lifestyle factors made it possible to apply interventional methods to investigate how a change in 
lifestyle might increase or decrease risk of the disease   
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     To conduct a comparison between lifestyle factors and genetic risk, population attributed risk 
was utilized. Several studies have reported population attributed risk of SNPs with strong effect 
on type 2 diabetes. Risk alleles of variants near TCF7L2, CDKN2A/B, KCNJ11and PPARG 
were reported to have a population attributed risk varying between 2% and 16% (54-58). Given 
the modest effects of these SNPs, population attributed risks were consequently small. However, 
a study indicated that combined population attributed risk of variants near KCNJ11and PPARG 
reached 28% (58).  
     The modest effects of detected SNPs indicate that detected genes are not strong enough to 
cause development of type 2 diabetes. A study which investigated population attributed risk of 
lifestyle factors revealed that low physical activity and consumption of processed red meat have 
a population attributable risk of 13% and 27% in men and 29% and 23% among women (59).  
Additionally, population attributable risk of high BMI is 49% among men and 50% among 
women (59). Given the reported population attributed risks of lifestyle factors compared to 
detected SNPs, it could be argued that combined lifestyle factors including level of physical 
activity and dieting behavior are likely to have a stronger influence on the disease compared to 
the detected genetic associations. However, it is possible that the combined effect of multiple 
SNPs is likely to have a higher population attributed risk that could be similar to the effect of 
combined lifestyle factors.  
     It is difficult to state which is more important in increasing the risk of type 2 diabetes: 
lifestyle or genetic risk factors. However, we might suggest that environmental factors could be 
augmenting the causation of the disease if the genetic risk is present. This notion might partially 
explain why individuals with non-healthy lifestyles do not develop diabetes or at least have a 
delayed development of the disease.  Furthermore, if the genetic risk of type 2 diabetes is 
present in an individual, the risk of the disease could be reduced or the onset of the disease 
could be delayed by engaging in a healthier lifestyle.  In addition, recognizing the effect of 
ageing on increasing the risk of the disease indicates the importance of applying preventive 
measures in ageing populations. In conclusion, behavioural and genetic risk factors of the 
disease are significant components of the disease and should be considered in any prevention 
programmes. 
     Secondary prevention of type 2 diabetes aims to screen individuals at risk from the disease. 
Undiagnosed patients are at a higher risk of developing the chronic complications of type 2 
diabetes. Therefore, it is of great importance to establish cost-effective screening programmes 
for the disease and particularly for those with IGT who have an increased risk and who can 
potentially reduce the risks though lifestyle changes or drug treatment. Managing elevated blood 
sugar levels as early as possible can result in reductions of developing microvascular and 
macrovascular illnesses (60). 
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2.2 Type 2 diabetes in Saudi Arabia 
2.2.1 Introduction 
      Type 2 diabetes is unquestionably a public health concern in Saudi Arabia. The prevalence 
of diabetes in Saudi Arabia is one of the highest in the globe (61). In 2000, the WHO reported 
that 890,000 individuals in Saudi Arabia were affected with diabetes and by 2030, this number 
is projected to  increase to 2,523,000 (62). This profound increase in diabetic cases is likely to 
be related to several environmental and genetic factors. These factors appear to make the Saudi 
population more susceptible to the disease than other populations.   
2.2.2 Prevalence of type 2 diabetes in Saudi Arabia 
     Several epidemiological studies have been conducted in Saudi Arabia to estimate the 
prevalence of diabetes in Saudi Arabia (63-69). An early review has explored this subject. It 
indicated an increase in the prevalence of diabetes from  2.5%  in 1982 to 23.7% in 2004 (70). 
A more recent study, which was published in 2011, reported that the prevalence of diabetes in 
Saudi Arabia was 34.1% in males and 27.6% in females. It also reported that the mean age for 
the onset of diabetes in males and females was 57.5 (SD 13.1) and 53.4 (SD 13.1) years, 
respectively (69). 
     According to the International Diabetes Federation, Saudi Arabia is among the top 10 
countries for the prevalence of Type 2 diabetes across the globe. The prevalence of diabetes in 
Saudi Arabia is almost four-fold the prevalence in the UK and twice the prevalence in the USA. 
The prevalence of diabetes in Saudi Arabia came second to the prevalence in Kuwait which has 
the highest prevalence of diabetes in the Middle East (1).  
     The prevalence of diabetes has been reported to have taken a different form in the Saudi 
population. Diabetes normally tends to be equally distributed between males and females. 
However, two studies conducted in the Saudi populations showed a gap between the prevalence 
of diabetes between men and women (68, 69). Seemingly, the prevalence of diabetes is higher in 
male subjects, but this suggestion remains inconclusive, as other studies suggest opposite results 
(64, 67).  Furthermore, one study reported a higher prevalence of diabetes among the urban 
population (67). This might be explained by the differences in lifestyle and physical activity 
between the rural and urban populations.  
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2.2.3 Attitudes, knowledge and behaviour toward type 2 diabetes in Saudi Arabia 
     In addition to the increased prevalence of diabetes in Saudi Arabia, the situation is worsened 
by limited levels of knowledge about the disease and the preventive measures mentioned above. 
A study conducted in the eastern province of Saudi Arabia reported that less than a half of the 
primary care centres attendees  knew about the risk of diabetes and how to prevent it (71). 
Another study conducted among intermediate and secondary school students suggested that 
most pupils do recognise the role of obesity in development of illnesses, in general but not as a 
risk factor for development of diabetes (72).  
         In addition to low public awareness about type 2 diabetes risk factors, health care 
providers in Saudi Arabia do not seem to be properly advocating the measures necessary for 
prevention of the disease. One study was conducted to measure the effort applied by primary 
care physicians in Riyadh City to educate their patients in the importance of physical activity. 
Only 24% of physicians were satisfactorily engaged in such educational activity and only 45% 
of the physicians were properly exercising themselves (73). These reports suggest a lack of 
proper public educational effort to raise awareness of diabetes.  
2.2.4 Overweight and obesity in Saudi Arabia 
      Increased prevalence of overweight and obesity in the Saudi population gives an important 
explanation for the increase in type 2 diabetes. Table 2.1 shows several epidemiological studies 
estimating the prevalence of overweight and obesity in the Saudi population. Classification of 
weight is based on BMI, which is calculated by dividing weight in kilograms by the square of 
height in metres. Individuals with BMI below 18.5 are considered underweight, individuals with 
BMI between 18.5 and 25 are considered normal. Those with BMI above 25 are considered 
overweight and those above 30 are presumed obese (74). 
        The prevalence of overweight individuals ranges between 13.8% and 30.7%, while for 
obesity it ranges between 14.2% and 26.4%. Another two studies included diabetes and 
hypertension patients and revealed a noticeably higher prevalence of overweight and obesity 
among them than in the normal population (75, 76).   
     Overweight and obesity in the Saudi population seem to be influenced by several factors. 
Studies conducted of younger people suggest a smaller prevalence of obesity and overweight 
compared to older subjects. Furthermore, studies conducted in diabetes  and hypertension 
patients yielded higher percentages with elevated BMIs. The influence of gender on the 
prevalence of overweight and obesity varies across different studies.  
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Table 2.1: Prevalence of overweight and obesity in the Saudi population:  
(Reference) 
publication 
year 
Sample 
Size 
Age Overweight obese Study population 
Males Females Males Females 
(77) 2003 894 12-20 13.8% - 20.5% - Males only 
(78) 2007 19598 0-75 30.7% 28.4% 23.6% 14.2% Mixed 
(79) 2008 1072 8-12 - - - 14.9% Females only 
(80) 2010 7056 2-18 18% 20% 26.4% 19% Mixed 
(81) 2010 239 13-18 21.35% 23.41% - - Mixed 
(82) 2011 1869 11-19 11.5% 15.5% 11.8% 13.9% Mixed 
 
       Several studies reported different reasons behind the increased prevalence of overweight 
and obesity. One study reported a high intake of carbohydrates and fat among adolescents in 
Jeddah city in Saudi Arabia (81). Another study reported family history as a risk factor for high 
BMI in Saudi adolescents (77). Moreover, physical inactivity is another contributor to the 
increased prevalence of overweight and obesity in Saudi individuals (77, 83-86). Saudi men are 
more likely to engage in physical activities than women (72).  
     Amin et al compared patterns of leisure physical activity between males and females where 
six out of 12 types of sports and leisure activities were not even practised by females(87). 
Another study including adult subjects confirmed this association indicating that females were 
more likely to exhibit a sedentary lifestyle compared to males (p value <0.001) (88).  
Additionally, a similar trend was observed in Saudi adolescent subjects (89). This could be a 
result of the cultural background in Saudi Arabia, which limits the physical activity of females. 
Furthermore, a lack of resources can be another barrier leading to both men and women 
engaging in less physical activities (83, 90).  
       A cross-cultural study compared levels of physical activity in male and female adolescents 
aged between 15 and 17 years. Three groups were selected from Birmingham and Coventry in 
the UK and a third one from the Al-Ahsa region in Saudi Arabia. This study showed that the 
proportion of adolescents with low levels of physical activity in Saudi Arabia is higher than 
those reported in the UK. Additionally, the proportion of individuals engaged in physical 
activities in the UK was higher compared to Saudi adolescents (91). This study signifies the 
effect of cultural attitude toward reduced physical activity observed in Saudi Arabia.   
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     In addition to the environmental factors causing overweight and obesity, there might be other 
non-environmental factors that render the Saudi population more susceptible to increased BMI. 
One study reported a higher speed of intestinal glucose absorption in Saudi subjects in 
comparison with other African individuals (92). Faster absorption of glucose will eventually 
lead to higher levels of blood sugar and it  is more likely that some of this glucose will be stored 
as fat and that this will increase the risk of obesity and consequently of type 2 diabetes.   
  2.2.5 Complications of type 2 diabetes in Saudi Arabia 
      An increase in diabetes will eventually lead to an increased incidence of the complications 
related to diabetes. One of the commonest complications is diabetic retinopathy. Its prevalence 
among type 2 diabetes patients reached 25.3% (93). Diabetic retinopathy was reported to be 
higher in patients with diabetes residing in urban areas. Its risks were also reported to be higher 
with a longer duration of diabetes and poor control of the disease (94).  
       In addition to diabetic retinopathy, other complications have been reported as affecting 
patients with diabetes in the Saudi population. According to the Saudi Stroke Data Bank, 
diabetes is the second commonest risk factor for cerebrovascular accidents in Saudi Arabia (95). 
Another study conducted in the Eastern province in Saudi Arabia reported that 37% of stroke 
cases in the province were affected by diabetes (96). Diabetic nephropathy has been reported to 
be the most common cause of end stage renal failure in the Al-Madinah province in Saudi 
Arabia (97). The list of illnesses associated with diabetes in Saudis also includes coronary heart 
disease (98), peripheral arterial disease (99), neuropathy (100) and erectile dysfunction (101).  
      Complications of diabetes are more likely to increase when there is poor management and 
control of the disease. The majority of patients with diabetes in Saudi Arabia do not achieve 
good glycemic control. Only 27% to 33.8% of patients with diabetes manage to reach a normal 
glycemic level (102, 103). A study reported that higher age, smoking, and lack of physical 
activities were significantly associated with poor control of diabetes (102). 
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2.2.6 Conclusion 
 Type 2 diabetes is a major health concern in Saudi Arabia.  
 Its prevalence is progressively increasing. This increase has been augmented by a 
lack of appropriate public knowledge about the risk of the disease and how to 
prevent it.  
 The increase in prevalence of overweight and obesity is an important explanation of  
the prevalence of elevated type 2 diabetes.  
 Increase of type 2 diabetes is associated with the increased prevalence of several 
complications such as diabetic retinopathy, cerebrovascular accidents and diabetic 
nephropathy.  
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2.3 Genetics of type 2 diabetes 
2.3.1 Introduction 
    The genetic impact on illnesses and phenotypes has a wide range of variations. On certain 
occasions, a change of a single nucleotide can result in a disease such as sickle cell anaemia. 
Alternatively, genetic determinants may not be enough to cause the disease and environmental 
components are deemed essential. Type 2 diabetes is an example of a disease where the genetic 
determinants are not solely responsible for the development of the disease and the augmenting 
environmental causes are important.  
2.3.2 Familial risk 
     A simple way of attributing the genetic impact to a trait or an illness is to observe its 
recurrence in families. Higher recurrence of a disease or a trait within family members could be 
evidence of a common genetic effect. The presence of this effect renders family members more 
vulnerable to a particular phenotype than other members of the population. Furthermore, 
observing the pattern of the trait among family members and the fashion of its transmission 
might illustrate the mode of inheritance (104).  
      Type 2 diabetes is a disease which tends to appear within members of the same family. 
Having a member of the family with type 2 diabetes increases the risk of developing the disease 
(105). The risk of type 2 diabetes is higher among first degree relatives (106). Although this 
kind of aggregation signifies an inherited risk of the disease, we cannot neglect the importance 
of shared environment in causing the disease.  
     Another way of recognizing the genetic impact of a phenotype is by observing the 
concordance of traits in twins.  Monozygotic twins have identical DNA and any difference in 
their phenotype is assumed to be caused by a difference in their environments. Dizygotic twins 
only share half of their genes, so any difference between their phenotypes is due to genetic and 
environmental differences.  In the case of type 2 diabetes, concordance rates have been reported 
to be higher in monozygotic twins than dizygotic twins (107-109). Concordance rates have also 
been reported to increase with ageing among monozygotic twins, which signifies the importance 
of ageing in causing type 2 diabetes (108).  
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2.3.3 Heritability estimates of type 2 diabetes 
2.3.3.1 Estimation of heritability 
      Differences in genetic and environmental factors can help in creating a wide range of 
phenotype variations. On a population level, the proportion of trait variance accounted for by 
genetic variance is called heritability. Family and twin studies have been utilised to estimate the 
heritability of different phenotypes and illnesses. Higher heritability estimates indicate a higher 
influence of genotypic variations in causing the variation of a particular phenotype. Lower 
heritability estimates are more likely to signify the role of environmental variations in causing 
trait variations.  
     Heritability has been further divided to broad and narrow sense heritability. Broad sense 
heritability measures phenotype variations that are attributed to genotype variation. Genotype 
variation has been further divided to variation caused by additive variation, dominance variation 
or interactive variation. The proportion of phenotype variation that is attributed by additive 
variation of genotypes is defined as narrow sense heritability.       
      Trait resemblance between parents and their offspring indicates the narrow sense heritability 
that is contributed by passing alleles from parents to their offspring. The assumption remains 
valid if we assume a similar environment shared between parents and their offspring. The 
regression coefficient of association between mid-parent value of a particular trait and their 
offspring represents the narrow sense heritability of the trait. However, estimating heritability 
from full siblings is complicated by the probability of inheriting identical genotypes rather than 
just identical alleles. The later notion suggests an additional effect of dominance variation on 
the overall phenotype variation (110).  
    Monozygotic twins mostly share identical alleles and identical genotypes. High trait 
correlation in monozygotic twins might indicate strong genetic influence. However, correlations 
in monozygotic twins might be also influenced by the shared environment. To solve this issue, 
correlation in monozygotic twins is compared to correlation in dizygotic twins who share half of 
their alleles and one quarter of their genotypes in addition to the assumption of sharing a similar 
environment.  
 
     Heritability in twin study is estimated by doubling the difference of correlation between 
monozygotic twins and dizygotic twins (110). For continuous traits, correlations are calculated 
to estimate heritability. However, for binary traits, such as having a disease or not, twin 
concordance rate is usually utilised to estimate heritability. 
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     Several heritability estimates have been provided for type 2 diabetes. The heritability of type 
2 diabetes ranges between 26% and 73% (12, 111-113). The lower heritability estimates suggest 
the  importance  of environmental components. Even when there is genetic propensity to 
develop type 2 diabetes, environmental factors have to be present for the disease to develop.  
2.3.3.2 Heritability of type 2 diabetes risk factors 
       The risk of developing type 2 diabetes is linked to several continuous traits.  These traits 
include BMI, waist circumference, and blood glucose. Genetic components have been reported 
to affect the variation of these traits. Consequently, genetic components affecting the variation 
of these traits are likely to contribute to the variation of incidence pattern of type 2 diabetes in 
the population. 
        Heritability of BMI has been investigated by various family and twin studies which have 
been carried out in different populations. A review by Maes et al reported a 20% to 90% 
heritability of BMI. They also state that the levels of heritability reported in twin studies are 
usually higher than those in family studies. That might be due to the higher levels of 
environmental variation seen among families rather than among twins (114). Another 
systematic review studied the heritability of BMI among children by reviewing twin and 
adoption studies. Although it reported similar levels of heritability of BMI, it emphasized the 
importance of common environmental factors during mid-childhood (115).   
     A variety of factors seem to have an influence on the heritability of the BMI. Ageing has 
been reported to increase the heritability of BMI (115-117). Another study reported a relatively 
higher heritability of BMI among twins with parental type 2 diabetes (118). It has also been 
suggested that the heritability of BMI has been modified by environmental factors. Physical 
activity has been reported to decrease the heritability of BMI, indicating an interaction between 
genetic and environmental factors (119-121). Furthermore, it has been proposed that BMI may 
be genetically correlated with dieting behaviour (122). 
     Most family and twin studies have been concerned with estimating heritability of BMI have 
been conducted in white European populations. Lack or rarity of family and twin studies related 
to other populations has limited our ability to study the variations in BMI heritability between 
populations. However, the small number of family and twin studies conducted on the Asian 
population have revealed similar BMI heritability estimates to those reported in Caucasians 
(123-127). One study reported a similar heritability estimate of BMI among African individuals 
living in Jamaica, USA, and Nigeria (128). It seems that having a similar genetic background 
might have a stronger influence on BMI heritability, despite the fact that the individuals 
concerned are living in different environments.   
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       The genetic components of waist circumference variation seem to be similar to those of 
BMI. Table 2.2 shows heritability estimates for waist circumference. In a similar way to what 
has been seen in heritability of BMI, twin studies reported higher heritability of waist 
circumference than family studies. Twin studies reported a 56% to 80% heritability of waist 
circumference while family studies reported a heritability of between 28% and 59%.   
    Variations in age, gender and ethnicity do not show an obvious effect on waist circumference 
heritability. However, a study conducted on subjects from the South of India has revealed the 
lowest estimate of waist circumference heritability. Furthermore, two family studies conducted 
in the USA on a mixture of black and white individuals revealed two different estimates (129, 
130).   
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  Table 2.2: Heritability of Waist Circumference reported in twin and family studies.    
Reference Year Type Age Sample 
Size 
Population Heritability Comments 
(131) 2000 Family  35-65 953 Amish (USA) 55% Included 
diabetics 
(129) 2005 Family 38-86 554 White (90%), 
Black(10%) 
(USA) 
55% Included 
diabetics 
(130) 2007 Family 15-53 818 White and 
Black  (USA) 
44% Healthy 
subjects 
(132) 2008 Family 33-62 2506 White 
(Netherland) 
40%  
(133) 2009 Family 19-57 524 Indian (South 
India) 
28% Included 
diabetics 
(111) 2009 Family 34-70 400 Black 
(Mauritius) 
59% Included 
diabetics 
(127) 2010 Family 15-66 425 Asians(China) 51% Healthy 
subjects 
(134) 2009 Family 24-74 293 White (Italy) 38% Included 
diabetics 
(135) 2005 Twin 50-74 302 White (Finland) 68% Healthy 
Subjects 
(136) 2008 Twin 18-34 768 White 
(Belgium) 
80% (Men) 
78%(Women) 
Healthy 
subjects 
(137) 2009 Twin 7-11 186 White (UK) 74% Healthy 
subjects 
(138) 2009 Twin 30-53 1942 Asians (Korea) 59% Healthy 
subjects 
(119) 2009 Twin 22-27 4343 White (Finland) 56% (Men) 
71%(Women) 
Healthy 
subjects 
(124) 2010 Twin 13-20 1613 Asians (China) 77%(Men) 
78%(Women) 
Healthy 
subjects 
        
    Environmental influences on FBG might be stronger than genetic ones. Table 2.3 shows the 
FBG heritability reported in family and twin studies. This ranges from between 10% and 75% in 
both twin and family studies. Unlike other traits related to type 2 diabetes, the heritability of 
FBG appears relatively similar in both study types. There is no clear evidence of any difference 
in heritability of FBG between ethnicities, genders, and health conditions.  
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 Table 2.3: Heritability of FBG reported in twin and family studies.    
Reference Year Type Age Sample 
Size 
Population Heritability Comments 
(139) 1990 Family 0-70 2113 Black and 
White (North 
America) 
33% Healthy 
subjects 
(131) 2000 Family 35-65 953 Amish (USA) 10% Included 
diabetics 
(140) 2003 Family 29-57 1379 Black and 
Hispanic (USA) 
28% Healthy 
subjects 
(141) 2004 Family 41-55 811 White (UK) 72% Healthy 
subjects 
(142) 2006 Family 48-56 852 White 
(Netherland) 
42% Healthy 
subjects 
(130) 2007 Family 15-53 818 White and 
Black  (USA) 
34% Healthy 
subjects 
(133) 2009 Family 19-57 524 Indian (South 
India) 
24% Included 
diabetics 
(111) 2009 Family 34-70 400 Black 
(Mauritius) 
47% Included 
diabetics 
(143) 2010 Family 12-64 425 White (France) 20% Healthy 
subjects 
(127) 2010 Family 15-66 425 Asians(China) 47% Healthy 
subjects 
(144) 1999 Twin 37-51 418 White 
(Netherland) 
50%(Women) Healthy 
subjects 
(145) 1999 Twin 39-65 302 White (USA) 75% Healthy 
subjects 
(146) 2003 Twin 18-67 607 White 
(Denmark) 
38% (Men) 
12%(Women) 
Healthy 
subjects 
(135) 2005 Twin 50-74 302 White (Finland) 45% Healthy 
subjects 
(147) 2008 Twin 20-45 185 White 
(Netherland) 
66% Healthy 
subjects 
(136) 2008 Twin 18-34 768 White 
(Belgium) 
59% (Men) 
70%(Women) 
Healthy 
subjects 
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2.3.4 Inheritance and Detecting Genetic Variants 
     Segregation analysis helps in identifying the mode of inheritance of traits or illnesses. 
Without requiring measured genotypes, observing the recurrence and aggregation of a particular 
trait among family members might indicate how the genes are being transmitted (104). If the 
assumption is that a single major gene affects a certain trait, its inheritance could be recessive or 
dominant, with different degrees of penetration.   
    Segregation analysis studies concerned with type 2 diabetes have revealed contradicting 
results. One study conducted on Pima Indians revealed a major gene effect with different 
degrees of expression based on environmental circumstances (148). Another two studies have 
suggested the possibility of dominant inheritance of type 2 diabetes (149, 150). However, the 
polygenic mode of inheritance has been suggested as the best fit for type 2 diabetes inheritance 
(149-152). 
   Several approaches have been utilized to identify genes related to type 2 diabetes. A candidate 
gene approach is based on previous understanding of the metabolic pathway associated with a 
protein of interest. An effort is then made to locate the specific gene responsible for the coding 
of the protein (153, 154).  Other approaches do not require prior knowledge of metabolic 
pathways. The linkage analysis approach utilizes measured phenotypes and investigates the 
transmission of specific DNA segments between family members. On a population level, 
association studies are used to identify loci related to a phenotype by comparing cases with 
unrelated controls (104).  
          So far, about 42 loci have been shown to be significantly associated with type 2 diabetes 
(155). Another more recent review revealed that this number has increased to about 60 loci 
detected in European and Asian populations (156).  The large number of genetic variants proves 
the multiple genes influence on type 2 diabetes. However, these loci only explain about 10% of 
type 2 diabetes heritability (157).   
2.3.5 Candidate Gene approach 
   Candidate genes studies have been successful in detecting loci associated with type 2 diabetes. 
Several candidate genes were selected based on prior knowledge about their roles in glucose 
metabolism, insulin action, and other relevant pathways, such as  metabolic rates and energy 
expenditure (158). More than 200 candidate genes have been investigated (158, 159). However, 
most of these studies have provided weak associations which lacked reproducibility (160). 
Nevertheless, few candidate genes were significantly associated with type 2 diabetes or were 
replicated in other associated studies.  
     Table 2.4 shows loci associated with the risk of type 2 diabetes found by candidate gene 
studies, which were confirmed by large-scale genome-wide association studies. These loci are 
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KCNJ11 (158, 159, 161, 162), PPARG (159), and WFS1 (163). KCNJ11 gene codes can be 
used for a K+ inwardly-rectifying channel which is associated with insulin secretion in beta 
cells (160). The PPARG (Peroxisome proliferator-activated receptor Gama) gene encodes a 
nuclear receptor which is a target for thiazolidinedione compounds used for sensitizing insulin 
(160). A WFS1 (Wolfram syndrome 1) gene may cause Wolfram Syndrome. Diabetes mellitus 
is one of the manifestations of this syndrome (164).  
Table 2.4: Genetic variants associated with type 2 diabetes reported by candidate genes 
studies and replicated by genome wide association studies.  
Locus Chr Marker Allele 
(Effect/Other) 
Effect: OR (95% CI) 
KCNJ11 11 rs5219 T/C 1.15 (1.09–1.21)(165) 
PPARG 3 rs1801282 C/G 1.15 (1.10-1.21)(166) 
WFS1 4 rs1801214 T/C 1.13 (1.07-1.18)(167) 
 
2.3.6 Linkage Analysis approach 
       Linkage analysis has been successful in identifying rare genetic loci with a strong effect on 
illnesses. However, its role in identifying multiple genetic loci which have a modest effect on 
phenotypes has been limited. Therefore, its role in identifying genetic variants for complex 
illnesses has been less fruitful (157). Nevertheless, one locus was found by linkage analysis to 
be associated with an increased risk of type 2 diabetes.  
    A TCF7L2 (transcription factor 7-like 2) has been reported by a linkage analysis study to be 
associated with increasing the risk of type 2 diabetes. The study was conducted on Mexican 
American families and the locus was suggested to be on chromosome 10 (168). The locus was 
also suggested to be on chromosome 10 by another linkage analysis conducted on the Icelandic 
population (169). TCF7L2 was later to be replicated by association studies in European, Asian, 
and African ethnicities (170) and was found to have the strongest effect on the type 2 diabetes 
risk (160). A meta-analysis reported higher odds of type 2 diabetes when inheriting the risk 
allele of TCFL2 [OR 1.46 (95% CI: 1.42-1.51)] (170).     
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2.3.7 Genome-wide Association 
     Genome-wide association studies (GWAS) are able to scan the whole genome and recruit 
larger numbers of individuals. Having a larger number of scanned SNPs and the ability to 
compare unrelated cases with controls has increased the power to detect variants with modest 
effect on phenotypes. Several novel loci and several previously discovered ones have been 
reported by different GWAS and replication studies to be associated with type 2 diabetes.  
    Table 2.5 illustrates loci reported by genome-wide association studies and replicated by other 
association studies. Although there are other novel loci not reported in this table, these loci in 
particular were replicated among several European and Asian populations. One study including 
Chinese subjects reported higher odds of the disease when inheriting loci near HHEX and 
CDKAL1 (171). However, there was no significant reported difference in the odds ratio among 
these populations. They are almost similar across populations and their confidence intervals are 
overlapping. This might indicate the similar role of these loci in terms of influencing the risk of 
type 2 diabetes across these populations.  
     Apart from the marker reported in SLC30A8 gene, all other markers listed in table 2.5 are 
located in non-coding areas. SLC30A8 codes for Zinc transporters in beta cells (172). CDKAL1 
(CDK5 regulatory subunit associated protein 1-like) has also been suggested to increase the risk 
of type 2 diabetes by affecting insulin secretion (173). HHEX (hematopoietically expressed 
homeobox) gene might be involved in pancreatic cell development (174). CDKN2B (cyclin-
dependent kinase inhibitor 2B) gene and IGF2BP2 gene (coding for insulin-like growth factor 2 
mRNA binding protein) have no known functional correlation to type 2 diabetes. However, the 
later has been suggested to affect beta-cell function (175). MTNR1B is a melatonin receptor 
expressed in pancreatic cells. Melatonin might influence the level of insulin through the 
circadian rhythm (176).   
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Table 2.5: Most replicated novel loci related to type 2 diabetes reported by GWASs:  
Gene Marker Chr. Allele 
(Effect/
Other) 
Effect: OR (95% 
CI) 
Population 
SLC30A8 rs13266634 8 C/T 1.07 [1.00–1.16] Finnish and Swedish (165) 
1.18 [1.09–1.29] Finnish (177) 
1.19 [1.06–1.33] Chinese (178) 
1.19 [1.08–1.31] Icelandic (178) 
1.51 [1.25–1.81] US White (178) 
HHEX rs1111875 10 C/T 1.14 [1.06–1.22] Finnish and Swedish (165) 
1.43 [ 1.18-1.72] Korean (179) 
1.10 [1.01–1.19] Finnish (177) 
1.64 [1.25–2.15] Chinese (171) 
CDKN2B rs10811661 9 T/C 1.20 [1.12–1.28] Finnish and Swedish (165) 
1.47 [ 1.23-1.75] Korean (179) 
1.20 [1.07–1.36] Finnish (177) 
1.31 [1.12–1.54] Chinese (171) 
1.19 [1.11-1.28] White British (180) 
rs564398 9 C/T 1.13 [1.08–1.19] White British (180) 
IGF2BP2 rs4402960 3 T/G 1.17 [1.11–1.23] Finnish and Swedish (165) 
1.18 [1.08–1.28] Finnish (177) 
1.11 [1.05-1.16] White British (180) 
CDKAL1 rs7754840 6 C/G 1.49 [1.27–1.75] Chinese (171) 
1.44 [1.23-1.68] Arab Lebanese (181) 
1.77 [ 1.50-2.10] Korean (179) 
1.08 [1.03–1.14] Finnish and Swedish (165) 
1.12 [1.03–1.22] Finnish (177) 
rs7756992 6 G/C 1.23 [1.10–1.37] Icelandic (178) 
1.21 [1.10–1.33] Danish (178) 
1.25 [1.11–1.40] Chinese (178) 
1.38 [1.17–1.62] Chinese (171) 
1.35 [0.75- 1.09] Arab Lebanese (181) 
1.23 [1.15-1.32] Chinese (182) 
rs10946398 6 A/C 1.47 [1.25–1.73] Chinese (171) 
1.16 [1.10–1.22] White British (180) 
rs9465871 6 C/T 1.41 [1.21–1.66] Chinese (171) 
KCNQ1 rs2237895 11 C/T 1.34 [1.26-1.43] Japanese (183) 
1.25 [1.12-1.39] Chinese (183) 
1.27 [1.08-1.49] Korean (183) 
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     Several studies have reported the association between adiponectin, an adipocyte-derived 
protein, and a lower risk of Type 2 diabetes. A systematic review revealed that the relative risk 
of diabetes decreased with every increase in the level of adiponectin (RR: 0.72 [95% CI: 0.67-
0.78]). This effect was observed in Europeans, East Asians, Asian Indians, African Americans 
and Native Americans (189).  A genome-wide association study of European ancestry found 
several loci near gene ADIPOQ (which encodes adiponectine) associated with the level of 
adiponectine. Alleles near that gene which reduce the level of adiponectine, were associated 
with an increased risk of type 2 diabetes (190). However, a study conducted in Saudi Arabian 
subjects failed to replicate the effect of variants near the ADIPOQ gene on the risk of Type 2 
diabetes (191). 
2.3.8 Shared variants with monogenic forms of diabetes 
    Genes which are influencing monogenic forms of diabetes might be involved in the causation 
of type 2 diabetes. GWASs were able to detect variants related to type 2 diabetes near genes 
which were previously known to cause neonatal diabetes (ND) and maturity-onset diabetes of 
the young (MODY). Although these forms of diabetes were caused by a single gene, variants 
detected near these genes  are not independently strong enough to cause type 2 diabetes (192) 
but they might give a clarification on how these variants participate in the physiology of glucose 
metabolism and insulin action.  
      Table 2.6 list genes causing neonatal diabetes and maturity-onset diabetes of the young that 
are associated with increased risk of type 2 diabetes. GCK (glucokinase) gene is responsible for 
causing  neonatal and maturity-onset diabetes of the young type 2 (MODY2). Patients with 
neonatal diabetes were homozygous for mutation in this gene while patients with MODY2 were 
heterozygote (193).GCK was later on found to increase the risk of  type 2 diabetes (186). 
1.32 [1.20-1.45] Japanese (184) 
1.14 [1.03-1.26] Singaporean (184) 
1.24 [1.16-1.32] Danish (184) 
rs231362 11 G/A 1.08 [1.06-1.10] European (167) 
1.24 [1.08-1.43] Punjabi (185) 
rs2237892 11 C/T 1.31 [1.10-1.56] Korean (179) 
rs2237897 11 C/T 1.41 [1.29–1.55] Japanese (184) 
1.22 [1.09–1.35] Singaporean (184) 
1.36 [1.16–1.60] Danish (184) 
MTNR1B rs10830963 11 G/C 1.09 [1.06-1.12] European (186) 
1.16 [1.03-1.31] Chinese (187) 
rs2166706 11 A/G 1.21 [1.06-1.38] Indian Asian (188) 
27 
 
KCNJ11 has been reported to cause neonatal diabetes. However, this gene in particular has 
different sorts of mutations and different modes of inheritance(194).  HNF1α and HNF1β 
(hepatic necrosis factors 1 α and β) mutations cause other forms of MODY. These genes are 
structurally related and are both nuclear transcription factors (195). 
 
Table 2.6: Genes causing neonatal and MODY and related to type 2 diabetes:  
Gene Disease Chr Inheritance T2D Risk 
Marker 
Allele 
(Effect/ 
Other) 
Effect: OR (95% 
CI) 
GCK ND and 
MODY 
2 
7 Autosomal recessive 
(196) 
rs4607517 A/G 1.07     (1.05–1.10)  
(186) 
KCNJ11 ND 11 Autosomal dominant 
or recessive (194) 
rs5219 T/C 1.15     (1.09–1.21) 
(165) 
HNF1α MODY
3 
12 Autosomal dominant 
(197) 
rs7957197 T/A 1.07     (1.05-1.10) 
(167) 
HNF1β MODY
5 
17 Autosomal dominant 
(195) 
rs757210 A/G 1.12     (1.07-1.18)  
(167) 
 
2.3.9 Genetic variants affecting traits related to type 2 diabetes 
      A large number of genetic variants have been reported to be associated with continuous 
traits related to type 2 diabetes. Some of these variants do not have a direct impact on type 2 
diabetes risk but may act on intermediate phenotypes such as elevating blood sugar, increasing 
risk of obesity, or decreasing insulin secretion and sensitivity. However, several variants have 
been reported to increase the risk of type 2 diabetes and affect continuous traits related to the 
disease. Table 2.7 illustrates the genetic variants that affect more than one trait related to type 2 
diabetes.  
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     Variants reported in table 2.7 were detected in healthy subjects. All these variants seem to be 
associated with an increased  level of FBG.  Moreover, they independently increase the risk of 
type 2 diabetes except for three variants, G6PC2 (glucose-6-phosphatase, catalytic, 2), FADS1 
(fatty acid desaturase 1), and GLIS3 (GLIS family zinc finger 3).  These variants do not have a 
direct impact on type 2 diabetes susceptibility but might increase the risk by increasing the level 
of blood glucose.  
     Variants near GCKR (glucokinase regulator), ADCY5 (adenylate cyclase 5), and DGKB-
TMEM195 (diacylglycerol kinase, beta 90kDa - transmembrane protein 195) have weaker 
associations with type 2 diabetes risk. However, variants with moderate and weak association 
might be acting additively and increasing the risk of the disease. A study reported a higher risk 
type 2 diabetes when inheriting several risk alleles related to GCK, GCKR, G6PC2, AND 
MTNR1B. The odds ratio of type 2 diabetes increased to 2.05 (1.50-2.80) when inheriting 6-8 
risk alleles near these genes (198).  
     Homeostasis Model Assessment B (HOMA-B) is a method of estimating beta cell function. 
Most of the variants reported in table 2.7 are associated with decreased beta cell function. In 
contrast, GCKR has been suggested to increase beta cell function and insulin secretion. In 
addition, variants near IGF1 (insulin-like growth factor 1) gene has been associated with 
increased fasting insulin level (0.14 mmol/l increase per risk allele SE: 0.57) (186).  
    The majority of variants reported in table 2.7 are associated with increased risk of higher 
level of HbA1(c). Nonetheless, Variants near TCF7L2, and SLC30A8 are suggested to decrease 
the level of HbA1(c). Another  meta-analysis reported a higher HbA1(c) when inheriting risk 
alleles of TCF7L2 and SLC30A8 but did not reach genome-wide significance (186).     
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Table 2.7: Genetic variants associated with traits related to type 2 diabetes:  
Gene Marker Allele 
(Effect/ 
other) 
FPG (mmol/l) 
B (SE or 95%CI) 
HOMA-B 
B(SE) 
HbA1(c) % 
B(SE) 
TCF7L2 rs7903146 T/C 0.023 (0.004) (186) –0.020 (0.004)(186) −0.054  (0.014) 
(199) 
G6PC2 rs560887 C/T 0.075 (0.003) (186) 
0.06(0.04, 0.09) 
(198) 
–0.042 (0.004) (186) 0.032 (0.004) 
(186) 
MTNR1B rs10830963 G/C 0.067 (0.003) (186) 
0.056  (200) 
0.08  (198) 
–0.034 (0.004) (186) 0.024 (0.004) 
(186) 
 rs1387153 T/C 0.058  (0.038-0.078)  
(200) 
 0.028 (0.004) 
(201) 
GCK rs4607517 A/G 0.062 (0.004) (186) –0.025 (0.005(186)  0.041 (0.005) 
(186) 
 rs1799884 T/C 0.075 (0.049-0.101) 
(200) 
 0.038 (0.004 ) 
(201) 
SLC30A8 rs13266634 C/T 0.027 (0.004) (186) –0.016 (0.004) (186) -0.0189 (202) 
GCKR rs780094 C/T 0.029 (0.003) (186) 0.014 (0.003) (186)  
ADCY5 rs11708067 A/G 0.027 (0.003)   (186) –0.023 (0.004) (186)  
DGKB-
TMEM195 
rs2191349 T/G 0.030 (0.003) (186) –0.017 (0.003) (186)  
FADS1 rs174550 T/C 0.017 (0.003) (186) –0.020 (0.003) (186)  
GLIS3 rs7034200 A/C 0.018 (0.003) (186) –0.020 (0.004) (186)  
 
     Variants near FTO (fat mass and obesity associated) genes are presumed to increase the risk 
of type 2 diabetes. The odds of having type 2 diabetes increases by 1.15 (95% CI: 1.09-1.22) 
when inheriting the risk allele of rs8050136 near the FTO gene (166). However, the effect of the 
FTO gene on type 2 diabetes is more likely to be mediated through its effect on BMI (203). In 
addition to the effect of FTO on BMI and type 2 diabetes, another study reported an increased 
risk of higher paediatric BMI when inheriting the risk allele of variant rs 7923837 near the 
HHEX gene (B: 0.06523 increase in BMI, SE: 0.02865 (204)), which as has already been 
suggested, may increase the risk of type 2 diabetes.  
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     The influence of BMI on type 2 diabetes susceptibility has more dimensions of complexity. 
Variant rs8050136 near FTO gene has been revealed to impose more risks of type 2 diabetes in 
obese individuals (RR: 1.49 (95% CI: 1.34-1.66)) while variant rs7901695 near TCF7L2 has a 
weaker impact in obese individuals (RR: 1.07 (95% CI: 0.97-1.19)). In contrast, the rs7901695 
risk allele has been suggested to have more influence on type 2 diabetes susceptibility in non-
obese subjects (RR 1.53 (95% CI: 1.37-1.71)) (205). Two studies have reported the similar 
stronger influence of rs7903146 near TCF7L2 on type 2 diabetes risks in non-obese individuals 
in the Tunisian (206) and French (207) populations.  Additionally, a variant (rs8090011) near 
the LAMA1 gene was revealed to be significantly associated with a higher increase in the risk 
of developing type 2 diabetes in lean individuals compared to obese ones (OR 1.13 [95% CI: 
1.09-1.18] in lean individuals compared to OR 1.03 [95% CI: 1.00-1.06] (208).  
2.3.10 Conclusion 
 Familial recurrence and heritability indicate a genetic influence on type 2 diabetes 
risk.  
 The genetic risk was confirmed by several approaches to detecting genetic variants 
increasing the risk of type 2 diabetes.  
 Linkage analysis revealed the gene TCLF7 as a risk factor for type 2 diabetes, and 
this was later confirmed to have had the strongest genetic effect yet detected.  
 GWASs were the most successful in detecting multiple risk alleles with smaller 
effects.  
  All the variants detected only explain a small part of type 2 diabetes heritability.  
 Discovering several genetic variants related to type 2 diabetes indicates a polygenic 
influence.  
 These variants appears to act additively to increase the risk of type 2 diabetes.  
 Inheriting more risk alleles increases the risk of developing type 2 diabetes.  
 There are other alleles which might act as surrogates. These variants were not shown 
to influence type 2 diabetes directly but to influence other traits related to type 2 
diabetes, such as blood glucose and insulin levels.  
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2.4 Interpretation of detected type 2 diabetes risk alleles 
2.4.1 Introduction 
   GWASs assume no biological pathways when choosing single nucleotide polymorphisms. 
However, it is rather important to understand how these variants confer the risk of type 2 
diabetes biochemically. Figure 2.1 shows how these genes might affect biochemical 
mechanisms and eventually lead to an impaired glucose metabolism and reduced insulin 
secretion and action. It has been suggested that these genes affect the development and 
functioning of beta cells, and the ability of insulin to activate glucose metabolism in other cells.   
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Figure 2.1: Variants influencing type 2 diabetes and related biochemical pathways.  
WFS1:  Beta cell loss through impaired cell cycle.  
HHEX: Decrease pancreatic cells embryonic development.   
SLC30A8: Maturation and storage of insulin.  
TCF7L2, MADD: higher level of proinsulin.    
GCK: Failure to using glucose to initiate insulin signalling pathway.  
KCNJ11: Failure to control K+ movement through beta cell membrane. 
KCNQ1:  Associated with K+ movement through beta cell membrane.   
 
CDKAL1: Associated with less ATP generation and 
 impaired insulin signalling.    
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WFS1: Regulates Ca++ homeostasis.  
PPARgamma: Nuclear Transcription factor.   
ADCY5, CDKAL1, and KCNJ11: Associated with low birth weight  
HNF1A: Nuclear Transcription factor.   
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   2.4.2 Production and function of insulin 
     Figure 2.2 shows the process of conversion of insulin to an active form. The production of 
insulin proceeds through three steps. Firstly, insulin is produced in the endoplasmic reticulum of 
beta cells in the form of preproinsulin. At this stage, it is composed A, B, C chains and a signal 
sequence. The signal sequence’s function lies in guiding the protein to secretory granules in beta 
cells cytoplasm. Once the preproinsulin reaches the secretory granules, it loses its signal 
sequence and becomes proinsulin (209). Elevated blood sugar triggers the cleavage of the C 
chain of the proinsulin, converting it to active insulin and making it ready for secretion through 
the blood stream (209-211). Zinc has also been reported to participate in the maturation of 
insulin in these secretory granules (212).  
 
 
 
Figure 2.2: Steps in the conversion of insulin to an active form. 
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       The secretion of insulin from beta cells is initiated by the entrance of glucose to the cells. 
Figure 2.3 shows the process of insulin secretion. GLUT2 are glucose transporters which are 
predominantly located in a beta cell (213). Similar to other cells in the body, degradation of 
glucose (glycolysis) is started by Glucokinase (209, 214).  The end result of glycolysis is 
Pyruvate and Adenosine Triphsophate (ATP). ATP forces ATP-gated K+ channel to close 
leading to depolarization of cell membrane. This depolarization leads to activation of voltage-
gated Ca++ channel leading influx of Ca++ to beta cell. In addition to the Ca++ released from 
the endoplasmic reticulum, the increased level of Ca++ activates the release of active insulin 
from the granules to blood stream (209).  
      Figure 2.4 depicts how insulin acts on target cells such as muscle cells. Insulin does not 
enter cells but attaches itself  to an insulin receptor (215). An insulin receptor is composed of 2 
alpha subunits and 2 beta subunits (214, 215). Once insulin is attached to the receptor, the beta 
subunits of the receptor become closer to each other and exhibit autophosphorylation (214). The 
activated beta subunits activate insulin receptor substrate-1, which in turn initiates a cascade of 
events ending with the transcription and translation of around 100 genes related to insulin action 
(215). 
 
Figure 2.3: Steps of insulin secretion.  
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       One of the main actions of insulin is increasing the influx of glucose into the cells’ 
cytoplasm. Glucose  is transported to muscle and fat cells by GLUT 4, which is different to the 
receptors present in pancreatic cells (213). However, GLUT4 is present in small quantities in the 
cell membranes of fat and muscle cells and GLUT4 transporters are usually stored inside 
vesicles in the cytoplasm of these cells. Having the insulin attached to its receptors in these cells 
will eventually initiate the exocytosis of the GLUT4-containing vesicles on the cell membranes. 
The increased amount of GLUT4 in the cell membranes increases the transportation and 
utilization of glucose. Once insulin secretion is reduced, these transporters return and are stored 
in their vesicles (214, 216).  
2.4.3 Genes affecting Beta cells 
       Certain genes have been reported to decrease the development of beta cells or increase their 
cell death. It has been noticed that the HHEX gene influences embryonic pancreas development. 
Mutations in this gene are associated with a failure of pancreatic specification, while the liver is 
not affected (174).  Patients with Wolfram’s syndrome were found to have their beta cells 
selectively absent (164). Furthermore, WFS1 gene deficiency leads to impaired beta cell cycle 
and increased apoptosis (217). Variants detected near these genes related to type 2 diabetes 
might indicate some degree of beta cell death or impaired function although not strong enough 
to solely cause type 2 diabetes.  
     An association between insulin resistance and fetal development has been suggested. 
Impaired sensing of glucose and reduced insulin secretion might be associated with reduced 
birth weight. Genetic causes of this association are seen in monogenic forms of diabetes 
affecting glucose sensing and insulin secretion and causing low birth weight (218).   Several 
studies have investigated the association between type 2 diabetes risk variants and low birth 
weight. Variants near ADCY5 (219, 220), KCNJ11 (221), HHEX and CDKAL1 (220, 222) 
have been revealed to be associated with increased risk of type 2 diabetes and a higher risk of 
low birth weight (table 2.8). This genetic association between birth weight and type 2 diabetes 
could be explained by the influence of birth weight on beta cell function in the later period of 
life (219).  
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Figure 2.4: Insulin signalling and glucose entrance in muscle cell.  IRS-1: Insulin Receptor 
Substrate-1.  
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  Table 2.8: Type 2 diabetes variants associated with the risk of reducing birth weight:  
 
*The odds of having low birth weight for gestational age when inheriting the risk allele.  
2.4.4 Genes affecting insulin processing 
         SLC30A8 gene codes for ZnT-8 which is a zinc transporter are expressed in pancreatic 
beta cells (172). These transporters are located in the membrane of secretory granules 
containing insulin. The increased transportation of zinc into these granules has been suggested 
to aid in the maturation and storage of insulin in these granules (223). A SLC30A8 gene 
knockout in mice resulted in the reduction of plasma insulin (224). An association study 
indicated that type 2 related variant rs13266634 near SLC30A8 gene was associated with 
increased proinsulin level (Beta: 0.031, SE 0.0067) (225). Having a higher level of proinsulin 
when inheriting the risk allele of this variant might indicate the significance of zinc transporters 
in the conversion of proinsulin to insulin which would consequently aid in the pathogenesis of 
type 2 diabetes.  
      In addition to SLC30A8, other variants have been suggested to increase the level of 
proinsulin. Variant rs7903146 near TCF7L2 gene has been revealed to have a higher effect on 
the proinsulin level than SLC30A8 (Beta: 0.045, SE 0.0066) (225). However, the mechanism in 
which TCF7L2 increases the level of proinsulin is not evidently apparent. Other variants were 
reported to increase proinsulin level but not to increase the type 2 diabetes risk. Variants 
rs7944584 near MADD (MAP-kinase activating death domain) were noted to have a strongest 
effect on the proinsulin level (Beta: 0.10 SE: 0.0059) (225) but no risk of developing type 2 
diabetes (186). On a nuclear level, transcription factor HNF1 alpha has been shown to act on 
beta cells through regulating the expression of gene coding for insulin and GLUT2, thus 
affecting insulin production (226).  
 
Locus Chr Marker Allele 
(Effect/Other) 
Effect:  
KCNJ11 11 rs5219 T/C OR and 95% CI : 1.90 (1.04-3.50) (221)* 
ADCY5 3 rs11708067 A/G Reduction per risk allele (g):-33  
( 95% CI:-10,-55) (220) 
CDKAL1 6 rs7756992 G/C Reduction per risk allele (g):-22 
 ( 95% CI:-1,-43) (220) 
HHEX 10 rs1111875 C/T Reduction per risk allele (g):-16 
 ( 95% CI:-08,-24) (220) 
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2.4.5  Genes affecting insulin signalling 
       We have seen that sensing glucose elevation and its effect on insulin release goes through 
several steps. Any impairment in any of these steps will eventually lead to impaired insulin 
signalling and secretion. Hence, glucokinase plays a key role in sensing glucose elevation and 
the initiation of insulin signalling, and any impairment in its activity will have an impact on 
subsequent events. In addition to its major role in other monogenic forms of diabetes, variants 
near the GCK gene have been shown to increase the risk of type 2 diabetes. This risk is more 
likely to be caused by mutations in the GCK gene, leading to an inability of the enzyme to 
phosphorylate glucose and initiate insulin signalling. Furthermore, GCKR increases the risk of 
type 2 diabetes through its regulatory effect on glucokinase (227). 
     An ATP-sensitive potassium channel can be activated by the energy produced during 
glycolysis. Abnormality in ATP production will end in failure to control the K+ movement 
through a beta cell membrane and will eventually reduce insulin secretion. CDKAL1 knockout 
in mice has been shown to decrease the amount of glucose-induced ATP generated in beta cells 
(173). However, another study suggested that the variant rs7754840 near CDKAL1 is more 
likely to affect the genetic expression of another gene called SOX4 (sex determining region Y-
box 4) which is located near the CDKAL1 gene. This implies that the SOX4 gene is more likely 
to inflict the risk of type 2 diabetes than CDKAL1 gene (228).  
       ATP-sensitive potassium channel is composed of two subunits, namely, the sulphonylurea 
receptor (SUR) and the K+ inwardly rectifier channel (KIR) (229). These subunits are coded by 
ABCC8 and KCNJ11 genes, respectively, and are located 4.5Kb of each other within 
chromosome 11 (158).  Abnormality in ATP-sensitive potassium channel is associated with 
impairment of beta cell membrane depolarization, less Ca++ influx and subsequently decreased 
insulin secretion. Patients who suffer mutations in the KCNJ11 gene are shown to have an 
increase in insulin secretion when taking Sulfonylurea treatment and have more effective 
glycemic control than when taking insulin injections (230). Due to the polygenic nature of type 
2 diabetes, Sulfonylurea has a different effect among people with type 2 diabetes. One study 
suggested that patients with a risk allele of variant rs12255372 near TCF7L2 are more likely to 
encounter sulfonylurea failure to control blood glucose (1.95 95% CI 1.23-3.06) (231).   
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     KCNQ1 has been suggested to increase the risk of type 2 diabetes by limiting insulin 
secretion. KCNQ1 gene codes for voltage-gated potassium channels which control the 
movement of potassium. Functional loss of this gene has been linked to cardiac arrhythmias due 
to impairment in cardiac current (232). A voltage-gated potassium channel has been reported to 
increase the influx of K+ in beta cells (233). The increased influx of K+ will decrease the Ca++ 
influx to beta cells and will subsequently reduce insulin secretion. 
2.4.6 Genes affecting insulin secretion 
     Since calcium is important in the excretion of stored insulin from beta cells, a reduction in 
the quantity of calcium will lead to decreased excretion of insulin. WFS1 gene codes for a 
transmembrane protein are located in the endoplasmic reticulum of the beta cells in addition of 
other cells. This gene has been revealed to be associated with Ca++ homeostasis and the  
increased filling of endoplasmic reticulum of Ca++ needed for insulin secretion (234). In 
addition to its effect on Ca++ homeostasis, WFS1 gene deficiency has been recently revealed to 
influence insulin-containing granule acidification. It has been suggested that the acidification of 
these granules in mice may be  important in the insulin maturation process and lack of this gene 
resulted in increased proinsulin level (235). 
2.4.7 Gene affecting insulin action at target cells 
       Nuclear transcription factors have been revealed to modulate the action of insulin in target 
cells. It has been suggested that PPAR gamma can increase the risk of type 2 diabetes by 
impairing the transcription of genes related to insulin and glucose homeostasis (236). Another 
study proposed that PPAR gamma inhibits the transcription of GLUT4 and thus decreases the 
transportation and utilization of glucose in target cells. Rosiglitazone, an anti-diabetic oral agent, 
was revealed to increase insulin sensitivity by detaching PPARgamma from the promoter area 
coding for GLUT4 (237).  
      
2.4.8 Conclusion 
 Correlating detected type 2 diabetes risk alleles with impairments in insulin and 
glucose biochemical pathways indicates how complex this disease is.  
 Discovered biochemical pathways indicates the polygenic nature type 2 diabetes.   
 A better understanding of roles of these genes might help in better diagnostic and 
therapeutic applications, especially when addressing impairment in multiple 
biochemical steps.  
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2.5 Variation in type 2 diabetes across populations  
2.5.1 Introduction 
      Variation in the incidence of diabetes across ethnicities is well documented. White European 
populations are at a lower risk of developing diabetes than other ethnicities. In the USA, the 
incidence of diabetes was 19 times higher among the Pima Indians than among the white 
population in Rochester, Minnesota (238). Similarly, the incidence of diabetes among Indian 
Asian Immigrants living in the USA was reported to be higher than whites, Hispanics and 
Africans (239). In the UK, incidence of type 2 diabetes was reported to be up to 6 times higher 
in South Asian descent compared to white Europeans. The risk of type 2 diabetes was 3 times 
greater for those of African and African-Caribbean descent living in the UK compared with 
whites (240).  
      Pima Indians and Asian Indians are experiencing a relatively similar environment to White 
European individuals living in the UK or the USA. Despite the similarity in exposure to the 
western lifestyle in these populations, people from American Indian and Asian Indian ethnicities 
are at higher risk of developing type 2 diabetes. Having a variation in incidence of type 2 
diabetes despite having a relatively similar environment might indicate a significant variation in 
genotypes.  
2.5.2 Variation in allelic frequencies 
     Having a higher incidence of a certain illness in certain populations might indicate a higher 
aggregation of genetic risk factors. The effect of genes on influencing the incidence of illnesses 
depends on the effect size and on the frequency of these genes. In the case of type 2 diabetes, 
variants related to the disease have weak or moderate effects.  However, it appears that certain 
risk variants are experiencing a significant frequency variation between several ethnicities.  
      Figure 2.5 depicts risk allele variation among cases of type 2 diabetes in different ethnicities. 
It is apparent from the figure that populations who are ethnically related have relatively similar 
allelic frequencies. For example, the risk alleles frequencies of variants rs1111875, rs10811661 
and rs2237895 are almost similar among Asian populations. On the other hand, risk alleles 
frequencies of variants rs1111875, and rs10811661 are higher among European than Asian 
populations. Similarly, the risk alleles frequencies of variants rs7756992 and rs13266634 are 
higher among West African than Asians and Europeans. However, other variants near TCF7L2 
and MTNR1B did not show wide allelic frequency variation across ethnicities (170, 188).  
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Figure 2.5: Variation of certain risk alleles related to type 2 diabetes across populations 
from different ethnicities.(Number of type 2 diabetes cases [study reference])  
2.5.3 Forces of variation     
    The Hardy-Weinberg law states that allelic frequencies are constant when genes are passed 
from one generation to another, as long as mating is done randomly in a large population with 
no selection, no migration or mutations (110). However, these conditions are hard to maintain 
and consequently populations do exhibit deviation in their allelic frequencies. Hence, different 
populations are exposed to different degrees of these forces, whereas allelic frequencies are 
expected to vary across populations.  
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     It has been suggested that natural selection is one of the forces that may inflict the risk of 
type 2 diabetes on certain populations. Natural selection influences allelic frequencies based on 
the ability of individuals with certain genotype to survive in certain environments. When there 
is a genotype which has been selectively favoured, its frequency increases. If a person is 
carrying an unfavoured genotype, that person is more likely to have reduced viability and 
fertility and consequently may be less able to pass the unfavoured genotypes to the next 
generation (110).  
     The Thrifty Genotype Hypothesis has been postulated to explain the variation in the 
incidence of diabetes among ethnicities. This hypothesis claims that certain genotypes were 
advantageous during periods of starvation and low food availability in the past. Natural 
selection might have lead to an increased frequency of favoured genotypes, which later became 
risky genotypes in periods when food was abundant (241).   
    Although this hypothesis might sound biologically plausible, there is no consistent evidence 
to support it. However, certain studies have suggested a positive selection for certain type 2 
diabetes risk alleles. Variants near the gene TCF7L2 were reported to show evidence of natural 
selection (242, 243). Another study suggested that a variant near HHEX might have also been 
subjected to natural selection in East Asians (244). Nonetheless, other type 2 diabetes related 
loci did not show consistent evidence of selection (243).  
     In addition to natural selection, non-random mating is another important force that influences 
the genetic composition of populations. When individuals are more likely to mate due to their 
physical similarity or because they have a common ancestor, the mating is no longer random 
and this will eventually affect the allelic frequencies of the subsequent generations. In the case 
of inbreeding, individuals who are related share similar genes which have been passed down 
from their common ancestor. The mating of these related individuals will eventually increase 
the prevalence of homozygosity and reduce heterozygote genotypes. The likelihood of 
inbreeding will also increase when there is a small isolated population and eventually 
individuals will be more likely to become genotypically similar (110).  
     Inbreeding may lead to aggregation of type 2 diabetes risk alleles. Two epidemiological 
studies have suggested a synergism between type 2 diabetes and consanguineous marriages (245) 
(246). The increased degree of consanguinity increases the inbreeding coefficient and 
consequently increases the risk of inheriting a common allele shared by a common ancestor. On 
certain occasions, the shared allele could be a type 2 diabetes risk allele. However, no study has 
attempted to investigate the effect of inbreeding on  measured type 2 diabetes risk alleles 
aggregation.    
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2.5.4 Conclusion  
 There is an observed variation in type 2 diabetes prevalence between populations.  
 Two major forces have been proposed to increase the risk of type 2 diabetes  
 Natural selection may increase the risk by increasing the aggregation of risk alleles 
which were previously considered advantageous in low food availability periods.  
 Inbreeding might increase the risk of type 2 diabetes by increasing the possibility of  
inheriting homozygote type 2 diabetes risk alleles in inbred individuals.  
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2.6 Population genetics of Saudi Arabia 
 2.6.1 Introduction 
    Saudi Arabia has unique ecological and cultural conditions that make its population different 
to other populations. Due to these unique conditions, natural selection, migration, and 
inbreeding are very likely to be the major forces that have created the genetic admixture of 
Saudi Arabian population. Acknowledging these forces may help us correlate them to illnesses 
affecting the Saudis, such as type 2 diabetes.  
2.6.2 Natural selection  
     The Kingdom of Saudi Arabia is a relatively new country and was established about eight 
decades ago. It is dominated by deserts and upon its establishment, it suffered a major lack of 
resources and was one of the poorest countries in the world. Having this environmental 
condition might indicates that natural selection could be an important force favouring 
individuals who were able to survive in this environment.  
      Over the last 3-4 decades, Saudi Arabia has witnessed an economic surge caused by 
discovery of the world's largest reserve of oil in eastern parts of the country.  This change was 
associated with an increased availability of food and more exposure of Saudis to western life-
style. Subsequently, this change in life-style was associated with the increased prevalence of 
overweight and obesity which could be partially explained by the thrifty genotype hypothesis.      
2.6.3 Migration and genetic flow 
     Several studies have investigated the diversity of genetic structures in Saudi Arabia. The 
country is located in a migratory pathway between Europe, Africa and Asia. This location has 
aided in creating a genetically diverse population. Most of the genetic flow came from the West 
Asians area. In addition, a significant gene flow was found to be from African Areas (247-249). 
One study reported that Saudi Arabia might have received a minor genetic flow from central 
Asia, Indonesia, and even Australia (248). 
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2.6.4 Inbreeding 
     Another well studied force affecting the genetic structure on Saudi Arabian populations is 
inbreeding.  The percentage of consanguineous marriages ranged between 54% and 57% and 
most of these marriages were between first degree cousins (250-252). The prevalence of 
consanguineous marriages was also found to be higher in rural areas (252).  
    The prevalence of consanguinity depends on several traditional and social factors. Families in 
Saudi Arabia are adherent to cultural behaviour and marriage between first degree cousins is 
almost a norm. It has been argued that marriage between relatives is more likely to be easily 
mediated, hence mating individuals are brought up together in the same environment. 
Furthermore, such arrangements may ease spousal adjustment after marriage and enhance the 
stability of marriages. However, other economic reasons have been suggested, since marriage 
between relatives is a method of keeping fortunes and properties within the same family or tribe 
(250).  
2.6.5 Conclusion 
 Natural selection, migration, and inbreeding are three major forces that may have 
defined the Saudi Arabia population genetic structure. 
  Inbreeding is evidently the most apparent and quantified force.  
 Unlike other European or American populations, marriage between first degree 
cousins is a common practice in Saudi Arabia.  
 Approximately, half of marriages in Saudi Arabia occur between related individuals.  
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3 Chapter Three: Aims and Objectives 
3.1 Inbreeding and susceptibility to diseases 
      If parents share a common ancestor, they have a bigger chance of having similar inherited 
alleles. Once they pass their similar alleles to their offspring, their children will be at more risk 
of inheriting 2 identical copies of the same alleles which have been passed from the common 
ancestor. If the allele inherited from a common ancestor is a risk allele, having 2 identical  
copies will increase the risk of acquiring monogenic illnesses which can be inherited recessively. 
In this case, 2 copies of the risk allele are necessary for disease development.  
     The effect of inbreeding is rather apparent in illnesses where genes have a strong effect in 
developing diseases, especially at an early age. There are some monogenic forms of diabetes 
such as mutations in GCK (196) and KCNJ11 (194). These genes have been found to 
recessively cause neonatal diabetes. One study reported a higher risk of congenital heart disease 
among consanguineous families in Saudi Arabia (OR 2.12 (1.27-3.57) (251). Another study 
suggested that neonatal mortality is higher among inbred families, probably because of  
congenital malformations (253) 
    In addition to its effect on monogenic illnesses, it has been noticed that inbreeding can 
increase the risk of low birth weight. Several studies conducted in Arabic (254), Indian (255), 
Pakistani (256) and Norwegian (257) populations have revealed a significant association 
between consanguinity and decline in birth weight. After controlling for  medical and 
sociodemographic covariates, consanguinity was shown to reduce birth weight by 1.8% (beta = 
-0.018, 95% confidence interval: -0.027, -0.008) (254).  
 
3.2 Can inbreeding increase the risk of type 2 diabetes? 
        A study conducted in Qatar reported higher odds of developing type 2 diabetes among the 
consanguineous marriages of first degree cousins (OR=1.59, 95% CI=1.11-2.29). Furthermore, 
the odds of developing type 2 diabetes among consanguineous marriage of second degree 
cousins was smaller than in the case of marriage between first degree cousins. However, the 
later odds ratio was not statistically significant, probably because the number of marriages 
between second degree relatives was less in comparison to  mating between first degree cousins 
(245). 
 
     Another study conducted in Saudi Arabia revealed that a positive family history of type 2 
diabetes is more likely to be reported among families with consanguinity than families without 
consanguinity (OR: 13.4, 95% CI=8.64-23.98) (246). However, this study only reported the 
odds of having familial history of type 2 diabetes and did not actually provide the effect of 
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having a history of consanguinity on type 2 diabetes disease status. Although these studies 
appear to show a significant association between consanguinity and susceptibility to type 2 
diabetes, another similar study conducted in the European population showed contradicting 
results.   
       A study by Rudan et al studied the effect of inbreeding on several late-onset complex 
illnesses including type 2 diabetes in an European population (258). This study revealed a 
significant effect of inbreeding on several complex illnesses excluding type 2 diabetes. 
Although this study utilized a good measurement of inbreeding using a pedigree-based 
inbreeding coefficient, only 480 individuals were studied to assess the effect of inbreeding on 
10 different complex illnesses. The paper does not report the number of type 2 diabetes patients 
included. However, if this study had a small sample size of type 2 diabetes patients it would 
have had insufficient statistical power  to provide evidence of a lack of association between 
inbreeding and type 2 diabetes.  
     Based on the available evidence, a synergism between type 2 diabetes and inbreeding can be 
suspected. Recognizing how inbreeding increases the risk of type 2 diabetes is an important step 
in strengthening the effect evidence.  However, there is no evidence explaining how inbreeding 
might lead to an increased risk of type 2 diabetes. The following section will propose several 
hypotheses explaining the association.  
 3.3 How could inbreeding increase the risk of type 2 diabetes? 
   Due to the possibly polygenic nature of type 2 diabetes, inheriting more risk alleles has been 
seen to increase risk (198). In each locus, one might inherit a single or two copies of risk alleles. 
Those who inherit two copies of risk alleles at each locus could be at higher risk of developing 
type 2 diabetes than those who inherit a single risk allele at a locus. Since inbreeding increases 
the chance of inheriting identical alleles at loci, it can also increase the risk of inheriting two 
identical copies of particular risk alleles at each locus and thus increasing the risk of type 2 
diabetes. This is augmented by the chance of inheriting identical copies of risk alleles at several 
loci to inflict a possible cumulative recessive risk of the disease.  
     Another approach to explain the association between inbreeding and type 2 diabetes risk is 
simply to look at the effect of inbreeding on type 2 diabetes risk factors. Individuals who have 
suffered a low weight at birth are at a higher risk of developing type 2 diabetes at a later age. 
However, inbreeding is a risk factor for having a low birth weight. This association between 
inbreeding and low birth weight can partially explain how inbreeding increases the risk of type 
2 diabetes. We can hypothesize that inbreeding increases the risk of low birth weight and that 
low birth weight in turn increases the risk of having type 2 diabetes at a later age.  
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     Increased BMI, blood glucose, and central obesity are known to be risk factors for type 2 
diabetes. Part of the variation of these continuous traits can be explained by the existence of 
variations in genotypes, which signify an important genetic influence on these phenotypes. 
Since these traits incur genetic risk factors, we can hypothesize that inbreeding can help in 
aggregating risk alleles, leading to the elevation of these risk factors, and subsequently 
increasing the risk of type 2 diabetes.  
 
3.4 Aim and Research Questions 
   The aim of this study is to examine the possible mechanisms by which inbreeding might 
increase the risk of type 2 diabetes in a Saudi population.  
First question: Does an inbreeding coefficient predict the extent of aggregation of type 2 
diabetes risk alleles? 
 Second question: Does the aggregation of type 2 diabetes risk alleles predict the age at 
diagnosis of the disease? 
Third question: Does the aggregation of type 2 diabetes risk alleles predict the extent of type 2 
diabetes risk factors (BMI, waist circumference, fasting blood glucose)? 
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4 Chapter Four: Methodology 
4.1 Introduction 
      Answering the proposed research questions required different study designs, different sorts 
of collected data, different methodologies of collection and different analytic methods. Table 
4.1 summarises the research methods used in this study with reference to each research question. 
The process of approaching and recruiting study subjects was similar in each question.   
4.2 Study designs  
     As illustrated in Table 4.1, different designs were utilised to answer the research questions. 
The study utilised family-based study designs. It included a comparison between type 2 diabetes 
patients with different degrees of inbreeding and ages of onset of the disease. The study also 
made comparisons between unaffected adult subjects in order to examine continuous traits 
related to type 2 diabetes.  
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Table 4.1: Research method summary: 
 
  
Research question Population Design Variables Data collection  Analysis 
1st question: Does 
inbreeding coefficient predict 
the extent of aggregation of 
type 2 diabetes risk alleles? 
Patients and 
unaffected 
siblings.  
Comparison between subjects 
with different degrees of 
inbreeding. 
Inbreeding coefficient 
and number of loci 
identical for type 2 
diabetes risk alleles. 
Pedigrees for 
inbreeding coefficient. 
Genotyping for type 2 
diabetes risk alleles 
Correlation between inbreeding 
coefficient and number of loci 
identical for type 2 diabetes risk 
alleles. 
2nd question: Does the 
aggregation of type 2 
diabetes risk alleles predict 
the age at  diagnosis  of  the 
disease? 
Type 2 diabetes 
patients  
Comparison between type 2 
diabetes patients with different 
age at diagnosis of the disease. 
Age diagnosis of type 2 
diabetes, number of loci 
identical for  type 2 
diabetes risk alleles, 
food frequency and 
physical activity 
 
Questionnaires for age 
at diagnosis, food 
frequency and physical 
activity.  
Genotyping for  type 2 
diabetes risk alleles 
Correlation between age at 
diagnosis of type 2 diabetes and 
number of loci identical for  type 2 
diabetes  risk alleles.  
Data collected using questionnaires 
were used to adjust for possible 
confounding caused by 
environmental variation between 
patients.   
3rd question: Does 
aggregation of type 2 
diabetes risk alleles predict 
the extent of type 2 diabetes 
risk factors (BMI, waist 
circumference, FBG)? 
Adult 
unaffected 
relatives of 
recruited type 2 
diabetes 
patients. 
Comparison between unaffected 
adults who will have the same 
inbreeding coefficients of their 
affected relatives.  
Number of loci identical 
for  type 2 diabetes risk 
alleles, BMI, waist 
circumference, FBG, 
food frequency and 
physical activity 
Genotyping for type 2 
diabetes risk alleles. 
Physical measurement 
for continuous 
variables. 
Questionnaires for food 
frequency and physical 
activity 
Correlation between number of loci 
identical for type 2 diabetes risk 
alleles and BMI, waist 
circumference and FBG.  
Data collected using questionnaires 
were used to explain phenotype 
variation caused by environmental 
variation between individuals.  
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4.3 Ethical Approval 
4.3.1 Introduction 
     Application for ethical approval to collect data was conducted in two steps. The first step 
was to secure ethical approval from the Directory of Health in Jazan, Saudi Arabia where data 
collection was performed. The second part was to secure ethical approval from the School of 
Health and Related Research (ScHARR) Ethics Committee. The process of securing ethical 
approvals is detailed in the following sections.  
4.3.2 Directory of Health in Jazan ethical approval 
     Ethical approval from Directory of Health in Jazan was secured on 17
th
 of July 2011. The 
approval was granted by the Training Department, Continuous Medical Investigation and 
Clinical Supervision Department. To secure the approval from the department, a research 
proposal in both Arabic and English was submitted to the department accompanied by an 
official letter from the primary supervisor explaining the purpose of the research. This letter of 
approval is illustrated in appendix 1.   
4.3.3 ScHARR Ethical Approval 
4.3.3.1 Ethical concerns raised   
   One of the concerns raised by Scharr’s Ethic Committee was related to the process of 
identifying and approaching participants. We assured the committee that identification and 
approaching participants will be strictly performed by healthcare staff and not by study 
investigators. Additionally, the committee questioned our method of providing participants with 
information sheets and consent forms. The committee suggested using the postal system to send 
relevant forms and await the participant’s reply to confirm willingness to participate. However, 
we explained that the postal services in Saudi Arabia are not reliable especially in rural areas 
and therefore the using postal service was not an appropriate option for contacting potential 
participants.  
 
   The ethic committee provided several other ethical concerns. One of these concerns involved 
using birth registries to aid in estimating inbreeding coefficients instead of using extended 
pedigrees. The committee questioned our ability to retrieve sufficient information to generate 
informative genealogies. However, we provided explanations related to the pragmatic use of 
extended pedigrees in the target population.  
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     Using constructed pedigrees for estimating the inbreeding degree was the best choice 
according to the available facilities in Saudi Arabia. Using birth registry records would not have 
provided sufficient data to have a good estimation of inbreeding. The Saudi Arabian Ministry of 
Health was established approximately six decades ago and the Directory of Health in Jazan was 
established two decades ago. Therefore, the availability of informative genealogies in the target 
population and birth registry records would not be sufficient to estimate the degree of 
inbreeding.  
 
     The committee questioned our ability to retrieve information related to the genealogies of 
participating families. The committee thought that it might be difficult or impossible to 
construct extended pedigrees expanding for several generations. However, we assured the 
committee that by using our interviewing technique, we would be able to retrieve valuable 
information for our research from constructed pedigrees. The technique is explained in section 
4.7.4.2.  
    The committee thought that asking study’s participants about the history of consanguinity is 
likely to be stressful for participants. Asking about consanguinity history and mating between 
cousins is very unlikely to cause discomfort or psychological harm to participants from the 
targeted population. Almost 50% of marriages in Saudi Arabia are between cousins and this 
practice is highly respected for familial, traditional, and economic reasons. Mating between 
cousins is a lawful action in Saudi Arabia. Therefore, a stigma caused by marriage between 
cousins does not exist in Saudi Arabia.   
 
     The committee expressed concerns about other aspects of data collection. The committee 
requested the investigator to competently inform participants about possible risks and 
inconveniences that might be encountered during data collection. For example, inconveniences 
caused by requesting healthy participants to fast for eight hours before glucose measurement. 
Additionally, we were advised to provide a clear and easy-to-understand explanation of a blood 
glucose measurement and what nuisance it might cause to participants such as the pain caused 
by finger pricking.  
     In relation to the level of FBG in healthy participants, the committee requested a clear 
description of events and procedures taken when a healthy participant appears to have a high 
level of FBG. We clarified this point to the committee and stated that this test is not sufficient to 
clinically detect the status of the disease. Additionally, we stressed that we would be requesting 
participants to seek medical advice from their family doctors and not to take clinical advice 
from the study investigator.  
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    One of the most important concerns shared by the committee was related to collecting buccal 
swabs for the purpose of DNA analysis. The committee recommended seeking approval from 
bodies related to licensing activities related to importing and analysing DNA samples in the UK. 
Ethical approval was only secured when we provided evidence from the relevant authorities 
stating that our protocol is adherent to the regulations laid down by these authorities.  
     
    Other concerns related to the collection of DNA samples involved issues related to the safety 
of samples. The committee was assured that collected swabs were very unlikely to carry any 
risk of transmitting infections whether to the investigator or other individuals handling the 
samples. Additionally, the contamination of samples after collection was prevented by securely 
saving samples in designated isolating tubes.   
    The committee requested a clear description of the methods used to store DNA samples. The 
committee was informed that the principal investigator was responsible for securing the 
collected buccal swabs. Since there were no specific laboratories in the Jazan region where the 
investigator could securely store the samples and since the samples did not require laboratory 
facilities to store them, the principle investigator provided a secure cabinet to store the samples 
in his office. No freezing facilities were required hence samples could be stored at normal room 
temperature.  
      After explaining the storage procedures, we had to ensure that the process of storing samples 
in the UK is in good order. We explained to the committee that related authorities were 
contacted where the nature of the research had been clarified. In order to be able to import the 
samples to the UK, we had to ensure that those samples would not be stored in the UK for a 
period longer than a week and would not be stored once genetic analysis has been conducted.  
     
     Apart from the ethical issues related to collecting, storing and transporting samples, the 
committee stressed the notion of making approached participants entirely aware of the purpose 
of collecting their DNA samples. We had to assure the participants that those samples were 
merely collected to investigate selected risk factors related to type 2 diabetes only. We had to 
emphasise the thought of not utilising this sample for the investigation of any other illnesses. 
Additionally, we had to assure that those samples would never be used to investigate the 
certainty of sibship between siblings of each family.   
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     Security of identifiable data was a concern of the committee. The committee recommended 
not to use paper-based methods when dealing with data that could lead to the identification of 
participants. Therefore, we utilised an electronic database which can be encrypted to store 
information related to addresses and contact details of approached participants. We also used the 
same database to indicate those who we were not recruited to prevent re-approaching. Finally, 
we had to ensure that all other data was anonymised and identifiable data was only accessed by 
the principal investigator. We also stated that all identification data would be deleted at the end 
of data collection.     
      ScHARR's ethical approval was granted on 18
th
 of June 2012. The letter of approval is 
included in Appendix 2. All requirements are detailed in the following sections:  
4.3.3.2 Human Tissue Authority Licence 
      The committee postulated the need for a licence from the Human Tissue Authority (HTA) to 
enable the researcher to import collected DNA samples to the UK. After contacting the HTA 
and explaining the principles of the research, the authority informed the investigator that there 
was no need to obtain a licence, hence the collection of DNA samples was only needed for 
research purposes only, given that samples were anonymised and consent was taken from 
participants to use their samples in the research. The HTA response was forwarded as a part of 
the ethics application and accepted as an official form exempting the study from the licence.    
4.3.3.3 University Insurance 
        The committee advised the applicant to seek University Insurance as a part of the ethics 
application. The committee explained that the insurance is needed since the investigation 
involves the collection of DNA samples from participants. The insurance was granted on 19th 
of April 2012. University insurance is included in Appendix 2. 
4.3.3.4 Construction of Participants’ Information Sheets 
      Two information sheets were made. The first one was for type 2 diabetes patients and the 
second was for healthy participants. Several adjustments were made to the information sheets to 
make them easier to read and understand for a lay person. The information sheets explained to 
the potential participants the importance of their participation in the research and that they have 
the absolute right to reject the participation and withdraw at any stage. The sheets also included 
detailed descriptions of methodology and what participants are expected to do once they agree 
to participate. The sheets explained to the potential participants that the results of the research 
will be anonymised and will not disclose any personal information in case of publishing the 
results. All information sheets were translated to Arabic. Participants’ information sheets are 
included in Appendix 3. 
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4.3.3.5  Construction of consent form 
       A consent form was designed which participants were requested to sign before the 
commencement of data collection. The consent included items related to the declaration of 
understanding information provided in the information sheets, understanding their right to 
withdraw at any stage, and declaring their willingness to give DNA samples. The consent form 
was translated to Arabic. The consent form is included in Appendix 4. 
4.3.3.6 Construction of Interview Script 
        The script explained the process of interviewing participants. The interviews were 
conducted in two main stages. The first stage included pedigrees construction. The applicant 
provided a flow chart to explain the process of asking participants to construct pedigrees. The 
second part of the interview included interviewing participants to fill food frequency and 
physical activity questionnaires.  
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4.4 Study Settings and Recruitment   
      Recruitment of subjects took place in the Jazan region. It is located in the south west of 
Saudi Arabia and is composed of several urban and rural areas. Certain PHCs were targeted, 
based on their having specialised diabetes clinics. The selection of these centres was discussed 
with the Directorate of Health Care in Jazan upon the commencement of the data collection.  
     On 14
th
 of July 2012, a visit was made to Directory of Health in the Jazan region. The visit 
was made to discuss the selection of the most appropriate PHCs. During the visit, we were 
advised to visit selected PHCs within three sectors, namely Jazan, Sabia and Abuarish. These 
sectors cover several large PHCs and cover several urban and rural areas. The Directory of 
Health Care in Jazan brought our attention to the fact that there are no PHCs designated for rural 
areas and most PHCs are located in urban areas. However, large centres are likely to cover 
individuals who come from both urban and rural areas nearby.  
     We received a letter from the Directory of Health in Jazan stating the research mission. The 
letter was directed to all PHCs covered in the three sectors. This letter was used to illustrate the 
procedure of the research to the staff of targeted PHCs. In addition to the letter, the principal 
investigator explained in detail the procedure of the research to the staff working at the diabetes 
clinics. Illustrations to staff included how to identify the target population and specific 
statements used to approach patients.  
     Dr Mousa Altherwee, director of clinical training in the directory, provided a list of the 
largest and earliest-established PHCs in the three sectors. Recommended PHCs were targeted 
and the first recruitment of participants was made on 16
th
 of July 2012. Thirteen PHCs were 
visited during data collection. Map 1 illustrates the distribution of PHCs visited during data 
collection.  
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Map 4.1: Distribution of visited PHCs during data collection:  
  
Almabouj PHC 
AlQa’ariah PHC 
Mehliah PHC 
AlZabiah PHC 
AlBaher PHC 
Albedie PHC 
Sabiah PHC 
Alhusaini PHC 
Sanbah PHC 
Alrayian PHC 
Alghara PHC 
Alfeqra PHC 
AlAreesh PHC 
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       Figure 4.1 shows the research procedure flow chart. Identification of potential participants 
was conducted by PHC staff where identification of patients was based on diagnosis made by 
treating doctors. Treating doctors or nurses approached patients during follow-up sessions 
providing information about the research.  The principal investigator was available at the PHCs 
when health professionals were informing their patients. Those who appeared to be interested 
were informed by their doctors that they could have a brief meeting with the principal 
investigator immediately after the follow-up session. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Research procedure flow chart.  
 
Type 2 diabetes cases were identified and 
approached by PHC staff. Interested patients were 
interviewed by the investigator to assess eligibility.  
Eligible cases were given 
Information sheets and sample of 
questionnaires and their contact 
information were taken to confirm 
a date of a home visit 
Home visit and 
collection of data  
Ineligible cases or those who refused 
were not given information sheets 
and were indicated in the recruitment 
record to prevent re-approaching. 
Confirmation of home visit received 
Yes 
2 or 3 siblings  Single 
patients 
Healthy siblings refused Healthy siblings 
agreed 
No 
Send a 
reminder 
No 
Response 
Cases were indicated in the recruitment 
record as ineligible to prevent re-
approaching. 
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       Once patients agreed to meet the principal investigator, they were asked by the principal 
investigator to assess the availability of healthy siblings. The second step involved the 
identification of healthy participants by asking patients to enquire if their healthy adult siblings 
would be willing to participate. Patients who were not eligible were not recruited. Those who 
were not eligible during the identification and approaching stage were indicated in the 
recruitment record to prevent re-approaching of patients.   
    Approaching the study's participants was performed in four different stages, where each stage 
involved recruiting 100 participants. An electronic recruitment record was established by the 
principal investigator to facilitate the process of approaching and recruiting the study's 
participants. This record involved information about all selected potential participants during 
the identification stage. The record was in Microsoft Excel 2007 format where identifiable 
information such as names, address, and contact details were saved. The Excel file was secured 
by encrypting the file and the principal investigator was the only person who had access to this 
file. Table 4.2 is the recruitment record used to record the details of approached individuals. 
Those who refused to participate, or agreed but not eligible were indicated in the other remarks 
option.  
 
Table 4.2: Recruitment record: 
Other Remarks Address and 
agreed collection 
date 
Contact 
Number 
Names of 
Healthy 
Participants 
Given ID Name 
of 
patient 
PHC Date S. 
No 
  
 
 
  
 
     
 
 
     During the identification stage of patients, the principal investigator provided eligible 
patients with information sheets and samples of questionnaires. Healthy siblings received 
information sheets and questionnaires from their affected siblings. Information sheets included 
the contact details of the principal investigator.  The principal investigator informed the patients 
that they and their siblings had the freedom to call the principal investigator whenever they 
wished to confirm their participation. The principal investigator also informed the approached 
case that they would be reminded by phone about their potential participation after one week of 
receiving the study information sheets. The principal investigator requested the approached case 
to provide a contact number, preferably a mobile number, to facilitate sending a reminder.  
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      Potential participants had the freedom to decide the time needed before giving consent. The 
period before consenting varied between approached individuals. However, for the purpose of 
completing the recruitment on a timely manner, four weeks was presumed as a waiting period 
between providing documents to approached individuals and giving notice of approval to recruit. 
In the majority of cases, approached participants tended to give a decision about participation 
within two or three days.   
     Cases or siblings who did not call the investigator to confirm participation were reminded by 
calls or by sending an SMS text after one week of handing out the sheets. Then we waited for 
the response for another three weeks. If no response was received from approached participants, 
or if they rejected participation, they were presumed uninterested and this was noted in the 
recruitment record. Those who agreed to participate were asked to select a date and address to 
facilitate a home visit and recruitment. Healthy siblings who contacted the principal investigator 
and agreed to participate were requested to provide a contact number to aid in reminding them 
about the fasting needed for the glucose test.  Recruitment time and place were stated in the 
recruitment record.   
      For the information to be useful at least one case and one healthy sibling must agree to 
participate and in case any of them refused or were unable to participate, neither of them was 
recruited. The exception to this condition was made where the patient had at least one sibling 
affected with type 2 diabetes and there were no healthy siblings available to recruit. In situations 
where cases or their healthy siblings disagreed or could not participate in the research, their 
contact information was deleted from the recruitment record. The recruitment record indicated 
those who refused or could not participate. However, the names of index cases were not 
removed from the list to prevent re-recruitment and they were permanently removed once the 
recruitment of participants had ended at each stage. 
     Due to the cultural background of Saudi Arabian populations, families are large compared to 
western populations and siblings are more likely to live in the same neighbourhood. Adult 
siblings, who may have their own nuclear families, are very likely to be neighbours. This 
common traditional behaviour in Saudi Arabia facilitated the process of approaching potential 
study participants.  
     Participating cases and healthy siblings were asked if it was possible to recruit them in one 
home visit. Otherwise, recruitments were planned according to the convenience of cases and 
their siblings. In addition, healthy siblings were called or sent a reminding SMS about fasting 
for eight hours before the measurement of blood glucose a day before the planned home visit. 
However, asking healthy participants to fast before the data collection appointment seemed to 
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reduce the participation rate. Therefore, we decided to give the participants the convenience of 
choosing the most appropriate time to have their FBG measured. In most of the situations, 
healthy participants tended to choose having their blood glucose measured early in the morning 
before their breakfast.  
     On the arranged data collection date, cases and their siblings were requested to sign a 
consent form. They were informed that they had the choice of not participating even if they had 
signed the consent form. They were also informed that it was up to them to answer or give some 
data but not other. Once the consent form was signed, they were ready for data collection. If for 
any reason, healthy siblings were not able to fast before the measurement of blood glucose, they 
were asked if it was possible to rearrange the measurement of blood glucose at their 
convenience.   
     Recruitment of participants was conducted in four stages. Selected cases and siblings at each 
PHCs were approached and recruited in each stage. Once the target of number of participants 
per stage had been achieved, investigators were ready to start the identification, approaching, 
and recruitment process in the following stage in a similar manner to the previous stage. 
Recruitment records were permanently deleted by the end of each stage.  
   Subjects and unaffected family members were interviewed to fill a questionnaire covering 
information about demographics, family tree, food frequency and physical activity. After the 
interviews, unaffected individuals had their physical measurements taken. Height and weight 
were measured to calculate their BMI. We also measured their waist circumference. 
Additionally, we measured their FBG. The final step was the collection of buccal swabs from all 
recruited subjects.  
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4.5 Study Population 
     Patients were identified based on diagnoses made by general practitioners. The investigator 
informed PHC staff about excluding type 1 diabetes cases. In situations where an approached 
case would be suspected to be a type 1 diabetes case, the investigator asked a few questions to 
clarify this issue, such as asking about age at diagnosis, course of treatment, initial use of insulin 
and magnitude of blood glucose upon diagnosis. Patients were excluded if they were confirmed 
type 1 diabetes cases or if answers to any of these questions suggested that the patient 
approached was likely to be a type 1 diabetes case.   
     The initial intention was to recruit cases with available healthy siblings. However, a 
proportion of patients did not have healthy siblings but multiple siblings affected with type 2 
diabetes. A criterion for inclusion was changed to include patients with multiple affected 
siblings with no available healthy siblings. This change of inclusion criterion was made to avoid 
selection bias, since patients with multiple affected siblings are very likely to have a strong 
genetic risk of the disease.  
     Patients were not recruited based on their parental consanguinity. Nonetheless, the frequency 
of consanguinity was expected to be 50% in the targeted population. Approximately half of the 
recruited subjects had a history of parental consanguinity. The subjects of this study were 
restricted to individuals over the age of 18. 
    The third part of this study examined the effect of inbreeding on continuous traits. Recruiting 
type 2 diabetes cases to assess these traits might not be appropriate. Cases are likely to be taking 
medication and experiencing lifestyle changes to manage their disease and these factors will 
consequently have an effect on their BMI, FBG, and waist circumference. To avoid these 
confounding factors, we targeted healthy siblings of the recruited cases to answer questions 
related to continuous traits.  
        In the beginning of the study, we were aiming to recruit participants from both genders. 
However, we restricted the study to male participants. Female participants were extremely 
difficult to recruit due to two reasons.  
      Upon visiting the first PHC, we realised that it was quite difficult to recruit female 
participants. We could not work with female staff at PHCs hence PHCs in Saudi Arabia are 
divided in two sections, for males and females. Male staff are not allowed to enter or work in 
areas designated for female patients. Therefore, it was not possible to identify or approach 
female participants. However, we must clarify that this policy is not usually applied in hospitals 
where working with female staff is more acceptable than PHCs.  
     The second reason adding difficulties to the recruitment of females was due to the cultural 
background in Saudi Arabia. Apparently, recruiting male siblings was easier as male siblings, in 
63 
 
most occasions, were living together. However, the situation for females was reversed. Female 
siblings were less likely to live in the same neighbourhood. Females in Saudi Arabia are very 
likely to be married younger and once they get married, they move to other regions depending 
on the original location of their husbands. This is a standard social behaviour in the country. 
Therefore, female siblings were very unlikely to live together in the same neighbourhood and 
thus recruitment of female participants was found to be impractical.  
     Giving the circumstances, recruiting females would have required a larger budget to fulfil 
two issues. Firstly, we would have required a female investigator to aid in identifying and 
approaching female patients and participants. Secondly, since married female siblings were 
unlikely to live in the same neighbourhood, having to commute to collect data would have 
incurred more cost and time required. For these reasons, female participants were not recruited.    
4.6 Random Sampling 
     Several issues related to this study limited our ability to recruit eligible individuals on a 
random basis. Firstly, we needed to find Type 2 diabetes patients with available siblings who 
could be recruited. Secondly, the recruitment pattern varied according to the cooperation of 
PHC staff. In certain PHCs, the extent of staff cooperation in identifying and approaching 
patients affected the recruitment rate. Therefore, the mode of sampling was mainly opportunistic 
sampling based on the number of patients attending PHCs, cooperation of staff and the number 
of eligible patients.  
4.7 Data Collection Tools 
4.7.1 Introduction 
    The study utilised different collection tools at different settings. At PHCs, a recruitment 
record was utilised to collect data about index cases and information needed to arrange home 
visits. Upon family visits, pedigrees construction was performed, interviews were made to fill 
questionnaires, and physical measurements for body weight, height, waist circumference, and 
FBG  were conducted. Finally, buccal swabs were collected for DNA extraction and genotyping.  
4.7.2 Initial collection at PHCs 
     Once index cases agreed to participate in the research, details in the recruitment record were 
filled. A reference number was utilised to identify families and link siblings to each other once 
data had been anonymised. For example, families were coded by letters and each individual was 
given a number. So the first recruited family was coded AA and the first recruited member was 
numbered 01. So the study reference number of the first recruited case was AA 01.  
     Single patients were coded in a similar manner. The letter ‘S’ was designated to indicate that 
the patient recruited had no available healthy siblings to recruit and a number was given based 
on the order of the patient. For example, the third single patient was given the code S 03. 
64 
 
4.7.3 Data Collection Forms 
     Two forms were mainly used to record collected data. Both forms were anonymised and did 
not include any identification data except for participants’ codes. The first form is illustrated in 
Box 4.1 and is a checklist. This checklist was used to ensure the comprehensiveness of collected 
data. It was also used to indicate measurements which were not possible to be collected at the 
time forms were being filled. Using that form enabled us to indicate whether the item of interest 
was successfully collected, the participant rejected collection, or collection of item was 
rescheduled. Rescheduled time and date of items were stated accordingly. The same form was 
used for single patients or participants who belonged to the same family.     
  
65 
 
Box 4.1: Data Collection Checklist:  
  
Family Code:……………….      Commencement Date:……………….   
1) Patient Code: ………………………… 
Data Collected Refused Rescheduled  Rescheduled Date and Time 
Pedigree     
FFQ     
PAQ     
Buccal Swab     
2) Healthy Participant 1 Code: ………………………… 
Data Collected Refused Rescheduled  Rescheduled Date and Time 
Blood Sugar     
FFQ     
PAQ     
Buccal Swab     
Weight     
Height     
WC     
BW*     PHC Name: 
 
Record 
Number: 
 
3) Healthy Participant 2 Code: ………………………… 
Data Collected Refused Rescheduled  Rescheduled Date and Time 
Blood Sugar     
FFQ     
PAQ     
Buccal Swab     
Weight     
Height     
WC     
BW *     PHC Name: 
 
Record 
Number: 
 
*For BW, state name of registered PHC and record number .  
FFQ: Food Frequency Questionnaire, PAQ: Physical Activity Questionnaire, WC: waist 
circumference, BW: Birth Weight.  
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     The second form is illustrated in Box 4.2. This form was used to collect the data of single 
patients and participants who belong to the same family. In the patients’ section we recorded the 
age of diagnosis of type 2 diabetes, and data related to food frequency and physical activity. For 
healthy participants, we added rows for physical measurement such as weight, height, waist 
circumference, fasting blood glucose.  
Box 4.2: Data Collection Form:  
 
 
Data Collection Sheet 
Date :…………                     Patient's Code:……… 
Data Value 
Age at diagnosis with diabetes  
Daily Calorific Intake  
Number of Weekly Sedentary hours   
Number of hours spent performing moderate activities   
Number of hours spent performing vigorous activities  
 
Date :…………                     Healthy Participant 1 Code:……… 
Data Value 
Daily Calorific Intake  
Number of Weekly Sedentary hours   
Number of hours spent performing moderate activities   
Number of hours spent performing vigorous activities  
Fasting blood glucose  
Weight  
Height  
Waist Circumference  
 
Date :…………                     Healthy Participant 2 Code:……… 
Data Value 
Daily Calorific Intake  
Number of Weekly Sedentary hours   
Number of hours spent performing moderate activities   
Number of hours spent performing vigorous activities  
Fasting blood glucose  
Weight  
Height  
Waist Circumference  
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4.7.4 Pedigrees Construction 
4.7.4.1 Introduction 
     Constructing pedigrees of recruited families enabled us to calculate inbreeding coefficients. 
It aided in illustrating the mode of mating between parents in each family pedigree. Participants 
codes were indicated in the constructed pedigrees as illustrated in Figure 4.2. The pedigree 
drawing tool is depicted in Figure 4.3 and it was freely provided by the National Genetic 
Education and Development Centre – NHS.  
4.7.4.2 Purpose of using pedigrees to calculate inbreeding coefficients 
      Although using pedigrees is a simple yet effective method to calculate inbreeding 
coefficients, the limitedness of extending pedigrees to cover several generations would result in 
the inability to provide the exact estimate of inbreeding coefficients. Lately, another method has 
been introduced to measure the inbreeding coefficients from genomic data. However, this 
method requires large number of markers to be measured in order to enable a precise estimate of 
coefficients. For example, one study selected 1000 markers expanded on several regions in the 
DNA to measure inbreeding coefficients (259).   
      Given the large cost of estimating inbreeding coefficients from genomic data and due to the 
limitedness of our study, we had to resort to using genealogical data to estimate inbreeding 
coefficients. Additionally, the relation between inbreeding coefficients calculated from genomic 
data and genealogical data has been reported to be correlated. A study using both methods to 
calculate inbreeding coefficients in a sheep population reported a reasonable agreement between 
the two methods (R2 of 0.5353,  β: 0.6092) (260). 
4.7.4.3 Construction Process 
     It was preferable to arrange a home visit where both the case and healthy siblings were 
available to improve the pedigree construction process. If interviewing both the case and healthy 
sibling was not possible on the same occasion, interviews were conducted separately. If one 
member of the family (whether the case or the healthy sibling) was interviewed and was able to 
construct a pedigree where all required information was confidently given, there was no need to 
ask the other member questions related to pedigree construction as they will have the same 
inbreeding coefficient. In certain occasions, participants unconfident about their family tree 
were able to ask older family members who were able to give missing information.  
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Figure 4.2: Example of a pedigree and explanation of symbols.  
 
     
 
 
 
 
  
 
 
 
Figure 4.3: Pedigree drawing tool.  
 
 
Index Case  
Code :AA 
01 
Unaffected 
Code :AA 
02 
Unaffected 
Code :AA 
03 
              Male, Unaffected. 
              Female, Unaffected 
               Male, Affected  
               Female, Affected   
              Deceased 
               Related mating. 
               None-related Mating. 
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     Pedigree constructions were performed in two steps. In the first step, the researcher asked the 
participants about the names of siblings, parents, grandparents or great grandparents and stated 
their positions in the pedigree accordingly. This step made it easier for participants to remember 
their family history. The second step included replacing all written names with anonymised 
symbols and codes. Pedigrees which contained names were given to participants to keep. 
      Pedigrees were drawn on A4 paper. Anonymised pedigrees did not contain any names or 
any identifiable data. It only contained codes linking participants to other collected data. The 
investigator drew family trees using questions depicted in Figure 4.4. These questions were 
ordered where the investigator drew symbols according to answered questions starting from the 
bottom of the page.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Pedigrees construction guidelines.  
Are your paternal grandparents cousins? 
 
Are your maternal grandparents cousins? 
 
Are any of your great grandparents cousins? 
 
No further questions 
asked 
 
Number of brothers? 
 
Number of sisters? 
 
Are any of your brothers or sisters affected with type 2 diabetes? 
 
Are either of your parents affected with type 2 
diabetes? 
Are your parents related? 
 
Yes 
 
No 
 
No further questions 
asked 
 What is their relationship? 
 
Are any of your grandparents related? 
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4.7.4.4 Calculating inbreeding coefficient 
     Inbreeding coefficients calculations were based on drawn pedigrees. An inbreeding 
coefficient measures the probability of having two alleles that are identical by descent from a 
common ancestor. One of the methods of calculating inbreeding coefficients is called the path 
method (261). This method relies on the number of parents traced from an individual to a shared 
common ancestor. Inbreeding coefficients using the path method can be calculated by using the 
following formula: 
    (
 
 
)
 
       
Fx is inbreeding coefficient of individual. 
n is the number of parents connecting between the individual and the common ancestor.  
FA is the inbreeding coefficient of the common ancestor.  
 
4.7.4.5 Introducing new concepts in pedigree construction 
      Several mating systems had been observed during the data collection of the first phase. 
Marriages were, as expected, between non-related, first cousins, second cousins, third cousins, 
and marriage between an individual and a cousin of his parents. However, we observed two new 
relatedness values that have to be considered during the calculation of inbreeding coefficients. 
Therefore, we developed two new concepts when drawing pedigrees to aid in measuring these 
relatedness degrees. Marriage can be between individuals who are from the same tribe or 
subtribe. This relatedness degree was described when the participant interviewed did not exactly 
know who the common ancestor was.  
     It was relatively easier for those who could not describe the relatedness between their parents 
as third degree cousins or less to reveal that their parents are from the same tribe or subtribe. 
Figure 4.5 is an example of a tribe structure observed during data collection. It can be easily 
observed the sort of variation within the tribe and the degree of relatedness between individuals 
of interest.  
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Figure 4.5: Example of mating of individuals from shared tribe.   
        
     Here we examine mating between Individual A and Individual B. Individual A belongs to a 
subtribe 1, and individual B belongs to a subtribe 5 and both subtribes belong to the tribe X. It is 
not clearly apparent what sort of inbreeding coefficient could be estimated for their offspring. 
However, since they belong to the same tribe and are distantly related, there should be a small 
degree of inbreeding which is definitely smaller than those who are siblings of first degree or 
second degree cousins. Similarly, parents who belong to the same subtribe are likely to have an 
inbreeding coefficient smaller than those who are first cousins but definitely bigger than those 
who belong different subtribes but share the same tribe. 
       Estimating the exact inbreeding coefficients of individuals whom their parents are from the 
same tribe or subtribe is almost impossible. Therefore, we made an assumption to generate 
coefficients for those who belong to the same tribe or subtribe. The estimation is explained in 
Figure 4.6.  
 
 
 
Tribe X 
Subtribe1 Subtribe2 Subtribe3 
 
Subtribe4 Subtribe5 
 
Individual A 
 
Individual B 
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Figure 4.6: Estimation of inbreeding coefficients for mating of individuals with a shard 
tribe or subtribe.  IC: Inbreeding Coefficient.  
 
 
 
 
 
2nd Generation 
Generation of Individual X 
2nd Generation 
3rd  Generation 
4th  Generation 
5th  Generation 
6th  Generation 
7th  Generation 
8th  Generation 
9th  Generation 
10
th
  Generation 
IC for 1st  cousins: 0.0625 
IC for 2nd cousins: 0.0156 
IC for 3rd cousins: 0.0039 
      An assumed IC for parents from the same 
subtribe: 0.0002  
Equivalent to fifth degree cousins.   
     An assumed IC for parents from the same 
tribe: 0.00001 
Equivalent to seventh degree cousins.   
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     Figure 4.7 is a pedigree drawn to explain how inbreeding coefficients are estimated when 
utilising the new concepts introduced. The parents of the individual of interest are second 
degree cousins. In addition, there is a complicated network of relationships where several great 
grandparents belong to the same subtribe or tribe. We have calculated 15 pathways related to the 
shared tribe, one pathway related to the shared subtribe and two pathways related to a degree of 
second cousins. Calculated the inbreeding coefficients of parents with second degree cousins is 
0.0156 but once all other distant pathways are considered the coefficient is increased to 0.0169. 
This estimation although not precisely correct, takes into consideration other pathways that are 
difficult to ascertain such as a common ancestor in a subtribe or a tribe.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Estimating of inbreeding coefficients for a person utilizing the new concepts.      
 
Shared Subtribe Shared Subtribe Shared Subtribe 
Shared tribe 
Individual of Interest 
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4.8 Questionnaires 
4.8.1 The Purpose of Using Questionnaires 
       Environmental variation explains a large proportion of type 2 diabetes variations. Therefore, 
measuring the environmental variation between individuals is an important step in explaining 
the variation in the incidences of type 2 diabetes. Measuring daily calorific intake and level of 
physical activity may partially explain type 2 diabetes variations. Once the measurable 
environmental conditions of subjects has been established, we can then have a better 
understanding of the genetic effect on type 2 diabetes incidences.   
    In addition to measuring environmental variations between study subjects, questionnaires 
were utilised to collect the demographic data of the participants. The demographic section 
included questions about age. For type 2 diabetes cases, a question was added to ask about the 
age of the onset of the disease.  
4.8.2 Measuring food intake 
4.8.2.1 Exploration of methods used to measure food intake 
4.8.2.1.1 Dietary Recall 
     Dietary recall is one of the methods used to measure food intake. It depends on the ability of 
individuals to recall food and beverages consumed in a specific period of time, usually 24 hours 
(262). However, performing one interview might not be enough to provide an overall of dietary 
intake of participants. UK Low Income Diet and Nutrition Survey (LIDNS) performed four 
different 24 hours dietary recalls within a 10 day period (263). Conducting several interviews 
using this method is needed to avoid variations of food and beverage consumption exhibited 
between different days of the week.  
      Interviews conducted to record dietary intake during the previous 24 hours usually go 
through several steps. Firstly, interviewers would ask participants to recall all the items taken 
during the previous 24 hours. Once all items consumed have been provided, further details are 
requested for each food item. Details include exact time of consumption, a description of food 
item or specific brand name, recipes and method of cooking, quantity and portion of each food 
item and any combination of consuming several food items in one occasion. A final 
chronological review of all descriptions given is conducted by the end of the interview (263).  
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      This method has advantages such as a proper record of the quantity and portion size of food 
items and shorter period of recall given to estimate food intake. However, it has other 
disadvantages including increased cost and time needed to collect data over several occasions. 
Therefore, this type of measurement is usually applied to individual cases and less likely to be 
suitable for large mass investigations (264).   
4.8.2.1.2 Food Records 
     In this method, participants are asked to record their food intake on a daily basis. It does not 
rely on memory and participants can prospectively record their intake of the day. Participants 
are given a booklet which contains instructions about recording the type of food, brand name, 
cooking method and recipes. It also includes a description about portions of consumed food and 
beverages, and in some situations the weight of consumed food and waste food can be measured 
and recorded in these booklets (265).  
    This method does not require trained interviewers. However, participants have to be literate 
and educated about using the booklets and measuring weights of consumed food. Unlike dietary 
recall, seven days of recording is usually conducted to avoid bias caused by recalling food 
intake in only one day of the week (265).  
     Food records have the advantage of precisely recording consumed items and avoiding recall 
error. Additionally, weighing consumed items is likely to give a better estimate of intake 
compared to the recall of portion size. Although this method is less expensive as no interviewers 
are required, illiterate individuals cannot participate. Additionally, the process of recording food 
items might vary between different individuals based on motivation levels and literacy levels 
and thus lead to biased estimates of food intake. Finally, participants might tend to change their 
eating habits while recording their intake since they might become more conscious about their 
food intake.   
4.8.2.1.3 Food Frequency Questionnaires  
     In this method, participants are asked how frequently they consume several food items over a 
fixed time period (usually a year). Several frequencies can be reported varying from never to 
several times per day. Frequencies are usually fixed and similar in all items listed. A 
comprehensive food frequency questionnaire usually contains a large number of items 
commonly consumed in the target population.  
     This method can be self-administered or completed during interviews. These questionnaires 
are usually closed-ended but can contain open-ended sections to add food items not listed. 
Additional to the food items list, methods of cooking or the addition of other nutritional 
supplements can be integrated to the questionnaire. An average portion size is estimated for 
each food item.   
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    Although this method represents a comprehensive coverage of frequencies of consuming 
variety of food items, this method intensively relies on recall over a longer period of time 
compared to the 24 hours recall. Additionally, the estimation of average portion sizes is difficult 
and may vary between different individuals. Unlike food diaries and 24 hours recall, a food 
frequency questionnaire designed for a specific population cannot be utilised in another 
population and modifications are usually needed. Finally, the cost of using this method might 
increase if used in populations with high illiteracy rates.  
   Nonetheless, this method is more suitable for large-scale epidemiological studies compared to 
24 hours food recall or food diaries.  Using this method in large studies can be less expensive, 
easier and faster to conduct. Because responses to the questionnaires are usually fixed, analysis 
of food intake can be easier and less time consuming compared to other methods (266).   
4.8.2.1.4 Agreement between food frequency questionnaires and other methods 
     Several differences between administration and analysis of methods used to measure food 
intake mandate different analytic outcomes from each method. However, several studies have 
been conducted to measure the variability of outcomes of these methods. These studies revealed 
a reasonable agreement between the usages of food frequency questionnaires, 24-hour recall and 
food diaries.    
       One study made a comparison between three-day food diaries and semi-quantitative food 
frequency questionnaires. Three-day food records were conducted four times in a year to detect 
seasonal variations. The overall average calorific intake calculated from food diaries was similar 
in both methods. The Pearson correlation coefficient between the energy intake calculated in 
both methods was 0.42 after adjusting for sex (267). Similarly, another study assessed the 
association between seven day diary records and food frequency questionnaires and revealed a 
similar agreement (268). However, one study reported a significant effect of gender on the 
difference between energy intakes calculated from seven days diary records and food frequency 
questionnaires. While the energy intake in both methods was similar in males, the energy intake 
estimated from food frequency questionnaires was higher in female subjects compared to seven 
days food diaries  (269). 
     A similar agreement has been observed between using food frequency questionnaires and 24-
hour recall. A study investigated the association by conducting 12 different sessions to measure 
24-hour recall on a monthly basis over a year. Food frequency questionnaires were answered. 
The Pearson’s correlation coefficient between energy intakes estimated in both methods was 
0.77 in males and 0.62 in females (270).  
77 
 
 
4.8.2.1.5 Selecting food intake measurement method 
     Selecting a convenient and robust method to measure the variation of food intake between 
participants is a vital issue. However, utilising food diaries and food recodes would have been 
costly and time consuming if applied to our study design. Due to the reasonable agreement 
between food frequency questionnaires and other methods, using a food frequency questionnaire 
was a suitable option. Additionally, the large scale of this study mandated using food frequency 
questionnaires for easier administration and analysis.   
    An effort was made to find a comprehensive and easy method to fill in food frequency 
questionnaires. In addition, we were aiming to find questionnaires relevant to the Saudi 
population. We found several studies which measured the eating habits of Saudi subjects. We 
contacted the authors of these studies but unfortunately our efforts were fruitless. Out of three 
authors, only one replied to our request and the one who replied informed us about the 
impossibility of using their questionnaire.   
   Although we could not find food frequency questionnaires related to the Saudi population, we 
did find several questionnaires related to other populations. We found questionnaires which had 
been utilised in the USA, UK and China. Comparing these questionnaires clearly indicates a 
difference in listed food items. This signifies the importance of expecting variations between the 
food items listed in these questionnaires and the kind of food available in Saudi Arabia.  
    By comparing found food frequency questionnaires, we found a questionnaire designed by 
the European Prospective Investigation into Cancer Study (EPIC) Norfolk to be the most 
comprehensive tool for measuring food frequency (Appendix 6). In addition, its layout makes it 
easy to understand and fill in. We contacted one of the EPIC team members for permission to 
use the questionnaire and this was granted. However, we needed to perform several adjustments 
to make this questionnaire suitable for Saudi subjects.  
4.8.3 Measuring physical activity 
     In addition to finding questionnaires related to food frequency, we found several 
questionnaires concerned with measuring physical activity. Similarly, we could not find 
physical activity questionnaires conducted in a Saudi population. However, a physical activity 
questionnaire designed by EPIC was the best one to utilise in this study due to the same reasons 
found in the food frequency questionnaire (Appendix 7). Permission to use was granted, 
although adjustments were necessary to make this questionnaire more relevant to Saudi society.  
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4.8.4.Adjusting questionnaires 
 The food frequency questionnaire and physical activity questionnaire produced by the EPIC 
were mainly used to measure environmental variations in European subjects. In this study, 
several adjustments were proposed to make these questionnaires more relevant to Saudi subjects. 
A list of all changes is reported in Appendices 8 and 9.  
 
4.8.5 Questionnaire Translation and Answering 
     All questionnaires were transformed from paper-based questionnaires to electronic forms. 
Questionnaires were designed in a similar format to the EPIC questionnaire using Visual Basic 
2010. All questions were written in English during the programming and construction of the 
interface. Instant translation of questions from English to Arabic was made by the investigator 
during the data collection sessions. All participants were interviewed by the investigator and all 
data was entered immediately into the programme during data collection.  
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4.8.6 Food Frequency Analysis Programme 
4.8.6.1 Development of Nutrition Database 
4.8.6.1.1 Purpose of constructing Nutrition Database 
    The main purpose of constructing this database is to provide estimates of the average calorific 
value of a variety of food items most frequently consumed in Saudi Arabia. No effort was made 
to estimate nutrients or minerals available in each food as this goes beyond the interest of this 
research. Reported calorific values were later fed into the programme to facilitate the 
calculations of average calorific intakes.   
4.8.6.1.2 Format of Nutrition Database 
     A database was created using Microsoft Excel 2007. Using an Excel database is a convenient 
choice as it allows easier data entry utilising a spreadsheet. Excel database also facilitates 
performing calculations which can easily be copied and pasted on multiple rows. Figure 4.8 
gives an example of how the calculation of average calorific intake is estimated based on the 
frequency of food consumption. Figure 4.9 is a copy of the first line of the database. The 
database contained columns for type of foods, portion size, calorific values based on average 
frequency, source of calorific estimate.  
     The daily contribution of each food item was estimated in a similar manner to the way the 
EPIC food frequency questionnaire was analysed using Compositional Analysis from 
Frequency Estimates (CAFE) software (271). It was estimated by multiplying the average 
frequency of each food item by the calorific value of each food item. Those who consume a 
food item never or less than once in a month were given a value of zero for daily contribution. 
Other frequencies were converted to daily frequencies. A food item which is consumed from 
one-three times per month was given a daily frequency of 0.07. This daily frequency was 
calculated by dividing two (which is a midway point between one and three indicated in the 
choice) by 30.  The resulting number was rounded to 0.07. A food item which is consumed once 
a week was given a daily contribution of 0.14. This was calculated by dividing one by seven. 
Remaining figures were estimated in a similar manner.  
 
 
 
 
 
 
80 
 
 
 
 
 
 
 
 
Figure 4.8: Calculation of average calorific intake based on frequency of consumption. 
 
 
 
 
 
 
 
 
Figure 4.9: Copy of the first two rows of the Nutrition Database.  
 
 
 
 
 
Average Frequency of food items and estimated calorific 
contribution based on frequency. 
Type of 
Food 
Source or estimate 
based on ingredient 
Portion Size 
This formula calculates average calorific intake of a food item based on 
frequency and calorific value. The calorific value of the food indicated in 
the figure is entered in cell number D3. Microsoft Excel allows formulae to 
be copied and pasted in cells and the number of cells is automatically 
changed according to row and column. For example, the average daily 
calorific contribution of eating Chicken Kabsa five to six times per week is 
D4*0.79. D4 is automatically changed to D5 once the indicator moves to 
the following row.  
 
Cell D3 
Conversion of frequencies to a daily frequency of consumption 
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4.8.6.1.3 Estimation of calorific values 
     The calculation of the average calorific value of each food item was based on the type of 
food and average portion size. Calorific values were retrieved from two main databases, USDA 
National Nutrient Database for Standard Reference (USA) and Canadian Nutrient File (CNF). 
Food items which were not found in these two databases were retrieved from other databases or 
websites. Certain local food items in Saudi Arabia were not available in any database. The 
calorific values of these items were estimated using recipes of each kind of food. The calorific 
values of ingredients were retrieved from the USDA and CNF. The source or ingredients of 
each food item are indicated in our nutrition database including URL links to certain websites. 
constructed Nutrition Database is illustrated in appendix 10. 
     The method of cooking was incorporated in our estimates of calorific value. Rather than 
asking about the frequency of consuming raw food, we asked about the frequency of consuming 
food items the way they are served. Using this method, we incorporated all ingredients 
including usage of oil or butter in preparing food items. The choice of oil or butter was based on 
the ingredients of each recipe. Methods of cooking were consulted from several recipe websites 
as indicated in Appendix 10. Certain food items were more likely to be cooked using oils while 
others were more likely to be prepared using butter. In addition, the methods of cooking food 
items were also included where different estimates were given for the same food based on 
whether it was grilled, fried or stewed.  
     Average estimates of serving size were given according to type. There is no specific database 
where portion size of Saudi food items could be retrieved. However, for food items available in 
Saudi Arabia and are similar to items available in the USDA or CNF, serving sizes suggested by 
these two databases were used as a portion size. For other items unique to the Saudi society, we 
had to give best estimates based on serving methods.  
      Portion size varies according to the type of food served. Portion sizes are detailed in the 
nutrition database.  For example, Kabsa, a famous Saudi dish was assumed to be served in a 
400g portion because this item is served as a lamb Kabsa or chicken Kabsa which is cooked and 
served with rice. However, for dishes which are likely to contain meat only, a 200g portion size 
was assumed. For most pastries, sandwiches, salads, and vegetables portion size varied between 
100g to 170g.  For fruits, an average medium fruit, slice, or serving was specified for each kind. 
For sweets, biscuits and cakes, the average serving size varied between 100g to 150g except for 
snack bars and toffees which were given smaller portion sizes according to the way they are 
packaged. For dairy products, 100ml portion size was assumed. Other dairy products such as 
yogurt and cheese were given a portion size between 50g and 100g. A spoon of mayonnaise, 
jam, or honey was given a portion size of 15ml.  Milk added to coffee or tea was given portion 
size of 15ml. Most drinks were given a value of 100ml except for soft drinks which were given 
a portion size of a standard can.  
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4.8.6.2 Construction of programme interface by Visual Basic 2010 
 
     An easy-to-operate interface was designed to facilitate interviewing participants and entering 
their responses into the programme immediately. The programme is composed of five main 
components: database navigation bar, identification data section, questionnaire, database, and 
calculation button. These components are indicated in figure 4.10. Visual Basic 2010 was used 
to create this programme. The style of the interface is similar to the format of the EPIC food 
frequency questionnaire.  
 
 
 
 
 
 
Figure 4.10: Food Frequency Analysis Programme. 
 
 
      
 
 
Program Database Calculation Button 
Participants Identification Data 
Questionnaire 
Database Navigation Bar 
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      The main function of the database navigation bar is to allow the creation of new fields for 
each interviewed participant. It can also enable navigation between fields. The navigation bar 
has a saving icon which enables answered questions to be saved in the programme database.  
 
    The programme has a feature of identifying participants via entering given codes, age and sex 
of each participant. Once this information is entered in their designated text boxes, the 
interviewer was able to save this data alongside their answered questions. Upon designing the 
programme database, the ID was selected to be a unique value and thus used codes cannot be 
used again. Saving identification data is performed by pressing the saving button in the 
navigation bar.  
 
    The questionnaire section of the programme was designed in a similar format to the EPIC 
food frequency questionnaire. Figure 4.11 shows a description of the first four lines of the 
questionnaire. The first line is composed of 11 tabs where the user is able to navigate between 
types of food while interviewing participants. The second line states the frequency of food 
consumption in a similar way to the EPIC food frequency questionnaire. The final column of 
the questionnaire was added to give an estimate of the calorific contribution of selected food 
and selected frequency. Different background colours were used to facilitate distinguishing 
between different food items. The interviewer is able to select the frequency of consuming each 
food item by selecting a corresponding radio button.  
 
 
 
 
  
 
 
 
 
 
Figure 4.11: Sample of the questionnaire.  
 
        
 
Average calorific value will 
be displayed here 
Interviewer is able to select a 
radio button which 
corresponds to the selected 
frequency  
Food 
column 
Interviewer is able to navigate between 
food categories by selecting tabs 
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    Figure 4.12 shows a sample from the program database and calculation button. Once all 
questions are answered and the calorific contribution of each food item has been calculated, the 
interviewer will be able to save all entered data into this database. The data of each participant 
will be saved in a designated row. Each row is linked to the anonymised identity of participants 
by their unique IDs, age and sex. A database scrolling bar will allow navigation between food 
items.   
 
 
 
 
 
 
 
Figure 4.12: Program database and calculation button 
 
4.8.6.3 Programming 
      The programme was designed to perform three main functions. The first function is to 
facilitate interviewing subjects about their frequency of consuming various food items. The 
second function is to perform calculations of average calorific intake. The third function is to 
save performed calculations.  
       Coding for calculations was performed through several steps. The first step was to assign a 
value for each food item. 137 different food items were given numeric values. For example, the 
first food item was given the value of (num 1) using the following code  
''Dim num1 As Single''. ''Dim'' symbolises an identification method used to assign the indicated 
value (num1 in this example) as a single to allow saving the value as a numeric value.  
 
       Figure 4.13 illustrates the second step of coding. This step is initiated by assigning a label 
for each food item that is displayed on the interface. For example, the label indicating the 
calorific value of Lamb Kabsa was named ''Label11''. Labels are usually coded in text format 
and a code was used to convert labels to numeric values. For example, label11.text was 
converted to a numeric value by using the code ''Val(label11.text)''. The converted value was 
linked to the designated numeric value of the food item by typing ''Num1= Val(label11.text.). 
Using these codes allows numbers displayed in labels to be used in formulae needed to calculate 
the average calorific value of each food item and the total calorific intake of each participant.  
Identification data 
Calorific value 
saving area Scrolling bar 
Calculation 
button 
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Figure 4.13: Second step of coding. 
 
      Each line (as displayed in Figure 4.13) contains nine radio buttons. Each button represents a 
specific frequency. Each radio button has a name and was assigned a numeric value. These 
values were assigned by manually feeding values calculated in the nutrition database into these 
radio buttons. An example of the process of naming radio buttons is explained in Figure 4.13.  
 
 
Assigning numeric values to each radio button is performed using codes displayed in the 
following example:  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If RadioButton631.Checked = True Then 
            Label121.Text = 141 * 6 
        ElseIf RadioButton632.Checked = True Then 
            Label121.Text = 141 * 4.5 
        ElseIf RadioButton633.Checked = True Then 
            Label121.Text = 141 * 2.5 
        ElseIf RadioButton634.Checked = True Then 
            Label121.Text = 141 
        ElseIf RadioButton635.Checked = True Then 
            Label121.Text = 141 * 0.79 
        ElseIf RadioButton636.Checked = True Then 
            Label121.Text = 141 * 0.43 
        ElseIf RadioButton637.Checked = True Then 
            Label121.Text = 141 * 0.14 
        ElseIf RadioButton638.Checked = True Then 
            Label121.Text = 141 * 0.07 
        ElseIf RadioButton639.Checked = True Then 
            Label121.Text = 0 
        End If 
 
1: This column 
represents labels 
where calorific 
values will be 
displayed. Label 
indicated here is 
''Label11'' 
2: Radio button under the frequency ''never'' was 
named ''RadioButton1''. Radio button under the 
frequency ''1-3 times/month'' was named 
''RadioButton2''. Remaining radio buttons were 
named similarly.  
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       Using these codes allows the programme to display calorific values based on selected 
frequency. For example, if ''RadioButton634'' was checked, the programme will display the 
value ''141'' in label121. Radio button 634 corresponds to the calorific value of one fried egg 
consumed once per day. Other radio buttons are given values in a similar manner.    
 
      All labels created in this programme and assigned a numeric value will display the average 
daily calorific contribution of each food item. As all labels were converted to numeric values, it 
is possible to apply a formula to calculate the average daily calorific intake of each participant. 
The formula was created by using the following code 
total.Text = num1 + num2 + num3… +num137 
 
       This code combines all numeric values of all selected food items. Calculating total daily 
calorific intake is the final step of calculations performed by the programme.  
 
    The final step of coding of the programme is codes used to save calculated values. The daily 
calorific contributions of food items are displayed in designated labels. Labels were then linked 
to the programme database using a code shown in the following example: 
 
    The code ''Lamb_KabsaTextBox.Text'' represents the assigned cell in the programme 
database. Pressing the saving icon will send all calorific values shown in the labels to their 
corresponding cells in the programme database.  
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4.8.6.4 How to operate the programme 
 
     Steps of using the programme are displayed in Figure 4.14. The steps are in order from first 
to last. The process is ended by pressing the saving icon which will save all entered data and 
calculated values in the database.   
 
 
 
Figure 4.14: Food Frequency Programme Manual.   
1. Create a New Profile for Each Participant. 
2.Enter ID, Age and Sex of Participant. 
3. Select Food Category.  
4. Select Food Frequencies.  
5. Press this button to display daily calorific contribution of selected 
frequencies.   Pressing this button also calculates the total and displays it 
in the designated space for the total. If no frequency was selected for any 
food item, the word ''Missing'' will be displayed until selecting an 
appropriate frequency.  Once a page is completed, user can now move to 
the following page and repeat steps 3, 4, and 5.  
 
6. Save calorific values in 
the database. 
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4.8.6.5 Adding food items not included in the programme 
 
       We added another feature to the programme to allow adding food items not coded in the 
programme. Figure 4.15 illustrates the format of this feature. This feature was integrated in the 
last page of the software and it simply allows the interviewer to directly add food items and add 
given frequencies. This new information is saved in the software database once the operator 
presses the button save. The calorific values of the newly-added items are estimated in a similar 
manner used to construct the nutrition database.  
 
 
Figure 4.15: Feature used to add new items and frequencies.  
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4.8.7 Physical Activity Analysis Programme 
4.8.7.1 Purpose and analysis: 
     The physical activity analysis program was designed to facilitate interviewing participants, 
feeding their responses into the programme to facilitate data entry and perform data analysis. 
The programme is designed to look similar to the EPIC physical activity questionnaire. 
However, the analytic approach intended for this questionnaire mandated changes to certain 
categories. Once all questions have been answered, the programme will be able to calculate the 
hours per week spent in sedentary activities or hours spent performing moderate or vigorous 
activities.  
 
4.8.7.2 Constructing interface by Visual Basic 2010 
       Visual Basic 2010 was used to create an easy-to-use interface to facilitate interviews and 
data entry. The programme is composed of five components, database navigation bar, 
identification data section, questionnaire, results and calculation button, and the programme 
database. The format of the programme is slightly different than the EPIC questionnaire where 
tables have been replaced by ''Combo Boxes" which is a good alternative aiding in making the 
questionnaire shorter and easier to handle. Figure 4.16 describes the components of physical 
activity analysis programme. 
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Figure 4.16: Physical Activity Analysis Programme. 
 
 
      The database navigation bar, participants identification data, programme database, and 
calculation button are similar in design and function to the ones explained in the food frequency 
analysis programme. However, the questionnaire part of the programme is composed of four 
different tabs where each tab has a category of physical activity. In addition, several data entry 
tools have been introduced to this questionnaire such as using combo boxes where interviewers 
will be able to choose from a list of choices and text boxes into which the interviewer can enter 
numeric values.  
 
 
 
 
Example of Combo Box.  
Program 
Database 
Results and 
Calculation Button 
Questionnaire 
Participants Identification Data 
Database Navigation Bar 
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4.8.7.3 Programming 
4.8.7.3.1 Assigning numerical values and combo boxes 
       Similar to assigning numerical values to variables in the food frequency analysis 
programme, physical activities were assigned numerical values to aid in the analysis process. 
For example, the number of hours slept during a week is assigned the value of 
"numtotalsleeping". Assigning the value was performed using the code: ''Dim numtotalsleeping 
As Single''. ''Dim'' symbolises an identification method used to assign the indicated value 
(numtotalsleeping in this example) as a single to allow saving the value as a numeric value. 
Using the method will allow applying formulae on entered data.  
 
      Combo boxes were used to replace lengthy columns and tables. Coding of all combo boxes 
in this programme was similar. However different values were utilised for certain questions. For 
example, the frequency of climbing stairs at home was designed using a box called 
''ComboBox1".  A list of choices were entered in the box using the following codes: 
.  
ComboBox1.Items.Add ("None") 
        ComboBox1.Items.Add ("1-5 times a day") 
        ComboBox1.Items.Add ("6 to 10 times a day") 
        ComboBox1.Items.Add ("11 to 15 times a day") 
        ComboBox1.Items.Add ("16 to 20 times a day") 
        ComboBox1.Items.Add ("More than 20 times a day") 
 
Once these codes have been entered, the combo box would appear as shown in figure 4.17.  
 
.  
 
Figure 4.17: List of choices used in ComboBox1. 
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4.8.7.3.2 Coding Formulae 
     The analytic function of this programme was designed to calculate the average number of 
hours per week spent performing sedentary activities, moderate activities or vigorous activities. 
Table 4.3 summarises the process of sorting physical activities into these categories. These 
activities were already indicated in EPIC physical activity questionnaire. Activities which are 
more likely to cause an increase in heart rate and consume more calories are assumed to be 
vigorous activities. The total number of hours per week spent performing sedentary, moderate, 
or vigorous activities were calculated by summing the total of hours per week spent performing 
activities in each column.  
 
Table 4.3: Sorting of physical activities:  
Sedentary activities Moderate activates Vigorous activities 
Sleeping Walking Climbing Stairs 
Watching TV  Cooking Walking carrying things at work 
Driving Shopping Jogging 
Sitting at work Cleaning the house Running 
 Laundry Football 
 Caring for children Weight lifting 
 Caring for elderly Conditioned exercise 
 Standing at work Swimming competitively  
 Volleyball Mountain climbing 
 Leisure swimming Tennis 
 Fishing  
 Gardening  
 Home maintenance   
 Table tennis  
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4.8.7.3.2.1 Coding Combo Boxes 
       A part of calculating the number of hours spent performing physical activity is to assign 
numerical values to choices listed in combo boxes. Fixed values were used to facilitate the 
analysis of choice. Table 4.2 gives an illustration of the values assigned for choices given in 
combo boxes. 
Steps of calculating number of hours per week spent climbing stairs (AT HOME): 
1. The number of 10 steps was assumed to be a standard number of steps climbed during each 
flight as assumed in the EPIC physical activity questionnaire. For the purpose of estimating time 
spent climbing stairs, one second was assumed as the time needed to climb one step. Therefore, 
10 seconds would have been spent while climbing 10 steps.  
2. Number of minutes (approximately)  spent climbing stairs in each choice was assumed as 
follows: 
- Choice 1: None: given a value of 0 minutes. 
- Choice 2: 1-5 times a day: given a value of 1 minute spent climbing stairs every day. 
3. Minutes were converted to hours per week according to each choice by using the following 
formula: 
Choice 2: (1 minute / 60 ) * 7 = 0.12 hours per week 
 
4. As participants might give different a frequency of climbing stairs at home during weekdays 
and weekend, the following formulae were used to assign different values to time spent 
climbing stairs at home during weekends or weekdays:  
Choice 2: Stair climbing during weekdays = (5/7) * 0.12 hours per week = 0.08 hours/week                                                                            
                 Stair climbing during weekends = (2/7) * 0.12 hours per week = 0.04 hours/week 
5. These values were later transferred to the programme during the coding phase as 
illustrated in Table 4.2.  
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Steps of calculating number of hours per week spent climbing stairs (AT WORK): 
1. Number of steps and time spent climbing was calculated in a similar manner to stair 
climbing at home.  
2. Number of minutes (approximately)  spent climbing stairs in each choice was assumed 
in a similar manner to stairs climbing at home as follows: 
- Choice 1: None: given a value of 0 minutes. 
- Choice 2: 1-5 times a day: given a value of 1 minute spent climbing stairs every day. 
3. Proportion of months spent working at job1 during last year = number of months spent 
working at job1/12 
4. Proportion of months spent working at job2 during last year= number of months spent 
working at job 2/12 
5. Hours spent climbing stairs per week at job1 was calculated according to each choice 
by using the following formula: 
((Number of minutes spent climbing stairs every day at job1/60) * number of days per 
week attended at job1)) * Proportion of months spent working at job1 during last year  
6. Hours spent climbing stairs per week at job2 was calculated according to each choice 
by using the following formula: 
((Number of minutes spent climbing stairs every day at job2 /60) * number of days per 
week attended at job2)) * Proportion of months spent working at job2 during last year  
 
      Giving values for other combo boxes is relatively easier as the number of hours was stated 
in the choices or stated in text boxes linked to it. For example, a list of choices regarding 
activities around the house were given a medium number of hours listed in the choice such as a 
choice which states ''from 1 to 3 hours'' was given the value of 2 hours. Further illustrations are 
given in Table 4.4.  As for recreational activities, the values of choices were converted to the 
weekly frequency of each activity based on the choice given. The frequency is later multiplied 
by the number of hours spent performing each activities.  Further illustrations are given in Table 
4.4.   
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Table 4.4: illustration of values given in combo boxes:  
Activity name List of Choices Assigned Values Codes used to assign values 
Stair climbing at home (weekday) 
Coding Name: 
ComboBox1 
None 0 Hours / week Case 0 Stair1_WeekdayTextBox.Text = 0 
1-5 times a day 0.08 Hours / week Case 1 Stair1_WeekdayTextBox.Text = 0.08 
6 to 10 times a day 0.16  Hours / week     Case 2 Stair1_WeekdayTextBox.Text = 0.16       
11 to 15 times a day 0.2 Hours / week Case 3 Stair1_WeekdayTextBox.Text = 0.2 
16 to 20 times a day 0.35 Hours / week Case 4 Stair1_WeekdayTextBox.Text = 0.35             
More than 20 times a day 0.42 Hours / week Case 5 Stair1_WeekdayTextBox.Text = 0.42 
Stair Climbing at Home (weekend) Coding Name: ComboBox2 
Values were assigned in a similar manner to the above example with changes of values.  
Stair Climbing at Work Coding Name: ComboBox9 and 10 for Job1 and Job2 
Values were assigned in a similar manner in the above example except for the part of calculating number of days where 
work was attended for job1 or job2.  
Activities in and Around the House 
Example of coding is given for caring for elderly 
activity.  
Remaining activities are coded similarly 
None 0  Case 0 Adult_CaringTextBox.Text = 0 
Less than 1 hour a week 0.5 hour/ week Case 1 Adult_CaringTextBox.Text = 0.5 
1 to 3 hours a week 2 hours/week Case 2 Adult_CaringTextBox.Text = 2 
3 to 6 hours a week 4.5 hours/week Case 3 Adult_CaringTextBox.Text = 4.5 
1 hour per day 7 hours/week Case 4 Adult_CaringTextBox.Text = 7 
2 hours per day 14 hours/week Case 5 Adult_CaringTextBox.Text = 12.5 
More than 15 hours a week 16 hours/week Case 6 Adult_CaringTextBox.Text = 16 
Recreational Activities 
Volley ball is given as an example of recreational 
activity. Remaining activities are coded similarly 
None 0  Case 0 Volleyball_TextBox.Text = 0 
Less than once a month 0.2 times /week Case 1Volleyball_TextBox.Text = 0.2 
Once a month 0.25 times /week Case 2 
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Volleyball_TextBox.Text = 0.25 
2 to 3 times a month  0.5 times /week Case 3 Volleyball_TextBox.Text = 0.5 
Once a week 1 time /week Case 4 Volleyball_TextBox.Text = 1 
2 to 3 times a week  2.5 times /week Case 5 Volleyball_TextBox.Text = 2.5 
4 to 5 times a week  4.5 times /week Case 6 Volleyball_TextBox.Text = 4.5 
6 times a week or more  6 times /week Case 7 Volleyball_TextBox.Text = 6 
Activity name List of Choices Assigned Values Codes used to assign values 
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4.8.7.3.2.2 Calculation of number of hours per week spent performing sedentary activities 
     Several steps were used to calculate the number of hours per week spent in sedentary 
activities. Firstly, the number of hours spent sleeping was calculated by the following formula: 
Total number of hours slept per week = daily number of hours slept during a weekday * 5 + 
daily number of hours slept during weekend * 2 
     Secondly, the number of hours spent watching TV or playing video games per week was 
calculated using the following formula: 
Total number of hours spent watching TV or Playing video games per week = Number of hours 
spent watching TV or playing video games per day in weekdays * 5 + Number of hours spent 
watching TV or playing video games per day in weekends * 2   
     Thirdly, the number of hours spent driving the car per week (apart from going to work) was 
calculated by the following steps: 
1. Number of hours spent driving during every day =  ( number of minutes spent driving / 
60 ) + number of hours spent driving  
2. Number of hours spent driving car per week ( apart from going to work) = number of 
hours spent driving every day * 7  
     Fourthly, the number of hours per week spent driving to a job was calculated using the 
following steps: 
1. Duration of travel by car to Job1= (number of minutes spent driving to job1 /60) + 
number of hours spent driving to job1 
2. Duration of travel by car to Job2= (number of minutes spent driving to job1 /60) + 
number of hours spent driving to job2 
3. Number of hours spent driving to Job1 per week = (duration of travel by car to job 1 *  
number of travels per week) * proportion of months spent doing job1 
4. Number of hours spent driving to Job2 per week = (duration of travel by car to job 2 * 
number of travels per week) * proportion of months spent doing job2 
5. Total number of hours spent driving to work per week = number of hours spent driving 
to job1 per week + number of hours pent driving to job2 per week 
 
     Fifthly, the number of hours per week spent sitting at work was calculated using the 
following steps: 
1. Proportion of months spent working at job1 during last year = number of months spent 
working at job1/12 
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2. Proportion of months spent working at job2 during last year= number of months spent 
working at job 2/12 
3. Number of hours spent sitting at job1 per week= (number of hours spent sitting every 
day at job1* number of days attended at job1 per week) * proportion of months spent 
working at job1 during last year.  
4. Number of hours spent sitting at job2 per week= (number of hours spent sitting every 
day at job2* number of days attended at job2 per week) * proportion of months spent 
working at job2 during last year.  
5. Total number of hours per week spent setting at work during last year = Number of 
hours spent sitting at job1 per week + Number of hours spent sitting at job2 per week 
     Finally, the total  number of hours per week spent performing sedentary activities  = number 
of hours per week spent sleeping + number of hours per week spent driving (apart from going to 
work) + number of hours spent travelling to work by car + number of hours spent sitting at work. 
 
4.8.7.3.2.3 Calculation of number of hours per week spent performing moderate activities 
     The calculations in this section are similar to the calculations performed to calculate the 
hours spent in sedentary status. The following steps are a detailed explanation of the process:  
     Firstly, the number of hours spent walking per week (apart from going to work) was 
calculated by the following steps: 
1. Number of hours spent walking during every day =  ( number of minutes spent walking 
/ 60 ) + number of hours spent walking  
2. Number of hours spent walking per week ( apart from going to work) = number of 
hours spent walking in every day * 7  
      Secondly, activities performed in or around the house such as activities listed in Table 4.3 
under the moderate activities section are calculated by assigning a fixed value to each choice in 
the combo boxes. Table 4.4 shows the values assigned to choices in activities in and around the 
house section. All of these activities are assumed to be moderate activities and the values are 
assigned as hours spent every week performing each activity.  
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   Thirdly, the number of hours per week spent standing at work was calculated using the 
following steps: 
1. Proportion of months spent working at job1 during last year = number of months spent 
working at job1/12 
2. Proportion of months spent working at job2 during last year= number of months spent 
working at job 2/12 
3. Number of hours spent standing at job1 per week= (number of hours spent standing 
every day at job1* number of days attended at job1 per week) * proportion of months 
spent working at job1 during last year.  
4. Number of hours spent standing at job2 per week= (number of hours spent standing 
every day at job2* number of days attended at job2 per week) * proportion of months 
spent working at job2 during last year.  
5. Total number of hours per week spent standing at work during last year = Number of 
hours spent standing at job1 per week + Number of hours spent standing at job2 per 
week 
 
    Fourthly, the number of hours per week spent walking to work was calculated using the 
following steps: 
1. Proportion of months spent working at job1 during last year = number of months spent 
working at job1/12 
2. Proportion of months spent working at job2 during last year= number of months spent 
working at job 2/12 
3. Duration of walking to Job1= (number of minutes spent walking to job1 /60) + number 
of hours spent walking to job1 
4. Duration of walking to Job2= (number of minutes spent walking to job2 /60) + number 
of hours spent walking to job2 
5. Number of hours spent walking to Job1 per week = (duration of walking to job 1 * 
number of travels per week) * proportion of months spent doing job1 
6. Number of hours spent walking to Job2 per week = (duration of walking to job 2 * 
number of travels per week) * proportion of months spent doing job2 
7. Total number of hours spent walking to work per week = number of hours spent 
walking to job1 per week + number of hours pent walking to job2 per week 
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    Fifthly, the calculation of hours per week spent performing moderate recreational activities. 
These activities are listed in Table 4.3 as moderate activities. Its calculation is based on the 
value assigned for each list in the combo boxes as illustrated in Table 4.4 under the section of 
recreational activities. It is also based on entered number of hours and minutes spent performing 
each activity as illustrated in Figure 4.18.  
Example of calculating number of hours spent performing moderate recreational activities: 
Number of hours spent fishing per week = number of times spent fishing * average time per 
episode 
Example: the number of hours spent fishing per week if a person performs the activity once per 
month= weekly frequency (from table 4.4 = 0.25 times weekly) * Spent an hour and half in each 
episode = 0.37 hours per week.  
    Finally, the total number of hours per week spent performing moderate activities is the sum 
of hours per week calculated performing all moderate activities. 
 
 
 
 
 
 
 
 
 
 
Figure 4.18: Data entry for recreational activities. 
 
 
 
 
Spaces to enter number of hours 
and minutes spent performing 
each activity per episode  
List of Choices: choices are identical 
to choices given in EPIC questionnaire 
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4.8.7.3.2.4 Calculation of number of hours per week spent performing vigorous activities 
     It involves all the activities listed in Table 4.3 under the vigorous activities section. To 
calculate the number of hours per week spent performing these activities, the programme 
included coding of formulae as follows:  
Firstly, the number of hours spent climbing stairs at home: 
     The calculation of this section is already explained in section 8.7.3.2.1. Number of hours 
spent climbing stairs at home will be the total of number of hours per week spent climbing stairs 
during weekdays and number of hours spent climbing stairs during the weekend.  
     Secondly, the number of hours per week spent walking carrying things at work is calculated 
as follows:   
1. Proportion of months spent working at job1 during last year = number of months spent 
working at job1/12 
2. Proportion of months spent working at job2 during last year= number of months spent 
working at job 2/12 
3. Number of hours spent walking at job1 per week= (number of hours spent walking 
every day at job1* number of days attended at job1 per week) * proportion of months 
spent working at job1 during last year.  
4. Number of hours spent walking at job2 per week= (number of hours spent walking 
every day at job2* number of days attended at job2 per week) * proportion of months 
spent working at job2 during last year.  
5. Total number of hours per week spent walking at work during last year = Number of 
hours spent walking at job1 per week + Number of hours spent walking at job2 per 
week 
     Thirdly, the number of hours per week spent climbing stairs at work is calculated as 
explained in section 8.7.3.2.1. The total number of hours per week spent climbing stairs at work 
is the sum of hours per week spent performing this activity at job1 and job2.  
      Fourthly, the number of hours per week spent performing vigorous recreational  activities 
are calculated in a similar manner to the moderate recreational activities.   
     Finally, the total number of hours per week spent performing vigorous activities is the sum 
of all hours per week spent performing activities listed in Table 4.3 under the vigorous activities 
section.   
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4.8.7.4 How to operate the programme 
    The steps for using this programme are similar to the steps explained in the food frequency 
analysis programme. The steps for using the programme are displayed in Figure 4.19. Steps are 
ordered from first to last. The process is ended by pressing the saving icon which will save all 
entered data and calculated values in the database. The number of hours per week spent 
performing different types of activities will be separately displayed in the results section.   
 
 
 
 
  
 
Figure 4.19: Steps of using physical activity analysis program. 
 
 
 
 
 
 
1.Creat a New Profile for Each Participant. 
2.Enter ID, Age and Sex of 
Participant. 
3. Select Activity Category.  
4. Answer questions accordingly. 
5. Once all questions have been answered in all categories, interviewer 
will be able to click the estimate physical activity button and results will 
be shown in designated spaces.  
6. Save entered data in 
the database. 
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4.9 Physical measurements  
4.9.1 Body Weight 
     The body weight of healthy participants was measured using the Beurer PS05 scale. All 
participants were measured using the same device. At the time of measurement, participants 
were wearing light clothing, and standing barefoot. Participants tended to look downward to 
inspect the readings of the scale. However, this action appeared to influence the reading due to 
the scale’s sensitivity to minor movements. Therefore, participants were advised to remain 
stable until the reading was complete and shown on the scale’s screen. Body weight was 
recorded in kilograms.  
       We also noticed that using the scale on non-hard or non-flat surfaces provided faulty 
readings. Those surfaces included – but were not limited to – carpets, sand, and uneven 
pavements.  We tended to measure body weight on hard and flat surfaces to provide accurate 
measurements. To ensure the competent function of the scale, we also insured to always carry 
additional batteries to avoid the inability to perform measurements due to low batteries.     
4.9.2 Height    
     Height was measured using the Seca 213 Portable Stadiometer as illustrated in Figure 4.20. 
As all measurements were taken during homes visits, it was pragmatic to use this stadiometer as 
it can easily be dismantled and assembled. Once it is dismantled, it can be easily fitted to the 
case of the stadiometer and easily transported as depicted in picture A.  In addition, the scale 
weighs 2.4kg which enabled easy transportation. Once assembled, it will appear as shown in 
picture B.  
    Participants were advised to be barefoot while having their height measured. They were also 
advised to remove any unnecessary clothing worn on their heads. Once participants were 
standing on the base of the stadiometer, the indicator shown in picture C was lowered until the 
lower surface of the indicator was touching the head of the participants. Measurements of height 
were taken according to the location of the two red arrows on the height scale. Height was taken 
in centimetres. After converting height to metres, we were able to calculate BMI based on 
weight and height.  
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Figure 4.20: Measuring height using Seca 213. 
 
 
4.9.3 Waist Circumference 
       Waist circumference was measured using a measuring tape shown in Figure 4.21. 
Measurements were made according to the regulations of the Joint British Societies’ guidelines 
with minor exceptions. According to the Joint British Societies’ guidelines on the prevention of 
cardiovascular disease in clinical practice, abdominal circumference needs to be measured after 
clothes are removed, while standing, and the abdomen should be relaxed, feet should be about 
25-30 cm apart, and arms held loosely at the side. The tape shall be placed horizontally at the 
midpoint between the iliac crest (the upper edge of the hip bone) and the lower edge of the 
lower rib. After asking the subject to gently breathe in and out, measurements can then be taken 
(272). In this study, the measurements were not performed in clinical settings therefore, 
measurements were made while participants were wearing light clothing.    
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Figure 4.21: Measurement tape used to measure waist circumference.  
 
4.9.4 Fasting Blood Glucose  
    For several reasons, FBG was measured using a Glucometer. Firstly, this test is suitable to be 
performed in non-clinical settings. Secondly, it has been suggested as being more suitable for 
screening purposes than other measures such as Hb1Ac (273). Finally, this test is cheaper and 
more convenient than other laboratory tests. In addition to having a continuous measure of FBG, 
using this test also aided in assuring that unaffected cases did not have potentially undiagnosed 
type 2 diabetes. If an apparently normal subject appeared to have above the normal level of 
FBG (>126 mg/dl) they were not excluded from the study. Such subjects were advised to seek 
medical advice from their family physicians.  
    Measurements of blood glucose were made using Optium Xceed glucometer Figure 4.22 (A). 
Before performing a measurement of blood glucose, we ensured that participants were fasting 
for the previous eight hours. Otherwise, measurements had to be arranged. We used lancets 
(Figure 4.22 B) to acquire a capillary blood drop. Before applying the lancets, the site of 
applying the lancets was disinfected using an alcohol swab (Figure 4.22 C). Usually, 
participants tended to have their thumbs pricked. We only used new capped and sterile lancets 
as shown in Figure 4.22 (B).   
    Lancets were loaded in the lancet applicator (Figure 4.22 D). In order to insert the lancet in 
the applicator, the plastic cover of the applicator (Figure 4.22 E) had to be removed. Once the 
lancet was inserted in the applicator, we were able to remove the cap of the lancet and cover the 
applicator. The investigator had to make a judgment regarding the strength of the prick.  
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 Figure 4.22: Tools of measuring blood glucose.   
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    The strength of the prick is indicated in numbers as shown in Figure 4.22 (F). For individuals 
who have thicker thumb skin, we had to set the strength indicator at 8 to successfully acquire a 
blood drop. Otherwise, acquiring the drop would not have been possible. For individuals with 
thinner thumb skin, a smaller unit was used. The most often used unit was 7. Changing the 
strength unit was made using adjustment knob indicated in Figure 4.22 (G). 
     Glucose strips were used to apply blood drops to the glucometer. Glucose strips are indicated 
in Figure 4.22 (H). A new strip was used for each participant. Inserting strips into the 
glucometer is shown in Figure 4.23 (A). Once the strip was inserted, the glucometer started 
immediately and was ready to have the measurement taken. Once a blood drop was acquired, 
the glucose measurement was taken as shown in Figure 4.23 (B). Finally, the blood glucose 
level would appear on the glucometer screen in mg/dl. Afterward, participants were given new 
and sterile cotton balls to apply at the site of the finger prick.   
 
Figure 4.23: Applying Glucose Strip to Glucometer and blood glucose measurement.  
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    To ensure that all used lancets were disposed of appropriately, we needed to use a medical 
waste bin. However, we could not find a medical waste bin in the Jazan region available for sale. 
Therefore, we had to use a normal bin and had it pierced to allow the insertion of strips without 
opening the bin. The bin used is shown in Figure 4.24 (A). To ensure our safety from being 
pricked by used lancets, we removed the lancet using the method shown in Figure 4.24 (B) and 
disposed of lancets as shown in Figure 4.25 (C). The bin was saved in a secure location and was 
disposed of appropriately by the end of the data collection.  
 
Figure 4.24: Waste Bin and disposal of Lancets.   
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4.10 DNA Samples and Genetic Analysis 
4.10.1 Collection Tool 
     We used buccal swabs as an option of collecting DNA samples from participants. Unlike the 
collection of blood samples, it is a non-invasive procedure, painless, and does not introduce 
patients to the risk of infections caused by phlebotomy. In addition, it can be performed by non-
professionals in non-clinical settings. Using buccal swabs appeared to increase the participation 
rate due to its convenience. Buccal swabs (SK-1S  DNA Swab Pack) were purchased from 
Isohelix (a division of Cell Projects, UK). Each swab includes swab, tube and a cap as 
illustrated in Figure 4.25.  
 
 
 
   Figure 4.25: Swab used to collect DNA samples.  
 
     According to the Isohelix, swabs had to be taken one hour after eating or drinking and the 
mouth had to be rinsed immediately with water prior to taking the sample. We were advised by 
Isohelix to take clean samples to avoid any possibility of contamination with any materials with 
anti-PCR (Polymerase Chain Reaction) qualities. Anti-PCR materials can be food or chemical 
materials which might interfere with DNA amplification. Participants were advised to hold the 
end of the swab and enter the swab in the mouth toward the inner side of the cheek.  They were 
later instructed to move the swab in a vertical movement and applying mild pressure toward the 
cheek for at least one minute.  
    Extreme measures were taken to avoid contamination of the swabs by the participants or by 
the investigator. If for any reason, a buccal swab was not appropriately placed in the tube in a 
secure condition, another swab was taken instantly with disposal of the unfit one.  By the end of 
collecting the swab, we were able to break the stick to allow storing of the swab in the tube. 
Place of breaking the stick is indicated by a red arrow in Figure 4.25.  
    In order to store the swabs for a long period we used preservative materials. Preservative 
capsules (SGC Dri-Capsules) were provided by Isohelix which allowed storing the samples at 
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normal room temperature. Samples were stored in a secured cabinet which was only accessed 
by the principal investigator. 
      While new capsules were yellow, a used one tended to be greenish. According to the 
guidelines of using the capsules, dri-capsule which are greenish in colour before using are not 
suitable for use. However, all unused capsules were yellow in colour once they were evacuated 
from their containers. The method of storing the swab in the tube and applying dri-capsules is 
illustrated in Figure 4.26. A comparison between new and old dri-capsules is also indicated in 
Figure 4.26. 
   
 
    Figure 4.26: storing buccal swabs using Dri-capsules.  
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4.10.2 Labelling Samples 
    Buccal swabs were anonymously labelled with codes given for each participant. Codes were 
written on white stickers. Stickers were applied to the storage tubes as indicated in Figure 4.26. 
We used additional adhesive material to ensure the strong attachment of the stickers.  
4.10.3 Importing Samples 
       Importing samples to the UK was conducted in several steps. Firstly, we had to ensure that 
samples were given necessary clarifications and permissions to be imported. In addition to 
contacting Human Tissue Authority, we contacted The Department of Health in the UK. The 
Department of Health replied by advising to seek approval from H&M Revenue and Customs.  
     The H&M Revenue and Customs directed our attention to fill needed forms which are 
illustrated in Appendix 11. We illustrated the academic nature of the research and therefore, the 
sample was exempt from duty or taxes.  Further clarifications of the shipment were detailed in 
an official letter (Appendix 12). 
    Once all necessary permissions were taken, samples were shipped using Fedex. As samples 
could be stored at normal temperature, no further regulations were given to the courier 
regarding the condition of transportation except not exposing the shipment to heat.  All forms 
and shipment letters were attached to the shipment box.  
    We were able to track the location of the samples using the tracking systems provided by the 
courier. The shipment was delayed in Manchester and a call had to be made by the principal 
investigator to give more clarification about the samples and the purpose of importing the 
sample to the UK. Once the call was made and clarifications were given, the samples were 
released from UK Customs. The route of shipping the samples is illustrated in Figure 4. 27. 
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Figure 4.27: Shipment of samples. Description of delay of samples release is indicated in the 
red rectangle.  
4.10.4 SNPs Selection 
     GWAS and replication studies are used to discover and confirm the association between risk 
alleles and the disease of interest. Currently, no one has performed an association or replication 
study in Saudi Arabia concerning type 2 diabetes. Therefore, no one knows if the type 2 
diabetes risk alleles which are detected in European and Asian populations are replicable in the 
Saudi Arabian population.  
    In this study, we have made an effort to avoid genotyping risk SNPs which might not be 
replicable in the Saudi population. The study genotyped selected SNPs based on several criteria. 
Firstly, we selected SNPs which were replicated in more than one population. Secondly, we 
genotyped SNPs which have been shown to affect more than one continuous trait related to type 
2 diabetes. Another criteria was based on selecting SNPs which were shared with reduction of 
birth weight. Finally, the study genotyped SNPs which were found to be shared with other 
forms of monogenic diabetes. A list of genotyped SNPs is illustrated in table 4.5.  
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Table 4.5: list of genotyped SNPs and reasons for selection of each SNP: 
No. Marker Locus Chr Allele 
(Effect/Other) 
Reason for Selection 
1 rs7903146 
 
TCF7L2 10 T/C Most replicated among 
ethnicities. Affects FBG, 
Insulin, and HbA1(c) levels 
2 rs13266634 SLC30A8 8 C/T Replicated in European and 
Asian populations. Affects 
FBG, Insulin, and HbA1(c) 
levels. 
3 rs1111875 HHEX 10 C/T Replicated in European and 
Asian populations. 
Associated with birth weight 
reduction. 
4 rs10811661 CDKN2B 9 T/C Replicated in European and 
Asian populations. 
5 rs7754840 
 
CDKAL1 6 C/G Replicated in European 
Asian, and Arab Lebanese 
populations. 
6 rs7756992 
 
CDKAL1 6 G/C Replicated in European 
Asian and Arab Lebanese 
populations. Associated with 
birth weight reduction.  
7 rs10946398 CDKAL1 6 A/C Replicated in European and 
Asian populations. 
8 rs2237895 KCNQ1 11 C/T Replicated in European and 
Asian populations. 
9 rs231362 
 
KCNQ1 11 G/A Replicated in European and 
Asian populations.  
10 rs2237897 
 
KCNQ1 11 C/T Replicated in European and 
Asian populations.  
11 rs560887 G6PC2 2 C/T Affect FBG, insulin, and 
HbA1(c) levels. 
12 rs10830963 
 
MTNR1B 11 G/C Affect FBG, insulin, and 
HbA1(c) levels.  
13 rs1387153 MTNR1B 11 T/C Affects FBG and HbA1(c) 
14 rs4607517 GCK 7 A/G Affect FBG, insulin, and 
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HbA1(c) levels. Shared with 
new natal diabetes and 
MODY. 
15 rs1799884 GCK 7 T/C Affects FBG and HbA1(c) 
16 rs780094 
 
GCKR 
 
2 C/T Affects FBG and insulin 
level.  
17 rs11708067 
 
ADCY5 3 A/G Affects FBG and insulin 
level. Associated with birth 
weight reduction. 
18 rs2191349 
 
DGKB-
TMEM195 
7 T/G Affects FBG and insulin 
level. 
19 rs174550 FADS1 
 
11 T/C Affects FBG and insulin 
level. 
20 rs7034200 GLIS3 
 
9 A/C Affects FBG and insulin 
level. 
21 rs5219 KCNJ11 
 
11 T/C Shared with neonatal 
diabetes. Associated with 
birth weight reduction. 
22 rs7957197 
 
HNF1a 
 
12 T/A Shared with MODY 3  
23 Rs757210 HNF1B 
 
17 A/G Shared with MODY 5 
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4.10.5 DNA Extraction and Genotyping 
     The process of DNA extraction and genotyping was performed by K-biosciences, UK. To 
gain knowledge about the steps of performing DNA extraction and genotyping, we visited K-
biosciences facilities in Hoddesdon, UK, to observe the process on-site and visited their website 
for more detailed information (www.lgcgenomics.com). Several steps were taken to ensure the 
extraction of DNA, preparing DNA for genotyping and reporting allelic variability in selected 
SNPs. 
     The process of extracting and genotyping DNA was performed using the following steps. 
Buccal swabs were stored in an incubator oven where DNA was extracted from buccal cells 
using a silica-based method. DNA attaches to the silica allowing other materials to be 
eliminated and therefore only maintaining participants’ DNA. This method is human-DNA 
specific and DNA from other sources would be eliminated.  
    In order to perform genotyping of selected SNPs, K-biosciences requested at least 50 bases 
on either sides of the SNP of interest. These sequences were used to establish assays needed in 
the genotyping process. KASP (Kompetitive Alelle Specific PCR) genotyping assays were 
designed to aid in the amplification of DNA and detecting variants of interest.  
    KASP genotyping assay contains several elements. Firstly, primers were built based on the 
sequence we provided for each SNP. Two forward primers were made with two different alleles 
at the 3’ end and one reverse primer is added to form the KASP Primer Mix which is the first 
element of the KASP assay. The second element of the KASP assay is the DNA sample 
provided by the participants. Thirdly, a master mix is added which contains specific sequence-
binding fluorescent dyes. Each sequence at the 5’ ends of the two forward primers contains 
specific sequence only matching a specific sequence-binding fluorescent dye.   
     Once DNA was extracted in a liquid format, the RepliKator was used to transfer liquid 
format material containing DNA to a 96 well-plates. Four plates were used to cover the whole 
samples of this study. A Plate Mate system was used to assign identification labels to each 
sample in the plate and linking it to the coding system we initially used during data collection. 
Barcodes were also used to identify each plate and were integrated in the K-bioscience 
laboratory workflow management system which is called Kraken.  
     Once assays were ready to be used, a machine called Meridian was used to transfer assays to 
the DNA samples already dispensed in the plates. This machine is automated so there is no 
human contact needed to transfer the samples. The machine aspires the needed assays and 
dispenses them into the plates with no risk of cross contamination.  
116 
 
     After dispensing assays into the plates, plates were sealed using Fusion 3. This machine uses 
non-heat laser technique to seal plates. Once the plates were sealed, the plates were ready to be 
used in the Hydro Cycler.    
    The Hydro Cycler is a water bath thermal cycler. It uses water to aid in conducting heat to the 
PCR samples. Several thermal cycles were conducted leading to the replication of DNA through 
several rounds. In the first round, heat results in the separation of two strands of DNA which is 
called denaturation. Once the strands are separated, the matching forward primer attaches to the 
DNA sample and elongates by adding nucleotides. 
     If we assume that the variation at the target SNP is either T or G, then the two forward 
primers assembled in the KASP assay will end in either A or C. If the allele in the SNP of 
interest is T, then the premier ending with A would attach to the DNA sequence where the 
primer ending with C would not attach. Once the matching primer is attached (in a process 
called Annealing), the polymerase reaction would start elongating the primer starting from the 5’ 
end to generate a new sequence containing the matching primer.   
      In the second cycle of PCR, the newly formed double strand of the original DNA sample 
and the matching primer sequence would denaturant. Then, the reverse primer attaches to the 
matching primer sequence and start creating a reverse copy (a complement). The final round of 
PCR includes denaturation of the double strand composed of the matching primer sequence and 
its complement strand. This is followed by the attachment of a specific fluorescent dye binding 
sequence to the complementary sequence. Once a new double strand is made containing a strand 
complement sequence of the matching primer sequence and one sequence containing 
fluorescent dye, amplification of this double strand leads to creation of multiple copies.    
    The final step of genotyping will be the detection of allele at the SNP of interest. Because the 
final round of PCR results in the amplification of DNA strands containing specific fluorescent 
dye, the type of alleles detected will be determined based on the colour of the fluorescent dye 
observed. The strength of the signal fluorescent dye will depend on how many of the final 
strands of DNA had been replicated.  
   The final report of allelic distribution of each SNP will be depicted as shown in Figure 4.28. 
Different colours are used to illustrate the variability of genotypes of each SNPs. Homozygote 
genotypes are depicted in red or blue and heterozygote genotypes are shown in green. Pink 
clusters indicated samples which were not successfully genotyped for the SNP of interest. Black 
clusters serve as control and are called NTCs (No Template Controls). Clustering of signals 
around NTCs points will indicate the invalidity of the genotyped sample.   
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Figure 4.28: Signals used to depict detected genotypes of a particular SNP.  
 
     The final report was made in an Excel format and an additional SNP viewer provided by K-
biosciences. Staff at K-bioscience explained that cross contamination with human DNA is a 
major risk factor influencing the successful yield of DNA.  This risk of reducing the yield is 
higher when the contamination of the participants’ DNA sample with other human DNA 
compared to contamination of a DNA sample with a non-human DNA. Furthermore, the 
duration spent using the buccal swab from each participant is another factor influencing the 
yield of DNA. Participants who spend a shorter period using the buccal swabs to retrieve buccal 
cells are less likely to yield a significant amount of DNA compared to those who spend longer 
periods.  
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4.11 Data Entry 
       Data entry was performed in several steps. Firstly, during home visits, we were able to save 
collected data using a food frequency analysis programme and physical activity analysis 
programme. At that stage, data was saved in the programmes’ database. Data was then 
transformed from the programmes’ database to a Microsoft Office Excel file. This measure 
allowed us to have several secured copies of collected data. Copying data to a memory stick was 
performed on a weekly basis to provide spare copies in case of any loss of the original data.  
      By the end of each of the four stages of data collection, all data was transformed from Excel 
files to SPSS. The final destination of all collected data is the designated SPSS database. All 
calculated inbreeding coefficients were fed to the SPSS database. All steps of data entry were 
performed by the principal investigator.  
 
4.12 Study Variables and analysis 
     Study variables and analysis are explained in Table 4.1. All of the variables explained in the 
table are continuous. Correlation analysis was utilised to assess the association of study 
variables. Regression analysis was utilized to account for multiple independent factors. SPSS 
was utilised to perform the analysis.  
 
4.13 Data Collection Team 
     Identification and approaching patients was the responsibility of PHCs staff. Recruitment of 
all participants was made by the principle investigator. All home visits and interviews and 
collection of anthropometric measures and biospecimens were performed by the principle 
investigator.  
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4.14 Piloting 
     We needed to assess the ability of the food frequency analysis and physical activity analysis 
programmes to perform their tasks. We made interviews with 10 individuals to assess the 
programmes. Every individual was interviewed using both programmes. Several faults and 
adjustments were made to the software. Other adjustments involved the process of interviewing 
subjects.  
     Regarding the food frequency analysis programme, the questionnaire performed well with 
most participants. However, a few additional food items were suggested by each participant. 
The action taken was to add spaces to the programme to allow entering open ended answers and 
frequency of consumption.   
     During the pilot stage of the food frequency analysis programme, we noticed that one of the 
items was not functioning properly. Selecting radio buttons of that item did not reveal 
corresponding calorific values. This problem was solved by rewriting commands of calculating 
the calorific value of that item.  
       Another issue was observed relating to reporting frequencies.  Some individuals tend to 
assume that they have consumed certain food items on monthly basis which in reality was not 
true. This assumption of consuming variety of food at least once a month resulted in 
exaggerated total calorific values. To resolve this issue, interviewees were clearly asked if a 
month would pass without consuming the item of interest. If the participant answers yes, then 
the frequency would be ''never''. This action resulted in giving reasonable values of calorific 
intake once applied in the actual collection of data.   
     Similarly, several changes were made to the physical activity analysis programme. The EPIC 
physical activity questionnaire included a section about sleeping time. During the pilot stage, it 
was observed that asking participants about approximate duration spent sleeping on a daily basis 
was easier than asking participants about the time they go to bed at night and the time they wake 
up in the morning as written in the EPIC questionnaire. That issue was complicated further if 
they have two episodes of sleeping in one day which was not indicated in the original EPIC 
questionnaire. The adjustment appeared to be beneficial in considering those who have more 
than one episode of sleep every day.  
      Asking about total duration spent driving or walking on a daily basis appeared to be more 
appropriate than asking about the duration of a single journey and then multiplying it by the 
number of journeys. Some individuals might have several journeys per day with different 
durations thus making the current format of the questionnaire inappropriate. Therefore, we 
changed this question to only ask about the total duration of hours or minutes spent driving or 
walking on daily basis without asking about the number of journeys.  
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         A distinction has to be made regarding considering walking as a vigorous activity during 
work. If walking during work included carrying heavy items, the activity was considered a 
vigorous activity. Otherwise, walking was assumed to be a moderate activity.  
 
4.15 Sample Size 
     To calculate the sample size needed to answer the questions, we consulted sample size tables 
(274) and GPower 3.1 software for sample size calculation. Table 4.6 shows the sample size 
needed for each research question and the correlation coefficients could be detected. These 
correlation coefficients are calculated assuming a two-sided type 1 error rate of 5% and 80% 
power to detect a true correlation. The total sample size was estimated to be 400. Approximately 
150 subjects were planned to be type 2 diabetes cases and 250 were planned to be healthy 
subjects.  
 
Table 4.6: Sample size calculations: 
 
     Although we were aiming to recruit 400 subjects, several factors interfered with our ability 
to achieve that objective. 362 participants were recruited which represents approximately 90% 
of the target sample size. 179 were type 2 diabetes patients and 183 were healthy participants. 
The recruitment pattern with the reasons behind the reduced number of recruited individuals are 
illustrated in Figure 4.29. Three cessations were due to national or religious holidays. During 
these seasons, participants were more likely to be engaged in religious and recreational activities 
which interfered with the recruitment process.  
      The study was originally aiming to recruit 250 participants with available birth weight 
record to investigate the association between inbreeding, low birth weight and risk of diabetes. 
However, since we were not able to retrieve the birth weight of participants, the number of 
participants needed to answer this question was no longer needed. In addition, several patients 
only had affected siblings. Families which had no healthy siblings were likely to have a strong 
genetic risk incurring the development of type 2 diabetes among its members. We thought that 
by excluding these families, we were neglecting an important part of the population who were 
Question Population Correlation Coefficient  Sample Size 
1
st
 question All sample 0.12 400 
2
nd
 question T2D patients  0.2 150 
3
rd
 question Adult unaffected relatives of 
recruited T2D patients. 
0.16 250 
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likely to provide a very good insight regarding genetic and familial causes of type 2 diabetes in 
the target population.  
     Based on the previous remarks, we made several changes to sample size. We reduced the 
number of healthy participants to from 250 to 200 which would be enough as presumed earlier 
to answer the remaining questions.  We also increased the number of patients from 150 to 200. 
The excess 50 patients was devoted to recruit single patients from families with no healthy 
siblings and multiple type 2 diabetes patient siblings.  
 
Figure 4.29: Recruitment pattern with cessations explanations.  
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10 days cessation  due to personal condition 
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4.15 Budget 
    Measuring several variables increased the cost of this study. Most of the study's fund was 
dedicated to the DNA extraction and genotyping process. In order to get the best available rates, 
we contacted several companies. The best rates were given by K-bioscience. Additionally, 
significant cost was also paid to cover shipping collection tools to Saudi Arabia and shipping 
the collected samples to the UK. Further details are illustrated in Table 4.7. The Saudi Cultural 
Bureau in the UK funded of budget of this study. Travelling costs to Saudi Arabia and back to 
the UK were also covered by Saudi Cultural Bureau.  
Table 4.7: Estimation of the study cost: 
Item Cost 
SK-1S  100 x 1 swab with 5ml tube £352.8 
SGC-50 50 Isohelix Dri-Capsules £688.8 
DNA Extraction Service from Buccal Swaps for 400 samples £2000 
Genotyping 23 SNPs for 400 samples £3253 
Glucose Meter (Optium Xceed) £46 
Glucose strips ( 4 Packs Optium Xceed strips) £86 
Reliject Alcohol Cleansing Wipes £9 
One Touch UltraSoft Lancets £24 
Small Sharps Bin £4 
Cotton Balls £5 
Portable Scale £20 
Portable Stadiometer (Seca 213) £70 
Printing forms. (Approximate cost for 400 subjects) £20 
Transportation cost (eg. Car Fuel) (approximate cost) £120 
Total £6689.6 
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5 Chapter Five: Results 
     This chapter provides a comprehensive descriptive and inferential analysis of variables 
collected in this study. In the first section we provide summary statistics relating to the 
recruitment process. Following the descriptive statistics, inferential statistics are presented in 
two parts. The first part is restricted to answering the study's research questions and in the 
second part several exploratory investigations are performed.   
 
5.1 Descriptive Statistics 
5.1.1 Introduction: 
     Several descriptive statistical measures were applied in this study. We calculated means and 
medians of continuous variables. In addition to using means and medians to assess the normal 
distribution of continuous variables, we used histograms with normal curves to give a better 
judgment of distributions. In addition to using standard deviations to assess the variation around 
means, we also used maximum and minimum values to have an overview of the spread of data.  
     In addition to giving an overview of the recruitment process results, descriptive analysis was 
performed for the following variables: 
- Ages of all participants and summary of the ages of healthy participants and 
patients. 
- Age at diagnosis of recruited patients.  
- Variables related to familial structures such as the number of siblings, the number 
of affected parents and the siblings in each family.  
- Inbreeding coefficients and description of degree of relatedness.  
- Variables related to food frequency and physical activity questionnaires. 
- Anthropometric variables: BMI, FBG and waist circumference. 
     The final section of this chapter is dedicated to illustrating descriptive aspects related to 
genetic analysis. We give a description of genotyping success. Genotypes and alleles 
frequencies are described in tables and visualized in histograms. Frequencies are reported for 
patients and healthy subjects.  
      
 
 
 
124 
 
 
5.1.2 Recruitment summary 
        Table 5.1 gives a description of the total number of participants recruited in this study. The 
total number of participants was 362; of these, 179 participants were type 2 diabetes patients. 74% 
of type 2 diabetes patients who were approached agreed to participate. Only three healthy 
participants did not give a buccal swab because they were chewing Khat during the visit, and, 
due to issues relating to communication, we could not arrange to revisit them. Approximately 
84% of recruited healthy participants had their FBG measured. The remaining 16% refused to 
give glucose measurement due to reasons such as a fear of being diagnosed with type 2 diabetes, 
a fear of needles and a lack of participants’ proper organization caused by Khat chewing. 
      
Table 5.1: Recruitment summary: 
Total number of participants 362 
Number of Healthy participants 183 
Number of families with three participants 51* 
Number of families with two participants 80 
Number of Single patients 48** 
Number of approached patients 240 
Number of patients who were not possible to recruit 61*** 
Number of participants who refused to give buccal swabs 3 
Number of participants who refused to give FBG test 29 
*One family included 4 participants: a monozygotic twins where one twin was type 2 diabetes 
patient and the other was healthy and additional two healthy siblings.  
**Patients whom all or most siblings were affected with type 2 diabetes and no healthy siblings 
were available for recruitment.  
**Reasons interfered with recruitment of patients:  
33 patients refused to participate, 24 patients had no available siblings or none of their siblings 
were affected with type 2 diabetes. Three patients agreed to participate but their healthy sibling 
refused to participate. One patient was not Saudi. 
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     Table 5.2 illustrates number of participants recruited in each PHC. 69 participants were 
recruited from a single PHC. This is the largest number of participants recruited from a single 
PHC. Although there are other PHCs similar to AlZabiah PHC in size, recruitment in ALZabiah 
centre was high due to cooperation of the PHC staff and due to large number of registered type 
2 diabetes patients. Additionally, this centre covered several urban and rural areas.  
    The smallest number of participants recruited from a single PHC was 9. This PHC was 
smaller than other PHCs and number of registered type 2 diabetes patients was smaller. Sabia 
and ALMabouj PHCs were two of the largest centres in addition to ALZabiah. However 
recruitments percentage from those two centres were 6% from Sabia PHC and 3.5% from 
ALMabouj PHC due to factors related to cooperation of the staff and participants.  
Table 5.2 Number of recruited participants per PHC:  
 
 
 
 
        
 
 
 
 
 
 
 
   
 
 
 
PHC Number of 
participants 
Percentage 
AlBaher 29 8% 
AlFeqra 24 7% 
AlGhara 31 9% 
AlAreesh 9 2.5% 
AlZabiah 69 18% 
Sabia 21 6% 
Sambah 25 7% 
ALBedie 27 7.5% 
ALRayian 13 3.5% 
Mehliah 22 6% 
AlMabouj 13 3.5% 
AlQa’ariah 38 10.5% 
AlHusaini 41 11% 
Total 362 100% 
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5.1.3 Age distribution 
      Table 2 shows the ages of patients and healthy participants. The mean age of patients was 45 
years compared to 36 years in the healthy subjects group. The youngest patient was 23 years old 
and the oldest one was 61 years old. The oldest healthy participant was 71 years old. There were 
40 recruited families where patients were younger than the healthy participants. In two families, 
we recruited two pairs of twins where one was an identical pair and the other was non-identical. 
In both twin pairs, one twin was a patient and the other one was healthy. Figure 1 depicts the 
distribution of ages in both groups.                 
 
Table 5.3: Age of patients and healthy participants: 
 
Age Patients (n=179) Healthy Subjects (n=183) 
Mean 45.84 36.40 
Median 47.00 35.00 
Std. Deviation 8.901 10.837 
Minimum 23 18 
Maximum 61 71 
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Figure 5.1: Comparison of age distribution in cases and healthy subjects.   
 
 
5.1.4 Age at Diagnosis with Type 2 Diabetes  
    Summary statistics of age at diagnosis are described in table 5.4. The mean age at diagnosis 
in the sample was 38.05 years (SD: 8.9 years). Age at diagnosis varied between 20 and 57 years. 
Figure 5.2 depicts an approximately normal distribution of age at diagnosis.  
 
Table 5.4: Statistics summary of age at diagnosis with type 2 diabetes: 
Age at Diagnosis 
Mean 38.05 
Median 38.00 
Std. Deviation 8.883 
Minimum 20 
Maximum 57 
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Figure 5.2: Distribution of age at diagnosis with type 2 diabetes. 
 
 
5.1.5 Familial patterns 
     Table 5.5 gives an overview of the number of siblings per family in the target population. As 
expected, the number of siblings per family is large in comparison to western societies. The 
mean number of siblings per family in the target population is 7.03 (SD= 3.04 siblings). 
Families with only one offspring were not recruited. Six families only had two siblings while 
approximately 23% of families reported having 10 siblings or more. Figure 5.3 illustrates the 
distribution of the number of siblings per family. The distribution appears to be approximately 
normal in the collected sample.  
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Table 5.5: Number of siblings per family: 
Number of 
Siblings per 
family 
Frequency Percentage 
2 6 3.4% 
3 13 7.4% 
4 16 9.1% 
5 18 10.3% 
6 29 16.6% 
7 17 9.7% 
8 15 8.6% 
9 21 12.0% 
10 14 8.0% 
11 15 8.6% 
12 7 4.0% 
13 1 0.6% 
14 2 1.1% 
18 1 0.6% 
Total 175 100% 
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Figure 5.3: Distribution of number of siblings per family. 
 
   In addition to the number of siblings per family, the constructed pedigrees reported several 
other variables. The total number of male siblings reported in the constructed pedigrees was 745 
while the number of female siblings reported was 514.  In the constructed pedigrees, 316 male 
siblings were affected with type 2 diabetes which represented 42% of reported male siblings. On 
the other hand, only 14% of reported females in pedigrees had type 2 diabetes. However, the 
low percentage of reported female siblings with type 2 diabetes might have been due to the fact 
that only the male siblings of each family were interviewed.  
    Table 5.6 illustrates the number of affected male and female siblings reported in constructed 
pedigrees. The highest number of siblings affected in the same family was 7 patients. 59% of 
the constructed pedigrees were revealed as having 2 or more siblings affected with type 2 
diabetes.   
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Table 5.6: Number of siblings affected with type 2 diabetes in each family: 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Constructed pedigrees reported different patterns which were related to a parental history of 
type 2 diabetes. The number of families reported a paternal history of type 2 diabetes was 80 
(45%). 71 families reported a maternal history of type 2 diabetes (40%). Only 34 families 
reported having both a maternal and a paternal history of type 2 diabetes (19% of constructed 
pedigrees). 57 families reported having at least one grandparent with a history of type 2 diabetes.  
5.1.6 Inbreeding Coefficients  
    Table 5.7 describes calculated inbreeding coefficients of recruited participants. 63% of 
constructed pedigrees revealed a history of consanguinity; in 37% of constructed pedigrees, 
participants reported that their parents were from different tribes. Constructed pedigrees 
revealed different and complex mating systems between individuals from the same tribe or the 
same subtribes, and parents who were third, second and first cousins. On several occasions, 
different combinations of mating patterns were observed in the same family.  
 
 
 
 
 
Number of siblings 
affected in each 
family 
Frequency Percent 
1 74 41.3% 
2 52 29.1% 
3 25 14.0% 
4 11 6.1% 
5 11 6.1% 
6 4 2.2% 
7 2 1.1% 
Total 179 100% 
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Table 5.7: Distribution of inbreeding coefficients: 
Inbreeding coefficient Frequency Percentage  
0%  66 36.9% 
0.001% 8 4.5% 
0.002% 12 6.7% 
0.004% 9 5% 
0.024% - 0.044%. 8 4.5% 
0.084% - 0.196% 4 2.25% 
0.39% - 1.5%. 14 7.8% 
1.56% - 6.24%. 24 13.5% 
6.25% - 12.5% 32 18% 
 
   Using our method of calculating inbreeding coefficients revealed 57 distinct inbreeding 
coefficients. The calculated inbreeding coefficient of 8 (4.5%) families was 0.001%.  In these 
families, the only relationship found between the parents was that one pair of grandparents 
either from the maternal or paternal side was from different subtribes but within the same tribe. 
Another 12 (6.7%) families had inbreeding coefficient of 0.002% where three grandparents 
shared the same tribe but did not share a subtribe. Similarly, 9 (5%) families had inbreeding 
coefficient of 0.004% where all grandparents shared the same tribe.  
     8 (4.5%) families had calculated inbreeding coefficients ranging between 0.024% and 
0.044%. In these families, grandparents belonged to a shared subtribe in addition to belonging 
to the same tribe. Families which were given inbreeding coefficients of 0.044% had three 
grandparents who shared the same subtribe and all grandparents shared the same tribe. Four 
(2.25%) families had inbreeding coefficients varying between 0.084% and 0.196% where all 
grandparents belonged to the same subtribe. 
      14 families had a history of mating between third degree cousins (7.8% of families). 
Calculated inbreeding coefficients for these families varied between 0.39% and 1.5%. Variation 
between inbreeding coefficients of these families was augmented by a variation in the mating of 
grandparents form shared tribes or subtribes. Similarly, 24 (13.5% of families) inbreeding 
coefficients were calculated for families where parents were second cousins and coefficients 
varied between 1.56% and 6.24%. 32 families reported a history of mating between first degree 
cousins (18% of recruited families). Inbreeding coefficients of families of first degree 
consanguinity varied between 6.25% and 12.5% where the latter figure represents inbreeding 
coefficient of mating between parents who were double first cousins.  
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     Studies which have measured the prevalence of consanguinity in Saudi Arabia have provided 
different results. The range of consanguinity varied between 52% and 67% (250-252, 275), 
which is similar to our estimated rate of consanguinity. However, these studies reported that the 
frequency of marriages between first cousins was high compared to other marriages between 
distantly related subjects. In our study, only 18% of recruited families had a mating history of 
parents who were first degree cousins. This largely explains why the inbreeding coefficients 
calculated by those studies (0.02 to 0.03) were high compared to the average inbreeding 
coefficient of our sample (0.016). However, we must consider that their methods of categorizing 
mating as between first cousins, second cousins and distant cousins is quite different from our 
pedigree-based method.  
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5.1.7 Questionnaires analysis 
5.1.7.1 Food Frequency Questionnaire 
     Summary statistics of average calorific intake are illustrated in table 5.8. The mean calorific 
intake in this sample was 3816 (SD: 1151.49) calories per day. According to the British 
Nutrition Foundation, the recommended average daily calorific intake for men is about 2500 
calories (276). Therefore, there is a tendency in our sample to exceed the recommended daily 
calorific intake.  The distribution of average calorific intake per day in this sample appears to be 
approximately normally distributed (figure 5.4). However, there were several outliers with an 
average daily consumption exceeding 7000 calories per day.  
 
Table 5.8: Average Calorific Intake of patients and healthy subjects (n=362): 
 
Average Calorific Intake 
Mean 3816.7557 
Median 3639.2180 
Std. Deviation 1151.49314 
Variance 1325936.451 
Range 6921.62 
Minimum 1706.42 
Maximum 8628.04 
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Figure 5.4: Distribution of Average Calorific Intake of the Sample. (n=362). 
 
     A comparison between the average calorific intake of patients and healthy subjects is 
depicted in table 5.9. The mean intake in patients is apparently lower than those of healthy 
subjects. Mean average daily calorific intake of healthy subjects was on average 275 calories 
more than patients.  Furthermore, the distribution of both patient and healthy samples appear to 
be in normal distribution as depicted in figure 5.5. 
 
 
 
 
 
 
 
 
 
Average Calorific Intake 
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Table 5.9: Comparison between Average calorific intake of patients and healthy 
siblings:  
 
Average Calorific Intake Patients (n=179) Healthy Subjects (n=183) 
Mean 3677.7079 3952.7642 
Median 3508.2430 3805.6720 
Std. Deviation 1128.54 1160.50 
Minimum 1706.42 1895.59 
Maximum 8628.04 7958.94 
Sum 658309.71 723355.85 
 
 
 
Figure 5.5: Comparison of distribution of average Daily Calorific Intake between 
patients and healthy subjects.  
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    A study was conducted in Saudi Arabia to measure the effect of the diet consumed by 
adolescents on their nutritional status (81). This study utilized 24-hours diet recall and 17-items 
food frequency questionnaires. This study calculated the average daily caloric intake in addition 
to other nutrients. However, the daily caloric intake estimated by this study is smaller than our 
estimate (2025 Kcal compared to our study 3816 Kcal). This large difference could be caused 
by the  age difference between the populations in each study.  However, no similar studies were 
found where the average caloric intake was calculated in adult Saudi subjects.  
       Table 5.10 illustrates a comparison between different studies which have calculated an 
average daily caloric intake using food frequency questionnaires. All reported values were 
related to male subjects recruited in those studies to make it comparable to our sample which 
did not include females. The average calorific intake in our study is relatively high compared to 
other studies. Although there is a chance of an overestimation of calorific intake in our study, 
there could be several factors contributing to the higher calorific intake in our sample.  
     As we illustrated earlier, the prevalence of obesity and type 2 diabetes in the Saudi Arabian 
populations is high compared to other populations. A contribution to this increased prevalence 
could be the high calorific intake as illustrated in our sample. However, the food list length in 
our study was relatively high compared to the remaining studies, which could have contributed 
to the recording of higher average caloric intakes. 
      Our sample included a large proportion of young participants, and, as shown in our analysis, 
younger subjects are likely to have a high calorific intake compared to older adults. Finally, 
there could be racial variations leading to different consumption of different food types with 
different calorific values as in our sample there was a tendency for subjects of our study to 
report frequent intake of high calorie food items.  
Table 5.10: Description of studies used food frequency questionnaires to calculate average 
daily calorific intake in male subjects: 
Study 
Reference 
Population Sample size Food list age calorific intake 
(SD) 
(267) Korean 33 103 42-55 1953.3 (473.5)   
(268) UK 457 127 39–61 2292 (716) 
(269) Australian 37 129 25–75 2269 (559) 
(277) Greek 5633 150 25-65+ 2740 (870) 
Current study Saudi 362 157 18-71 3816 (1151) 
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5.1.7.2 Contributors to Calorific Values 
      Certain food items appear to be popular in the selected sample. These food items 
contributed about 40% of the total calorific value of the whole sample. These items are 
listed in table 5.11. Differences between patients and healthy siblings are also illustrated 
in table 5.11. However, there is similarity of most favoured food items between the two 
groups.  
 
      In both groups, the most popular food items were Marsa, Chicken Kabsa and bread. 
These items were consumed several times on a weekly basis in the recruited sample. 
Marsa has a high calorific value because it contains wheat, banana, butter and honey in 
its ingredients. The high calorific value of the chicken Kabsa is principally contributed 
by chicken, rice and cooking oil. In addition to the items listed in table 5.11, other items 
appear to be important contributors but to a lesser extent. These items include, but are 
not limited to, lamb stew, fried fish, fried chicken, dates, biscuits, fries, fried egg and 
boiled egg sandwiches.  
 
Table 5.11: Top Contributors to Calorific Values: 
 
Patients Healthy Subjects 
Food Item Contribution 
Percentage 
Food Item Contribution 
Percentage 
Marsa 10% Marsa 10% 
Chicken Kabsa 9% Chicken Kabsa 10% 
Bread 8% Bread 7% 
Lamb Kabsa 5% Rice 4% 
Grilled Chicken  4% Grilled Chicken 4% 
Rice 4% Lamb Kabsa 3% 
Fish Stew 3% Cakes 3% 
Total 43% Total 41% 
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5.1.7.3 Physical Activity Questionnaire Analysis 
     The physical activity questionnaire was analysed by calculating the number of hours spent 
performing sedentary, moderate or vigorous activities. Table 5.12 shows summary statistics of 
physical activities reported in the total sample (n=362). An average of 88 hours (SD: 24 hours) 
per week was spent performing sedentary activities. The distributions of hours spent performing 
different forms of activities  per week are depicted in 5.6.  
    The distribution of number of hours spent performing sedentary activities appears to be 
approximately normal. However, the distribution of the number of hours spent performing 
moderate and vigorous activities per week are positively skewed. The medians of moderate and 
vigorous activities indicate that, on average, about 11 hours (SD: 11 hours) are spent performing 
moderate activities per week and almost four minutes (SD: 2.6 hours) are spent performing 
vigorous activity per week.   
      Physical activity levels in our sample were markedly deviated toward sedentary activities. 
Higher levels of moderate and vigorous activities were reported more in the healthy group 
compared to patients.  
     
Table 5.12: Summary Statistics of physical activities:  
Physical Activity 
Category 
Weekly 
Sedentary Hours 
Weekly Moderate 
Activity Hours 
Weekly Vigorous 
Activity Hours 
Mean 87.89 13.15 0.88 
Median 85.10 10.75 0.06 
Std. Deviation 23.74 10.60 2.64 
Minimum 41 0 0 
Maximum 165 69.3 32.08 
Sum 31819.16 4762.50 318.68 
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5.1.7.4 Comparison of Physical Activity between Patients and Healthy Siblings 
       Referring to table 5.13, we can observe that the mean number of hours spent performing 
sedentary activities per week was 5.5 hours more in healthy subjects in comparison to patients. 
However, the medians of the number of hours spent on moderate or vigorous activities per week 
were higher in the healthy group. Figure 8 compares the distribution of physical activity 
between patients and healthy subjects.  
Table 5.13: Comparison between level of activity between patients and healthy subjects: 
 Sedentary activities* Moderate Activities* Vigorous Activities* 
Patients 
(n=179) 
Healthy 
(n=183) 
Patients 
(n=179) 
Healthy 
(n=183) 
Patients 
(n=179) 
Healthy 
(n=183) 
Mean 85.9 89.84 11.44 14.8 0.33 1.4 
Median 81.25 89.31 9.50 12.71 0.055 0.12 
Std. Deviation 25.32 21.98 9.42 11.42 1.15 3.46 
Variance 641.32 483.24 88.78 130.63 1.34 12.01 
Minimum 41.26 41.00 0 0.50 0 0 
Maximum 165.00 147.50 57.00 69.30 12.30 32.08 
Sum 15377 16442 2049 2713 60.45 258.238 
*Number of hours per week. 
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Figure 5.6: distribution of physical activity in patient and healthy groups.  
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5.1.7.5 Physical activity behaviour  
       The number of hours per week spent performing sedentary activities varied between 41 and 
165 hours per week. Sedentary activities included sleeping, watching TV or other devices, 
driving and sitting during work. There was a higher tendency to drive as a means of 
transportation compared to walking among recruited participants. Only 7% (n= 26) of the 
participants revealed walking to their work as a means of transportation. The vast majority of 
participants used cars as the usual mode of transportation.  
     Certain physical activities appeared to be more frequently reported in our sample. Table 5.14 
illustrates the frequency of performing these activities in patient and healthy groups. The 
frequency of performing these moderate activities was almost similar between the two groups 
except caring for children which was higher amongst the patient group and gardening activities 
which appear to be reported more in the healthy group.   
Table 5.14: Most frequently reported moderate activities:  
Activity Number of patients  
(Percentage) (n=179) 
Number of healthy subjects 
(Percentage) (n=183) 
Shopping 163 (91%) 161 (88.5%) 
Walking 79 (44%) 69 (38%) 
Caring for Children 68 (38%) 63 (25%) 
Gardening 23 (13%) 45 (25%) 
Home maintenance  8 (4.5%) 5 (3%) 
Fishing 6 (3.3%) 9 (5%) 
 
    Table 5.15 illustrates most reported vigorous activities. There was a clear tendency 
for healthy subjects to report performing vigorous activities in comparison to patients. 
The most common sport reported by participants was football and it was reported more 
amongst healthy subjects (33%).    
Table 5.15: Most Frequently Reported Vigorous Activities: 
Activity Number of patients  
(Percentage) (n=179) 
Number of healthy subjects 
(Percentage) (n=183) 
Football 10 (7%) 33 (18.5%) 
Jogging 3 (1.6%) 17 (9%) 
Conditional Exercise  4 (2%) 7 (4%) 
Weight Lifting 3 (1.6%) 3 (1.6%) 
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     Table 5.16 gives an illustration of the occupations reported by participants. Most of 
recruited participants were teachers or soldiers. 27% of patients were retired at the time 
of recruitment. Most of these occupations are more likely to exhibit sedentary or 
moderate level of activity. Only a minority of jobs were reported which might have 
included vigorous physical activities such as mechanics or occupations which include 
carrying heavy machinery.  
 
Table 5.16: Description of most reported occupations: 
Patients (n=179) Healthy Subjects (n=183) 
Occupation Frequency (Percentage) Occupation Frequency (Percentage)  
Teachers 49 (27%) Soldiers 48 (26%) 
Retired 48 (27%) Teachers 42 (23%) 
Soldiers 39 (22%) Students 24 (13%) 
Clerical Jobs  24 (13%) Clerical Jobs 18 (10%) 
Others  13 (7%) Others 22 (12%) 
Unemployed 6 (4%) Retired 15 (8%) 
 Unemployed 14 (8%) 
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5.1.8 Anthropometric Variables 
5.1.8.1 Fasting Blood Glucose  
    Descriptive statistics of FBG are stated in table 5.17. We were able to collect 154 values of 
FBG which represents 84% of the total sample of healthy subjects. The mean FBG  was 95 
mg/dl (SD: 23.89 mg/dl). The distribution of FBG appears approximately to be normal as 
shown in figure 5.7. About 90% of FBG values were within the normal range (60 – 126 mg/dl). 
Four readings were below the normal range of FBG and 12 values were above the normal range. 
The minimum value reported was 41 mg/dl and the maximum one reported was 248 mg/dl.  
     Participants who were not diagnosed with type 2 diabetes when they were recruited were 
presumed to be healthy. However, since type 2 diabetes can be an asymptomatic illness, 
detecting several healthy participants with high levels of FBG was expected.Twenty subjects 
had FBG levels varying between 6.1 mmol/l (110 mg/dL) and 6.9 mmol/l (125 mg/dL) and were 
very likely to be diagnosed as having impaired fasting glucose once consulting their health 
professionals. Twelve subjects had FBG above 7mmol/l (126 mg/dl) upon blood glucose 
measurement. Those subjects are very likely to be diagnosed with type 2 diabetes once they 
consult their health professionals.  
     Subjects suspected with impaired fasting blood glucose and FBG above 126 mg/dl were 
classified as healthy subjects in this study, given that they were not adhering to any type 2 
diabetes management plans or change of lifestyle. Engaging in lifestyle change or taking 
medications is likely to influence BMI, FBG and waist circumference. Therefore, those 
participants remained in the control arm of the study to investigate aspects related to these 
continuous traits, since they were blind to their possible disease status and were not engaged in 
any change in lifestyle or taking medication.  
Table 5.17: Description of Fasting Blood Glucose: 
Number of 
cases 
Valid 154 
Missing 29 
Mean 95.4784 
Median 93.00 
Mode 84.00 
Std. Deviation 23.89 
Minimum 41.00 
Maximum 248.00 
 
 
Figure 5.7: Distribution of Fasting Blood Glucose 
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5.1.8.2 Body Mass Index 
       Descriptive statistics of BMI are illustrated in table 5.18. The mean BMI was 28.15 (SD: 
6.8). The distribution of BMIs is depicted in figure 5.8 which seems to be a normal distribution 
with a few extreme values slightly skewing it.    
 
Table 5.18: Descriptive Statistics of Body Mass Index: 
 
BMI (n=183) 
Mean 28.15 
Median 27.40 
Std. Deviation 6.858 
Minimum 15.10 
Maximum 67.00 
 
        By observing table 5.19 we can detect a prevalence of overweight and obese individuals in 
our sample. 4 participants were reported to have below normal BMI and only 30% of the 
healthy subjects had normal BMI.  The percentage of overweight and obese individuals in this 
sample was about 68% and 8 participants were morbidly obese.  
 
Table 5.19: Interpretation of BMIs:  
BMI Category Frequency (Percentage) 
(n=183) 
Underweight (<18) 4 (2.2%) 
Normal Weight (18 –25) 55 (30.1%) 
Overweight (25 – 30) 69 (37.7%) 
Obese (30 - 40) 47 (25.6%) 
Morbidly Obese ( > 40)  8 (4.4) 
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Figure 5.8: Distribution of BMI in healthy.  
    Most previously published studies concerned with the measurement of the prevalence of 
overweight and obese healthy subjects in Saudi Arabia reported overall rates among children. 
Only one study reported the rates of overweight and obese subjects in a population which 
included adults. This study was published in 2007 and reported that 30.7% of male subjects 
were overweight and 23.6% of male participants were obese (78). The rates provided by this 
study are smaller than rates provided in our study.  
      In the current study, the proportion of healthy participants who were overweight was 37.7%. 
Additionally, 30% of healthy participants were obese. Upon comparing the prevalence of 
obesity in our sample to the rates reported by other studies we can observe a tendency of our 
sample to have had higher body weights. This could be largely explained by the fact that all of 
our healthy participants had a family history of diabetes and consequently, had the genetic and 
environmental risk of developing obesity and perhaps type 2 diabetes.  
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5.1.8.3 Waist Circumference  
   Table 5.20 describes summary statistics of the waist circumference of healthy participants. 
Mean waist circumference was 96.22 cm (SD: 14.96 cm). Distribution of waist circumferences 
is depicted in figure 5.9 and appears to be approximately normal.  
Table 5.20: Summary statistics of waist circumferences: 
 
Waist Circumference (n=182) 
Mean 96.22 
Median 95.00 
Std. Deviation 14.96 
Minimum 60.00 
Maximum 151.00 
 
 
 
 
Figure 5.9: Distribution of waist circumferences.  
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5.1.9 Descriptive analysis of genetic data 
5.1.9.1 Genotyping Success 
     Out of 362 participants, 3 participants refused to give buccal swabs during data collection. 
Additionally, 5 collected samples were not reported by the genotyping agent and were likely to 
have been lost during DNA extraction and analysis.  Out of the remaining 354 samples, 
undetected signals of each SNP varied between 15 and 30. The proportion of successfully 
genotyped SNPs varied between 91% and 95%. Further details are illustrated in table 5.21.  
    Although we made an effort to avoid taking swabs of subjects who were actively chewing 
Khat or other materials, we collected three samples which were visibly contaminated with Khat, 
chewing tobacco and food. However samples of these participants were successfully genotyped. 
Additionally, other subjects for whom buccal swab collection was rescheduled due to Khat 
chewing during home visits yielded valid samples. However, nothing peculiar was detected 
upon reviewing the data of subjects who did not provide good DNA samples and there was no 
report of Khat chewing during their data collection sessions.  We could conclude that Khat 
chewing is unlikely to have anti-PCR qualities and it is unlikely to interfere with DNA 
extraction and genotyping.  
     Upon reviewing SNPs signal density charts provided by the genotyping company, we 
observed variations between call rates of each used plate. Four plates were used during 
genotyping. Figure 5.10 illustrates an example of SNPs signal density.  
     It can be observed in figure 5.10 how the genotype of each subjects was decided.  Cases with 
calls clustering toward one axis of the chart were determined to be homozygote genotypes. Calls 
which clustered in the middle were presumed to be heterozygote genotypes. However, if certain 
calls were not clustering toward any group, they were then called undetermined and are 
coloured in pink in figure 5.10. Additionally, DNA samples which had a bad quality are 
depicted in yellow as shown in wells diagram in the bottom of figure 5.10.  
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Table 5.21: Detected Signals of each SNP:  
No. SNP Detected  Undetected Call Rate 
1 rs10946398 334 20 94% 
2 rs10811661 338 16 95% 
3 rs1111875 332 22 93% 
4 rs13266634 330 24 93% 
5 rs7754840 339 15 95% 
6 rs560887 335 19 94% 
7 rs2191349 328 26 92% 
8 rs10830963 328 26 92% 
9 rs7034200 329 25 92% 
10 rs174550 324 30 91% 
11 rs11708067 333 21 94% 
12 rs4607517 330 24 93% 
13 rs7903146 334 20 94% 
14 rs1799884 339 15 95% 
15 rs5219 335 19 94% 
16 rs7756992 336 18 94% 
17 rs780094 333 21 94% 
18 rs2237897 336 18 94% 
19 rs2237895 332 22 93% 
20 rs1387153 330 24 93% 
21 rs231362 327 27 92% 
22 rs7957197 334 20 94% 
23 rs757210 327 27 92% 
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Figure 5.10: SNP rs757210 signal density detected in plate 1.  
     
     In table 5.22, we illustrate the number of undetected genotypes of each SNP in each plate.  In 
this table we only included the number of calls which were not given specific genotypes but not 
DNA samples which were described as bad and failed genotyping in all SNPs. By observing the 
table, we can notice a difference in the number of undetermined calls according to used plate.  
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Table 5.22: Frequency of undetected calls of each SNP according to the plate used 
(number of samples): 
No. SNP Plate 1 (96) Plate 2 (96) Plate 3 (96) Plate 4 (81) 
1 rs10946398 1 3 3 1 
2 rs10811661 0 2 1 0 
3 rs1111875 1 2 2 3 
4 rs13266634 0 5 5 3 
5 rs7754840 0 0 1 0 
6 rs560887 2 2 3 0 
7 rs2191349 1 6 6 1 
8 rs10830963 1 4 4 3 
9 rs7034200 4 5 2 2 
10 rs174550 1 6 6 2 
11 rs11708067 1 3 3 1 
12 rs4607517 4 3 4 0 
13 rs7903146 2 3 1 1 
14 rs1799884 1 1 2 0 
15 rs5219 1 1 2 2 
16 rs7756992 0 2 1 1 
17 rs780094 0 3 3 3 
18 rs2237897 0 1 2 3 
19 rs2237895 1 4 2 1 
20 rs1387153 2 2 5 1 
21 rs231362 1 6 4 2 
22 rs7957197 1 4 1 1 
23 rs757210 1 5 5 3 
 Total (Proportion) 26 (1.2%) 73 (3.3%) 68 (3.1%) 34 (1.8%) 
 
    According to the genotyping process, PCR can vary according to the condition which was 
applied to each plate. The performance of PCR and the number of calls detected can therefore 
vary according to the plates. We observed that the rate of undetected genotypes was higher in 
plates two and three compared to plates 1 and 2. Box 2 is an additional example of the variation 
of call rate according to the plate used.  
152 
 
        Box 5.1 illustrates signal density graph of SNP rs2191349 according to the plate used. We 
can notice that for the same SNP only 1 case was not detected in plates 1 and 4 compared to 6 
undetected cases in plates 2 and 3. This might indicate that the condition in which each plate 
was exposed to during the reaction might have contributed to the overall quality of the 
genotyping. 
Box 5.1: Missing Calls (Pink) of rs2191349 according to plate used.  
  
 
 
 
 
 
 
 
 
 
Plate 1 rs2191349 Plate 2 rs2191349 
Plate 3 rs2191349 Plate 4 rs2191349 
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     Our analysis mandates using all SNPs in estimating the association between detected alleles 
and study variables. The level of successfully genotyped SNPs of each participant varied greatly. 
Apart from missing swabs and samples with a bad DNA quality, the number of failures of 
reporting SNPs of each participant varied between failure of genotyping one SNP to 15 SNPs 
per sample. Because we are counting the number of identical and total risk alleles of each SNP, 
we needed to ensure that all samples were comparable to each other. For example, there might 
have been a chance of measurement bias if we compared a subject where all SNPs were 
successfully genotyped to a subject for whom 10 (out of 23) SNPs failed to be genotyped.  
    To resolve this issue, we needed to exclude all subjects where there was a failure to report 3 
or more SNPs. There is no specific reason behind choosing these inclusion criteria. However, 
we wanted to take the least risk of introducing measurement bias and at the same time not losing 
large number of participants who had a minimal number of SNPs that failed genotyping. 27 
subjects had a failure of genotyping 3 or more SNPs. Figure 5.11 illustrates the distribution of 
cases with different magnitudes of genotyping failure.  After removing bad quality samples, the 
number of valid samples for the analysis was reduced from 354 to 316 (157 were patients and 
159 were healthy participants).    
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Figure 5.11: Distribution of number of non-genotyped SNPs according to number of 
participants. 
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5.1.9.2 Alleles and Genotypes Frequencies 
     Table 5.23 illustrates the overall frequencies of genotypes and alleles in the total sample. The 
risk status of alleles and genotypes were depicted according to results of related GWAS studies 
in other populations. Box 5.2 is a visualization of genotype frequencies in patients and healthy 
subjects.  
Table 5.23: Alleles and genotypes frequencies Number (Percentage):  
 
 
  
No SNP Homozygote 
genotypes of risk 
alleles 
Heterozygote Homozygote 
genotype of other 
alleles  
Risk alleles Other 
alleles 
1 rs10946398 (A:A) 188 (56.3%) (C:A)122 (36.5%) (C:C) 24 (7.2%) 498 (74.5%) 170 (25.4%) 
2 rs10811661 (T:T) 223  (66%) (T:C) 102 (30.2%) (C:C) 13 (3.8%) 548 (81%) 128 (18.9%) 
3 rs1111875 (C:C) 223 (67.2%) (T:C) 83 (25%) (T:T) 26 (7.8%) 529 (79.6%) 135 (20.3%) 
4 rs13266634 (C:C) 255 (77.3%) (T:C) 68 (20.6%) (T:T) 7 (2.1%) 578 (87.5%) 82 (12.4%) 
5 rs7754840 (C:C) 24 (7.1%) (G:C) 125 (36.9%) (G:G) 190 (56%) 173 (25.5%) 505 (74.4%) 
6 rs560887 (C:C) 199 (59.4%) (T:C) 116 (34.6%) (T:T) 20 (6%) 514 (76.7%) 156 (23.2%) 
7 rs2191349 (T:T) 130 (39.6 %) (T:G) 130 (39.6%) (G:G) 68 (20.7%) 390 (59.4%) 266 (40.5%) 
8 rs10830963 (G:G) 20 (6.1%) (G:C) 102 (31.1%) (C:C) 206 (62.8%) 142 (21.6%) 514 (78.3%) 
9 rs7034200 (A:A) 132 (40.1%) (C:A) 152 (46.2%) (C:C) 45  (13.7%) 416 (63.2%) 242 (36.7%) 
10 rs174550 (T:T)  226 (69.8%) (T:C) 91 (28.1%) (C:C) 7 (2.2%) 543 (83.7%) 105 (16.2%) 
11 rs11708067 (A:A) 257 (77.2%) (A:G)  74 (22.2%) (G:G) 2 (2 .6%) 588 (88.2%) 78 (11.7%) 
12 rs4607517 (A:A) 29 (8.8%) (A:G)  102 (30.9%) (G:G) 199 (60.3%) 106 (17.5%) 500 (82.5%) 
13 rs7903146 (T:T) 50 (15%) (T:C) 148 (44.3%) (C:C) 136 (40.7%) 215 (33.8%) 420 (66.1%) 
14 rs1799884 (T:T)  34 (10%) (T:C) 115 (33.9%) (C:C) 190 (56%) 183 (26.9%) 495 (73%) 
15 rs5219 (T:T) 23 (6.9%) (T:C) 94 (28.1%) (C:C) 218 (65.1%) 140 (20.8%) 530 (79.1%) 
16 rs7756992 (G:G) 22 (6.5%) (A:G)  135 (40.2%) (A:A) 179 (53.3%) 179 (26.6%) 493 (73.3%) 
17 rs780094 (C:C) 143 (42.9%) (T:C) 131 (39.3%) (T:T) 59 (17.7%) 417 (62.6%) 249 (37.3%) 
18 rs2237897 (C:C) 328 (97.6%) (T:C) 7 (2.1%) (T:T) 1  (0.3%) 663 (98.6%) 9 (1.3%) 
19 rs2237895 (C:C) 90 (27.1%) (T:C) 151 (45.5%) (T:T) 91 (27.4%) 331 (49.8%) 333 (50.1%) 
20 rs1387153 (T:T) 31 (9.4%) (T:C) 136 (41.2%) (C:C) 163 (49.4%) 198 (30%) 462 (70%) 
21 rs231362 (G:G) 116 (35.5%) (A:G)  153 (46.8%) (A:A) 58 (17.7%) 385 (58.8%) 269 (41.1%) 
22 rs7957197 (T:T) 253 (75.7%) (T:A) 71 (21.3%) (A:A) 10 (3%) 577 (86.3%) 91 (13.6%) 
23 rs757210 (A:A) 91 (27.8%) (A:G)  140 (42.8%) (G:G) 96 (29.4%) 322 (49.2%) 332 (50.7%) 
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Box 5.2: Visualization of genotypes variations in patient and healthy subjects: 
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Box 5.2: Continue: 
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Box 5.2: Continue: 
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Box 5.2: Continue:  
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     Table 5.24 illustrates summary statistics of several variables relating to the reported number 
of homozygote genotypes and number of risk alleles of the total sample. On comparing patients 
and healthy subjects, the number of inherited risk alleles and the levels of homozygosity are 
almost identical in both groups. 
 
5.1.9.3 Distribution of number of homozygote genotypes and detected risk alleles 
 
     Figure 5.12 illustrate distribution of homozygote genotypes in all subjects. This distribution 
appears to be negatively skewed. This skewedness indicates that there is a tendency of deviation 
towards carrying homozygote genotypes in the sample. This is consistent with that expected in 
inbred populations. However, by observing figure 5.13, we can notice normal distribution of 
homozygote genotypes for risk alleles. The last observation might indicate that inbreeding 
increases level of homozygote genotypes regardless to the risk status of the allele.  
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                                  Table 5.24: Genotypes summary statistics:  
 
 Total number of all homozygote 
genotypes  
Total Number of  homozygote 
genotypes for risk alleles 
Number of all risk alleles 
Status Total Patients Healthy Total Patient
s 
Healthy Total Patient Healthy 
No.  316 157 159 316 157 159 316 157 159 
Mean 14.99 14.80 15.18 9.06 9.15 9.15 25.86 25.89 25.84 
Median 15.00 15.00 15.00 9.00 9.00 9.00 26.00 26.00 26.00 
Mode 16 16 16 9 9 9 24 27 26 
SD 2.818 2.964 2.662 1.956 1.993 1.920 3.199 3.165 3.241 
Minimum 5 5 7 1 1 2 17 18 17 
Maximum 21 21 21 14 14 14 34 34 34 
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Figure 5.12: Distribution of number of homozygote genotypes of the whole sample. 
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Figure 5.13: Number of loci homozygous for risk alleles per participant.  
 
     In figure 5.14, we compared the distribution of the number of homozygote genotypes 
between patients and healthy subjects. There is similar deviation toward an increased number of 
homozygote genotypes in patients and healthy subjects. Additionally, there is no consistent 
difference in homozygote genotypes number between patients and healthy subjects. In figure 
5.15, we compared the distribution of homozygote genotypes of risk alleles of patients and 
healthy subjects. 
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Figure 5.14: comparison of distribution of number of homozygote genotypes in 
patient and healthy subjects.   
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Figure 5.15: Comparison of  number of loci homozygous for risk alleles in patients and 
healthy subjects.  
 
     Figure 5.16 illustrates approximately a normal distribution of number of detected type 2 
diabetes risk alleles in the total sample. In figure 5.17, we compared the distribution of detected 
risk alleles of patient and healthy subjects. Similar to what has been observed in figure 5.15, 
illustrating distribution of homozygote genotypes of risk alleles, both distributions of detected 
risk alleles are approximately normal. Additionally, in a similar pattern, the distribution of 
detected risk alleles appears to be  more consistent with normal in the healthy subjects’ group 
compared to patients’ group.  
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Figure 5.16: number of detected risk alleles in the sample.  
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Figure 5.17: number of detected risk alleles in patient and healthy subjects.   
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5.1.10 Conclusion 
 The total number of participants was 362, of whom 179 participants were type 2 
diabetes patients. 
 Several participants were reluctant to have their FBG measured but did not hesitate 
to give buccal swabs.  
  Patients were relatively older compared to healthy participants.  
 As expected, the number of siblings in Saudi families was large compared to that in 
western societies. The mean number of siblings per family in this sample was 7.03 
(SD= 3.04). 
 The prevalence of a history of consanguinity was 63% in our sample which is 
similar to the proportion of consanguineous marriages reported in studies conducted 
in Saudi Arabia. However, the number of marriages between first degree cousins 
was relatively lower in our sample compared to similar studies.  
 More than half of participants were exceeding recommended daily calorific values.  
 Healthy participants reported having a higher daily calorific intake compared to 
patients.  
 Healthy participants reported having a higher tendency to engage in sedentary 
activities compared to patients. In contrast, healthy subjects reported higher 
engagement with moderate and vigorous activity compared to patients.   
  The mean FBG was 95 mg/dl (SD: 23.89 mg/dl). Four readings were below the 
normal level of fasting blood glucose and 12 values were above the normal. 
  Mean BMI of healthy participants in this sample was 28.15 (SD: 6.8). There was a 
tendency of increased prevalence of overweight and obese individuals in our sample 
compared to a similar study conducted in Saudi Arabia.  
 The overall genotyping success was about 90%.  
 Khat chewing is less likely to interfere with genotyping quality. Genotyping success 
variation was observed between plates used during the genotyping process. 
 Overall genotype frequencies indicated a higher tendency to observe homozygosity 
in this sample.  
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5.2 Inferential Statistics 
5.2.1 Introduction  
      This chapter is composed of two main sections. The first section is dedicated to answering 
the study's research questions. The second section is a secondary analysis emphasizing the 
possible effect of consanguinity on traits related to type 2 diabetes. Questions stated in the 
secondary analysis were only established after completion of data collection.  
        We used Pearson’s correlation to test for the association between continuous variables. If 
distribution of variables was skewed, we utilized Spearman’s test. In both tests, significant a 
level was chosen at 0.05 and all tests were two-tailed. In addition to using a correlation test, we 
used scatter plots to visualize significant associations. Simple linear regression was utilized to 
measure effect levels and multiple linear regression was utilized to assess the effect of multiple 
independent variables. T-test was utilized to assess difference of means of selected variables.    
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5.2.2 Primary Analysis  
5.2.2.1 First question 
Does an inbreeding coefficient predict the extent of aggregation of type 2 diabetes risk alleles? 
Aim: In this question, we were aiming to investigate the possible association between the 
degree of consanguinity and the number of loci homozygous for risk alleles. We hypothesized 
that consanguinity is likely to increase aggregation of risk alleles by increasing the number of 
loci homozygous for risk alleles.  
Analytic Method: Spearman's rank correlation coefficient. 
Variables:    
- Number of loci homozygote for risk alleles. 
- Inbreeding coefficients. 
Subjects: 316 patients and healthy participants. 
Results: 
      Spearman's correlation coefficient indicates statistically non-significant association between 
degree of consanguinity and number of loci homozygote for risk alleles (0.01 p-value 0.856).  
Interpretation:  
      Calculated inbreeding coefficients might not be powered enough to predict an increase in 
homozygosity of measured SNPs. However, the direction is consistent with the hypothesis of 
increased number of loci identical for risk alleles with increased level of consanguinity. When 
assessing the association between the number of all risk alleles and inbreeding coefficients, the 
association was statistically not significant (Spearman's coefficient: -0.045, p-value: 0.427). The 
association between heterozygote genotypes and inbreeding coefficients was not statistically 
significant (Spearman's coefficient: -0.087, p-value: 0.122). However, the inverse association 
with heterozygote loci is consistent with the notion of inbreeding reducing levels of 
heterozygote genotypes. Finally, measuring the association between aggregation of risk alleles 
and inbreeding coefficients when separating patients and healthy subjects did not result in any 
statistically significant associations.  
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5.2.2.2 Second question  
Does the aggregation of type 2 diabetes risk alleles predict the age of onset of the disease?  
Aim: In this question, we were aiming to investigate the possible association between age at 
diagnosis and allelic aggregation induced by loci homozygous for risk alleles. The study utilized 
age at diagnosis as a proxy for age of onset. If there were a cumulative recessive effect, we 
would expect to see individuals with higher number of loci homozygous for risk alleles with 
earlier age at diagnosis compared to those with lower numbers of loci homozygous for risk 
alleles.  
Analytic Method: Simple linear regression to assess the association between age at diagnosis 
and number of loci homozygous for risk alleles. Multiple linear regression was later utilized to 
account for environmental factors.  
Variables:  
- Dependent variable: Age at diagnosis.    
- Independent variables: 
-  Number of loci homozygous for risk alleles. 
-  Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
Subjects: 157 type 2 diabetes patients.  
Results: 
      The univariate analysis reveals statistically non-significant association between number of 
loci homozygous for risk alleles and age at diagnosis (β: -0.106, p-value: 0.762). This 
association remained statistically non-significant using the multivariate analysis.  
Interpretation:  
       Measured SNPs did not provide any statistical evidence of cumulative recessive effect on 
age at diagnosis. However, the negative association might suggest a recessive effect that could 
be detected with a larger sample or larger number of SNPs. Additionally, we examined the 
association between the number of detected risk alleles (contributed from homozygote loci for 
risk alleles and heterozygote loci). However, no significant associations were detected between 
overall number of risk alleles and other traits. Only one association between age at diagnosis 
and total number of risk alleles became marginally significant after accounting for parental 
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history of diabetes and inbreeding coefficients (β: -0.399, p-value: 0.052) (Table 5.25 and 
Figure 5.18). We hypothesized that parental history of diabetes and consanguinity history might 
have captured additional genetic effect, which was not effectively captured by measured SNPs. 
In this final model, we categorized patients according to parental history of diabetes and only 
the maternal history of type 2 diabetes was statistically associated with reduced age at diagnosis. 
Other categories of parental history were not statistically associated with any effect on age at 
diagnosis. The final model suggests that increased number of detected risk alleles, higher level 
of consanguinity and maternal history of diabetes are likely to be associated with reduced age at 
diagnosis.    
Table 5.25: Association between age at diagnosis and number of all risk alleles:  
 
Model Unstandardized Coefficients t Sig. 
B Std. Error 
(Constant) 51.709 5.400 9.576 .000 
Number of risk alleles -.399 .204 -1.958 .052 
Mother Affected -5.307 1.319 -4.023 .000 
Inbreeding coefficients (%) -.533 .235 -2.266 .025 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: Normal probability plots and residuals of association between age at 
diagnosis and number of risk alleles accounting for parental history and consanguinity.   
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5.2.2.3 Third question 
 Does aggregation of type 2 diabetes risk alleles predict the extent of type 2 diabetes risk factors 
(BMI, waist circumference, FBG)? 
Aim: This question assesses the association between continuous risk factors and allelic 
aggregation induced by the number of loci homozygous for risk alleles. We hypothesized that 
individuals with higher number of loci identical for risk alleles could have been influenced by a 
cumulative recessive effect leading to higher BMI, waist circumference and FBG.  
Analytic Method: Simple linear regression to assess the association between risk factors and 
number of loci homozygous for risk alleles. Multiple linear regression was later utilized to 
account for age and environmental variables.  
Variables:  
- Dependent variables: BMI, waist circumference, and FBG.    
- Independent variables: 
-  Number of loci homozygous for risk alleles. 
- Age. 
- Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
Subjects: 159 healthy participants for BMI and waist circumference and 133 participants for 
FBG.  
Results:  
     The univariate analysis reveals statistically non-significant association between number of 
loci homozygous for risk alleles and continuous risk factors (BMI: β: 0.221, p-value: 0.438. 
waist circumference: β: -0.278, p-value: 0.658. FBG: β: 0.448, p-value: 0.652). This association 
remained statistically non-significant using the multivariable analysis.  
Interpretation:  
     Similar to what was observed in the first two research questions, no statistically significant 
cumulative recessive effect was detected. Even when utilizing number of all risk alleles, no 
additive effects were detected (BMI: β: 0.207, p-value: 0.217, waist circumference: β: -0.169, p-
value: 0.645), FBG: β: 0.967, p-value: 0.159). Not being able to find any recessive or additive 
effect on traits related to type 2 diabetes might suggest a lack of power or possibility of the 
contribution of unmeasured SNPs.  
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5.2.3 Secondary Analysis 
5.2.3.1 Association between age at diagnosis and inbreeding coefficients 
Aim: In this section, we were interested in testing whether higher levels of inbreeding 
coefficients are associated with earlier age at diagnosis.  
Analytic Methods: Firstly, simple linear regression was utilized to test the association between 
age at diagnosis and inbreeding coefficients. Secondly, multiple linear regression was 
preformed to control for other environmental variables.  
Variables:  
- Dependent variable: Age at diagnosis.    
- Independent variables: 
- Inbreeding coefficients (percentage). 
- Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
Subjects: 179 type 2 diabetes patients.  
Results:  
Table 5.26: Univariate analysis of association between age at diagnosis and inbreeding 
coefficients: 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
Sig. B Std. Error Beta 
 (Constant) 39.04
4 
.765 
 
.000 
Inbreeding coefficients (%) -.593 .236 -.186 .013 
a. Dependent Variable: Age at Diagnosis 
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Figure 5.19: Scatter plot of inbreeding coefficients and age at diagnosis.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.20: Normal probability plot and scatter plot of standardized residuals against 
standardized predicted values of association between age at diagnosis and inbreeding 
coefficients. 
R: - 0.186 
P: 0.013 
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Table 5.27: Multivariate analysis of association between age at diagnosis and inbreeding 
coefficients:  
 
Model 
Unstandardized 
Coefficients 
t Sig. B Std. Error 
 (Constant) 48.555 2.405 20.193 .000 
Inbreeding coefficients (%) -.572 .225 -2.544 .012 
Weekly Sedentray Hours -.087 .025 -3.513 .001 
Weekly Moderate Activity Hours -.142 .066 -2.138 .034 
Weekly Vigorous Activity Hours -1.380 .538 -2.566 .011 
a. Dependent Variable: Age at Diagnosis.  
 
 
 
 
 
 
 
 
 
 
Figure 5.21: Normal probability plot and scatter plot of standardized residuals against 
standardized predicted values of association between age at diagnosis and inbreeding 
coefficients after accounting for environmental variables. 
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Interpretation:  
    The univariate analysis indicates significant inverse association between inbreeding 
coefficients and age at diagnosis.  Although this negative association is weak, it gives us an 
indication that those who have higher inbreeding coefficients are likely to be associated with 
increased risk of developing type 2 diabetes at a younger age. Figure 5.20 shows an 
approximate linear distribution of residuals. Environmental variables were added to the model 
to test for possible effect on the association between inbreeding and age at diagnosis. However, 
after environmental variables were added to the model the association remained significant.  
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5.2.3.2 Association between age at diagnosis and inbreeding coefficients accounting for 
parental history of diabetes 
Aim: To assess whether parental history of diabetes has an effect on the association between 
inbreeding coefficients and age at diagnosis.  
Analytic Methods: Patients were divided into four groups based on parental history of diabetes. 
In each group, median of inbreeding coefficients, mean and standard deviation of age at 
diagnosis and Spearman's correlation coefficients were calculated.    
Variables:  
- Parental history of diabetes (four categories: both parents affected, neither 
affected, only father affected, only mother affected). 
- Inbreeding coefficients. 
- Age at diagnosis. 
 
Subjects: 179 patients.  
Results:  
Table 5.28: Inbreeding coefficients, age of diagnosis and their correlations 
according to parental history of type 2 diabetes:  
Parental History 
of Type 2 
Diabetes 
Paternal History 
Yes No 
M
a
ter
n
a
l H
isto
ry
 
Yes Median of inbreeding coefficients: 
0.23% 
Mean of age at diagnosis: 36.94 (SD: 
9 years).  
Correlation between IC and age at 
diagnosis: -0.502 (p-value: 0.003) 
N = 35 
Median of inbreeding coefficients:      
0. 04% 
Mean of age at diagnosis: 34.51 (SD: 7 
years).  
Correlation between IC and age at 
diagnosis: 0.117 (p-value:  0.491) 
N = 37.  
No Median of inbreeding coefficients: 
0.02% 
Mean of age at diagnosis: 38.96    
(SD: 9 years).  
Correlation between IC and age at 
diagnosis: -0.228 (p-value:  0.128) 
N = 46 
Median of inbreeding coefficients:      
0. 04% 
Mean of age at diagnosis: 40.26      
(SD: 9 years).  
Correlation between IC and age at 
diagnosis:  -0.158 (p-value: 0.223) 
N = 61 
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Figure 5.22: Association between age at diagnosis and inbreeding coefficients categorized 
according to parental history of diabetes.  
Interpretation: 
     Mean age of diagnosis with type 2 diabetes appears to be higher when there is no parental 
history of the disease. The mean age at diagnosis in the no parental history group is 40.26 years 
compared to 36.94 years in the group that reported both parents affected with the disease. 
Additionally, the lowest mean of age at diagnosis with diabetes is 34.51 years which is reported 
in the group that reported only maternal history of diabetes. The later statement might indicate a 
stronger association of diagnosing at younger age when there is a maternal history of type 2 
diabetes compared to the paternal history of the disease.  
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     As indicated in Table 5.28, all Spearman’s correlation coefficients in all groups were not 
significant except for one association. The association between inbreeding coefficients and age 
at diagnosis in families, which reported both parents as being affected is -0.502 (P value: 0.003). 
The correlation is stronger than that reported earlier correlating inbreeding coefficients with age 
of diagnosis in the whole sample. This higher correlation might indicate that those who have 
higher inbreeding coefficients and have both parents affected with diabetes are associated with 
development of the disease at a younger age compared to other individuals in the remaining 
groups.  
 
      For development of recessive illnesses, both parents must be either affected or carriers of 
genetic risk markers of the illness of interest. Observing a stronger inverse association between 
age at diagnosis and higher level of consanguinity in offspring where both parents are affected 
with type 2 diabetes might be attributed to possible recessive effect. Stratifying parents 
according to parental history eliminates possible source of confounding on age at diagnosis 
caused by parental history of diabetes.  
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5.2.3.3 Association between type 2 diabetes risk factors and inbreeding coefficients 
Aim: To establish if higher inbreeding coefficients are associated with an increase of BMI, 
waist circumference and FBG.  
Analytic Methods: Simple linear regressions to assess the associations between inbreeding 
coefficients and BMI, waist circumference and FBG. Multiple linear regression to account for 
environmental variables.  
Variables:  
- Dependent variables: BMI, waist circumference and FBG.    
- Independent variables: 
- Inbreeding coefficients (percentages). 
- Age. 
- Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
 
Subjects: 183 healthy participants for BMI, 182 for waist circumference and 153 participants 
for fasting blood glucose.  
 
Results:  
     No statistically significant associations were detected between inbreeding coefficients and 
BMI (β: 0.113, p-value: 0.476), waist circumference (β: 0.207, p-value: 0.607) or fasting blood 
glucose (β: -0.007, p-value: 0.991). Associations remained non-significant after accounting for 
environmental variables and age.  
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5.2.3.4 Correlations of variables between healthy sibling pairs in each family  
 
Aim: To assess resemblance between healthy siblings of several measured variables. We were 
interested in investigating possible shared genetic or environmental effects on resemblance of 
several measured traits. 
Analytic Methods: In this study, we recruited 153 participants from 51 families. In these 
families, three participants were recruited from each family where one participant was a patient 
and the remaining two were healthy participants. Therefore, we have 102 healthy participants 
where each two participants represent a familial unit. We studied the magnitude of correlation 
of several variables between healthy sibling pairs in each familial unit. Pearson's correlation 
coefficients were calculated for variables, which were normally distributed and Spearman's rank 
correlation coefficients were calculated for variables with non-normal distributions.  
Variables:  
In each healthy sibling pair, we calculated correlations of the following variables. 
- Age. 
- Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
- Weight. 
- Height. 
- BMI. 
- Waist circumference. 
- FBG.  
 
Subjects: 51 pairs of healthy participants for all variables except FBG (42 pairs).   
 
 
 
 
 
 
183 
 
Results:  
Table 5.29: Correlation of several variables between healthy siblings in each familial unit: 
Variables Test Type Correlation P-value Number of 
Familial Units 
Correlation of age between 
healthy siblings 
Pearson’s 
correlation 
0.611 0.000 51 
Correlations between healthy 
siblings calorific intake 
Pearson’s 
correlation 
0.459 0.001 51 
Correlations between healthy 
siblings sedentary activity 
Pearson’s 
correlation 
0.227 0.109 51 
Correlation between healthy 
siblings moderate activity 
Spearman's 
correlation 
0.182 0.202 51 
Correlation between healthy 
siblings vigorous activities 
Spearman's 
correlation 
0.161 0.258 51 
Correlation between healthy 
siblings weight 
Pearson’s 
correlation 
0.185 0.194 51 
Correlation between healthy 
siblings height 
Spearman's 
correlation 
0.277 0.049 51 
Correlation between healthy 
siblings BMI 
Pearson’s 
correlation 
0.260 0.065 51 
Correlation between healthy 
siblings waist circumference 
Pearson’s 
correlation 
0.206 0.147 51 
Correlation between healthy 
siblings FBG 
Pearson’s 
correlation 
0.317 0.040 42 
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Interpretation: 
    Correlation of age between healthy siblings in each family is 0.611. This indicates that 
siblings are reasonably within similar age range. Having similar age range allows us to assume 
that age is less likely to affect the association of any traits detected between siblings.   
    There is a significant association of eating habits in siblings of each family member. 
Pearson’s correlation coefficient for association between the calorific intake of each sibling is 
0.459. This gives a partial explanation of environmental effect of associations of any trait 
between siblings of each family. However, none of the parameters used to measure physical 
activity were significantly correlated between healthy siblings of each family member. This 
might indicate that unlike obvious familial effect on food intake, familial effect on level of 
physical activity is less likely to be significant in this sample. 
    Two significant associations of healthy siblings’ anthropometric measures were detected. 
Height of healthy siblings was significantly correlated. Additionally, correlation between FBG 
of siblings of each family was significantly associated (r: 0.317, p-value: 0.04). However, 
associations of waist circumference and body weight between healthy siblings were not 
statistically significant and correlation between siblings’ BMI indicated marginal significance 
(0.065).  
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5.2.3.5 Effect of consanguinity on correlations of BMI, waist circumference and FBG 
between healthy sibling pairs in each family 
 
Aim: To study the effect of consanguinity on direction of correlation of BMI, waist 
circumference and FBG between sibling pairs. We were interested in observing if families with 
higher inbreeding coefficients are associated with higher correlations between siblings of each 
family. 
Analytic Methods: The effect of consanguinity was assessed by grouping inbreeding 
coefficients into four categories, where Pearson's correlation coefficients were calculated in 
each category. In first stage, all families were included. The second stage comprised removal of 
all families with zero inbreeding coefficients. Thirdly, we removed all families where the only 
history of inbreeding coefficients was based on mating between couples from the same tribe or 
subtribe. In the final stage, we removed families with inbreeding history lower than 1.5%.  
Variables:  
In each pair, we calculated correlations of the following variables. 
- BMI. 
- Waist circumference. 
- FBG.  
Subjects: 51 pairs of healthy participants for all variables except fasting blood glucose (42 
pairs).   
 
Results:   
     Calculating correlation coefficients under a restricted range of consanguinity revealed an 
effect on correlations of FBG (Table 6 and Figure 5). No similar effect was observed on 
correlations of BMI and waist circumference.  
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Table 5.30: Studying the effect of inbreeding on association of FBG between siblings of 
each family:  
Inclusion Criteria Pearson’s 
Correlation 
Coefficient 
Significance Number of 
familial units  
All healthy siblings 0.317 0.040 42 
Only families with history of 
consanguinity 
0.419 0.015 33 
Only  families with inbreeding 
coefficients larger than 0.04% 
0.584 0.003 23 
Only families with inbreeding 
coefficients larger than 1.5% 
0.699 0.001 18 
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Interpretation: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.23: Scatter plots illustrating correlations of fasting blood glucose in different 
levels of consanguinity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All Healthy Siblings All families with history of consanguinity 
Only families with inbreeding coefficients larger than 
0.04% 
Only families with inbreeding coefficients larger than 
1.5% 
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Interpretation: 
    Estimating association of healthy siblings’ FBG according to inbreeding coefficients showed 
a significant trend. There is an increase in correlations from 0.317 between siblings in all 
families to 0.699 when restricting the association in families with inbreeding coefficients higher 
than 1.5%. This trend suggests that association of FBG between siblings is higher in families 
with higher inbreeding coefficients compared to families with lower inbreeding coefficients. 
This might give a partial explanation of the intensified genetic effect with increased inbreeding 
coefficients.  
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5.2.3.6 Effect of consanguinity on variation of FBG between healthy sibling pairs in each 
family 
 
Aim: In the previous analysis, we observed higher correlations of FBG between siblings of each 
family with increased inbreeding coefficients. In this section, we are interested in estimating the 
effect of consanguinity on reducing the difference of FBG between each pair and to account for 
the differences of other environmental variables and age.   
Analytic Methods: Difference of FBG was calculated within each pair. A simple linear 
regression was preformed to assess the direction of the difference of FBG with increased 
inbreeding coefficients. Differences in age and other environmental variables were all calculated 
and fitted in a multiple regression line to account for the effect of variation in these factors on 
the association between consanguinity and difference in FBG.  
Variables:   
- Dependent variable: Difference of FBG within pairs of each family. 
- Independent variables: 
- Inbreeding coefficients (percentage).  
- Difference of age of siblings of each pair.  
- Difference of daily calorific intake of siblings of each pair. 
- Difference of weekly sedentary hours of siblings of each pair.  
- Difference of weekly moderate activity hours of siblings of each pair.  
- Difference of weekly vigorous activity hours of siblings of each pair.  
Subjects: 42 pairs of healthy siblings.   
 
Results:   
      Inbreeding coefficients were inversely associated with difference of FBG  (β: -1.8,  p-value: 
0.039). Association between inbreeding coefficients and difference in FBG remained significant 
after accounting for difference in age and other environmental factors and none of the variables 
was significantly associated with difference in FBG. Figure 5.24 indicates the normal 
probability plot and residuals distribution. The distribution indicated in this figure did not 
improve by log transformation of the variables.   
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Figure 5.24: Normal probability plot and scatter plot of standardized residuals against 
standardized predicted values of association between difference in FBG and inbreeding 
coefficients. 
 
Interpretation: 
     As indicated in Table 5.30, the effect of inbreeding coefficients on association of FBG 
between siblings of each family is still significant after accounting for several other variables. 
These variables include difference of age, calorific intake and level of physical activity between 
healthy siblings of each family. The minus sign of the slope of association between inbreeding 
coefficients and difference of FBG between healthy siblings indicates that in families with 
higher inbreeding coefficients, the difference of FBG between siblings becomes smaller. 
Controlling of other environmental differences indicates the significant genetic effect of this 
association, which in this case could be largely explained by the effect of inbreeding.  
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5.2.3.7 Assessing the effect of measured environmental factors on age at diagnosis 
 
Aim: To study the association between measured environmental variables and age at diagnosis. 
Assessing the association might give an indication of performance of measured variables as 
predictors of age at diagnosis. 
Analytic Methods:  Pearson's correlation coefficients for variables with normal distributions 
and Spearman's correlation coefficients were calculated for others with skewed distributions.   
Variables:  
The association was measured between: 
- Age at diagnosis. 
- And: 
- Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
. 
Subjects: 179 patients.  
 
Results:   
Table 5.31: Associations between age at diagnosis and other environmental variables: 
Association Test Type Coefficient p-value 
Age at diagnosis and 
average caloric 
intake 
Pearson's coefficient -0.114 
 
 
0127 
Age at diagnosis and 
sedentary activity 
Pearson's coefficient -0.250 0.001 
Age at diagnosis and 
moderate activity  
Spearman's 
coefficient 
-0.150 0.045 
Age at diagnosis and 
vigorous activity 
Spearman's 
coefficient 
-0.209 0.005 
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Interpretation:  
     Table 5.31 shows no statistically significant association between calorific intake and age at 
diagnosis. This could be largely explained by the tendency of patients to report having a 
healthier lifestyle based on their GPs recommendations. This remark was observed when 
comparing calorific intake in patients with the intake in healthy siblings. Healthy siblings were 
apparently not following any dietary restriction and therefore were likely to report having higher 
calorific intake compared to patients.  
    Parameters of physical activity witnessed significant association with age at diagnosis. The 
inverse association between level of sedentary activity and age at diagnosis is contradicting the 
observations of association between age at diagnosis and moderate and vigorous activity.     The 
detected inverse association between age at diagnosis and sedentary activities might be 
biologically plausible. Those who are likely to engage in a relatively sedentary lifestyle are 
likely to develop the disease earlier compared to those engaged in a more active one. However, 
correlations with moderate and vigorous activity suggest a tendency for those who are active to 
have a higher risk of earlier diagnosis of the disease. However, this contradicting association 
could be explained by observing the association between levels of moderate and vigorous 
activities and age. Figure 5.25 suggests that younger patients are more likely to report engaging 
in physical activities compared to older patients.   
      Association between age and level of physical activity found in our study was detected by 
another recent study conducted in Saudi Arabia. A study by Amin et al. measured the level of 
physical activity in a sample of 2176 adult Saudi subjects. In this study, they calculated the 
number of minutes spent performing moderate or vigorous activities in addition to a third 
category of those with low levels of activity. In this study, they showed a statistically significant 
reduction in the level of vigorous activities with increased age (p-value 0.001) (87).  
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Spearman's Coefficient: -0.291  
P-value: 0.000 
Spearman's Coefficient: -0.294  
P-value: 0.000 
 
 
 
 
 
 
 
 
Figures 5.25: Correlations of moderate and vigorous activates with age in patients (N 
= 179) 
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5.2.3.8 Assessing the association between measured environmental factors and 
anthropometric variables 
 
Aim: To study the association between measured environmental variables and BMI, waist 
circumference and FBG. Assessing the association might give an indication of performance of 
measured environmental variables as predictors of anthropometric variables.   
Analytic Methods: Simple linear regression was firstly conducted to assess the association 
between dependent and independent variables on an individual basis. Then, multiple linear 
regression was utilized to assess the association between measured anthropometric variables and 
all measured environmental variables and age.   
Variables:  
- Dependent variables: BMI, waist circumference and FBG.  
- Independent variables:  
- Age.  
- Average daily calorific intake.  
- Number of weekly hours spent performing sedentary activities.  
- Number of weekly hours spent performing moderate activities. 
- Number of weekly hours spent performing vigorous activities. 
. 
Subjects: 183 healthy subjects for BMI and waist circumference and 154 for fasting blood 
glucose.  
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Results: 
Table 5.32: Simple linear regressions of associations between environmental factors and 
anthropometric variables: 
Associations BMI Waist circumference FBG 
Age β: -0.02, p-value: 
0.675 
β: 0.21, p-value: 
0.04 
β: 0.686, p-value: 
0.000 
Average daily 
calorific intake 
β: 0.001, p-value: 
0.047 
β: 0.00, p-value: 
0.624 
β: -0.004, p-value: 
0.005 
Weekly sedentary 
hours 
β: -0.018, p-value: 
0.446 
β: -0.029, p-value: 
0.565 
β: -0.208, p-value: 
0.007 
Weekly moderate 
activity hours 
β: -0.027, p-value: 
0.551 
β: 0.024, p-value: 
0.809 
β: -0.099, p-value: 
0.478 
Weekly vigorous 
activity hours 
β: -0.305, p-value: 
0.037 
β: -1.104, p-value: 
0.000 
β: -0.887, p-value: 
0.170 
  
       Multiple linear regression revealed several associations. The association between BMI and 
independent variants revealed only a single statistically significant association with level of 
vigorous activity (β: -0.510, p-value: 0.006) (Figure 5.26). Similarly, association between waist 
circumference and independent variants only showed statistically significant association with 
level of vigorous activity (β: -1.519, p-value: 0.001) (Figure 5.27). In both situations, age was 
not significantly associated with BMI or waist circumference. In contrast, FBG was not 
associated with any of the measured environmental variables and was only associated with age 
(β: 0.584, p-value: 0.001) (Figure 5.28).  
 
 
 
196 
 
 
Figure 5.26: Association between number of hours spent performing vigorous 
activities and BMI.  
  
R: -0.214 
P-value:0.013 
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Figure 5.27: Association between number of hours spent performing vigorous 
activities and waist circumference.  
 
 
 
 
 
 
  
Spearman's Coefficient: -0.214 
P-value: 0.004 
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Figure 5.28: Association between age and FBG.   
 
Interpretation: 
 
     This analysis indicates that measured calorific intake did not provide a significant influence 
on anthropometric measurement. Explanations for a lack of this association could involve 
related difficulties in estimating portion size or lack of power of this sample. However, the 
vigorous activity coefficients reach statistical significance with BMI and waist circumference. 
Failure to find statistically significant association with sedentary and moderate activities might 
indicate that, unlike vigorous activity, less intense activities are not strong enough to cause 
variation in BMI or waist circumference in this sample. FBG witnesses a different direction 
where multiple regression indicated that only age was significantly correlated and none of the 
environmental variables contributed to the variation of FBG.  
 
R: 0.365 
p-value: 0.000 
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5.2.3.9  Correlations between anthropometric variables 
 
Aim: Increased BMI and waist circumference are known to increase the risk of type 2 diabetes. 
We are aiming to investigate whether an increase in BMI and waist circumference is associated 
with an increase in FBG in the study's sample.    
Analytic Methods:  Pearson's correlation coefficient.   
Variables:  
- BMI. 
- Waist circumference. 
- FBG.  
Subjects: 183 healthy subjects for BMI and waist circumference and 154 for FBG.  
Results:  
Table 5.33: Association between anthropometric variables: 
Association Pearson’s Correlation 
Coefficient 
Significance Sample 
Size 
BMI and FBG 0.028 0.729 154 
Waist circumference and FBG 0.093 0.252 154 
BMI and waist circumference 0.927 0. 000 182 
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Figure 5.29: Scatter plot of the association between body mass index and waist 
circumference.  
 
Interpretation:  
     No significant association was detected between FBG and waist circumference or BMI. 
However, a strong correlation was detected between BMI and waist circumference.   
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5.2.3.10 Risk of aggregation of T2D risk alleles according to parental history of diabetes 
 
Aim: To investigate whether having both parents affected with type 2 diabetes is associated 
with increased risk of detecting loci homozygous for risk alleles or overall number of detected 
risk alleles. We assume that offspring with both parents affected with diabetes are likely to be 
associated with increased aggregation of risk alleles compared to offspring with no parental 
history.  
      We used two categories of parental history to investigate the possible effect of utilizing two 
extreme ends of parental history of diabetes on aggregation of risk alleles. Additionally, we are 
assuming that genetic effect contributed when both parents are affected might be stronger 
compared to having only one parent affected. Finally, having both parents affected is more 
likely to induce a possible recessive effect compared to having only one parent affected.  
 Analytic Methods: In the first stage, multiple linear regression was utilized to study the 
association between parental history of diabetes and number of loci identical for risk alleles and 
number of all detected risk alleles. Secondly, logistic regression was utilized to assess if 
parental history of diabetes has an effect on increasing aggregation of risk alleles of individual 
SNPs. Parental history of diabetes was categorized into having both parents affected with the 
disease or neither parents affected.  
Variables:  
- Dependent variables: 
     -     Number of loci homozygous for risk alleles. 
                  -    Number of all detected risk alleles.   
- Independent variables:  
- Both parents affected with diabetes.  
- Neither parent affected with diabetes. 
 
Subjects: 159 patients and their healthy siblings.  
Results: 
      There was no significant association between number of loci homozygous for risk alleles or 
number of all risk alleles and parental history of diabetes (Table 3.10.1).  
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Table 5.34: Association between parental history of diabetes and aggregation of risk alleles: 
 Number of loci homozygous 
for risk alleles 
Number of all risk alleles 
Both parents 
affected (n = 54) 
β: 0.242, P-value: 0.432 β: 0.588, P-value: 0.246 
Neither parents 
affected (n = 105) 
β: 0.143, P-value: 0.561 β: - 0.002, P-value: 0.995 
 
   Logistic regression showed only one statistically significant increased risk of detected loci 
identical for risk alleles at one SNP when both parents are affected in addition to another SNP, 
which had a marginal statistical significance. Similarly, only two significant associations 
witnessed increased risk of detecting a higher number of risk alleles in offspring with both 
parents affected (Table 5.35).  
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                Table 5.35: Odds of inheriting homozygote risk alleles based on parental history of type 2 diabetes:  
  
SNP Frequency Homozygote alleles OR 
[95% CI] 
P 
value 
All alleles OR 
[95% CI] 
P 
value Effect Other Effect Other Effect Other 
B*  N** B*  N** B* N** B*  N** 
rs2191349 59.4% 40.5% 25 40 5 26 3.2[1.1-9.5] 0.002 75 121 35 35 1.6[1.01-2.67] 0.04 
rs2237895 49.8% 50.1% 16 22 12 39 2.3[0.9-5.8] 0.06 62 91 54 125 1.5[1.01-2.48] 0.04 
 
 
                  *Both parents reported with history of type 2 diabetes. 
                  ** Neither of the parents reported with history of type 2 diabetes
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Interpretation:  
    This analysis indicates higher odds of inheriting loci identical for risk alleles or higher 
number of risk alleles when both parents are reported to be affected in two SNPs. However, as 
23 SNPs were tested and 23 hypothesis tests were conducted, we would expect 5% of these to 
be significant under the null hypothesis. A study which investigated the risk of inheriting risk 
alleles of 16 SNPs related to type 2 diabetes concluded that there is a tendency for subjects with 
both parents affected with diabetes to inherit a higher number of risk alleles compared to those 
with no history of parental diabetes or where only one parent was affected (p trend = 0.0004) 
(278). Although we only observed the effect of paternal history of diabetes on two SNPs, the 
findings of this study are consistent with ours indicating significant effect of parental history on 
inheriting risk alleles of SNPs and eventually increasing the risk of type 2 diabetes.  
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5.2.3.11 Hardy-Weinberg Equilibrium (HWE) test 
Aim: We made an effort to investigate whether allelic frequencies of selected SNPs fall under 
HWE or not. If there were a violation of the equilibrium and deviation toward having higher 
frequency of homozygote genotypes, this would suggest that genotypes frequency could be 
affected by inbreeding observed in the Saudi population.  
Analytic Methods:  
     HWE states that alleles and genotype frequencies in a population will remain constant 
between generations if mating between subjects is random and there are no other forces such as 
selection, mutation and migration affecting the population. Based on allelic frequency in any 
population, genotypes frequency under HWE can be calculated. If we assume that two alleles, A 
and B, with allelic frequency of a and b, then we would conclude that under equilibrium, 
genotype frequency of AA genotype is   , frequency of genotype AB is 2ab, and genotype 
frequency of BB is   . If the expected frequency of genotypes under HWE are different than 
observed frequencies, then we would conclude that the population of interest is not exhibiting 
HWE and there is a force deviating allelic and genotypes frequencies (110).  
    HWE calculator was utilized to assess maintenance of equilibrium (Michael H. Court (2005-
2008) HWE calculator (279)) .If the p-value of difference between observed and expected 
frequency is less than 0.05, allelic frequency is then presumed to have deviated from HWE. 
Otherwise, if the p-value is higher than 0.05, then we would conclude that allelic frequency of 
the SNP of interest is maintaining HWE.  
 
Variables:  
- Frequency of homozygote genotypes for risk alleles. 
- Frequency of homozygote genotypes for none-risk alleles. 
- Frequency of heterozygote genotypes.  
 
Subjects: 339 patients and their healthy siblings.  
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Results: 
Table 5.36: HWE of selected alleles of the whole sample: 
  
No. SNP Observed 
frequency 
Expected 
frequency 
P value 
1 rs10946398 (A:A) 188  
(C:A)122  
(C:C) 24  
185.6 
126.7 
21.6 
0.49 
2 rs10811661 (T:T) 223 
(T:C) 102    
(C:C) 13 
222.1 
103.8 
12.1 
0.75 
3 rs1111875 (C:C) 223  
(T:C) 83 
 (T:T) 26 
210 
107 
13 
0.000032 
4 rs13266634 (C:C) 255  
(T:C) 68 
(T:T) 7 
253.1 
71.8 
5.1 
0.33 
5 rs7754840 (C:C) 24  
(G:C) 125 
(G:G) 190 
22.1 
128.9 
188.1 
0.58 
6 rs560887 (C:C) 199  
(T:C) 116 
(T:T) 20 
197.2 
119.7 
18.2 
0.57 
7 rs2191349 (T:T) 130  
(T:G) 130 
(G:G) 68 
115.9 
158.1 
53.9 
0.0012 
8 rs10830963 (G:G) 20  
(G:C) 102 
(C:C) 206 
15.4 
111.3 
201.4 
0.13 
9 rs7034200 (A:A) 132  
(C:A) 152 
(C:C) 45   
131.5 
153 
44.5 
0.905 
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10 rs174550 (T:T)  226  
(T:C) 91 
(C:C) 7 
227.5 
88 
8.5 
0.53 
11 rs11708067 (A:A) 257 
(A:G) 74  
(G:G) 2   
259.6 
68.9 
4.6 
0.17 
12 rs4607517 (A:A) 29  
(A:G)  102 
(G:G) 199 
19.4 
121.2 
189 
0.0039 
13 rs7903146 (T:T) 50  
(T:C) 148 
(C:C) 136 
46 
155.9 
132 
0.35 
14 rs1799884 (T:T)  34  
(T:C) 115 
(C:C) 190 
24.7 
133.6 
180.7 
0.01 
15 rs5219 (T:T) 23  
(T:C) 94 
(C:C) 218 
14 
110.7 
209.6 
0.005 
16 rs7756992 (G:G) 22  
(A:G)  135 
(A:A) 179 
23.8 
131.3 
180.8 
0.607 
17 rs780094 (C:C) 143  
(T:C) 131 
(T:T) 59 
130.5 
155.9 
46.5 
0.003 
18 rs2237897 (C:C) 328  
(T:C) 7 
(T:T) 1   
327.1 
8.9 
0.1 
0.000 
19 rs2237895 (C:C) 90  
(T:C) 151 
(T:T) 91 
113.2 
104.6 
24.2 
0.000 
20 rs1387153 (T:T) 31  29.7 0.73 
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(T:C) 136 
(C:C) 163 
138.6 
161.7 
21 rs231362 (G:G) 116 
(A:G)  153   
(A:A) 58 
113.3 
158.4 
55.3 
0.54 
22 rs7957197 (T:T) 253 
(T:A) 71   
(A:A) 10 
249.2 
78.6 
6.2 
0.077 
23 rs757210 (A:A) 91  
(A:G)  140 
(G:G) 96 
107.6 
106.9 
26.6 
0.000 
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Interpretation:  
     By observing Table 5.36, we can detect eight SNPs deviating from HWE with p-values 
lower than 0.05. With exception of five SNPs, all remaining 18 SNPs witness a reduction of 
observed number of heterozygote genotypes compared to expected frequencies. This might 
indicate that in our sample there is an overall higher tendency of deviation from heterozygote 
genotypes to homozygote genotypes, which is in agreement with the observed rates of 
consanguinity in the Saudi Arabian population. 
     HWE exists at the population level and is frequently conducted as a quality control for 
genome-wide association studies to assess population stratification and genotyping errors. 
However, in this study, we were trying to investigate potential deviation from equilibrium 
induced by the high levels of consanguinity observed in the Saudi Arabian population. Testing 
for HWE in this study revealed deviation towards increased level of homozygosity among 
several SNPs. Although a random sample of the population may have a chance of including 
siblings, this study, however, has selectively sampled siblings from several families.  
     Although we observed a deviation towards increased level of homozygosity, this deviation 
could be due to the fact that the sample included siblings who have a chance of having similar 
genotypes. However, since subjects were recruited from different families, we would expect the 
skew in the distribution of genotypes due to sampling through siblings to be balanced.The fact 
that siblings have been systematically recruited means that the sample is not random and hence 
the distribution of the chi-square statistic under the null is compromised. Moreover, the sample 
contains pairs of relatives which are correlated by genotype, and hence we do not have full 
independence in the sample owing to the sibling clustering.  
     To remove the clustering induced by the sibling sampling, we performed HWE tests on 
patients who are not related. We did not do the same with controls because, unlike the patients 
group, several healthy participants were siblings as we recruited two healthy siblings from 51 
families. Fewer SNPs show a statistically significant deviation from HWE in the cohort 
restricted to patients only compared with the cohort including all subjects. The reduction of 
statistically significant deviations will be due in some part to the smaller sample size of 
recruited unrelated patients.  Among the unrelated patients cohort and apart from a few SNPs, 
there is an overall tendency to observe a reduced number of expected heterozygote genotypes. 
Based on these observations, it is possible to assume that deviation towards homozygosity in the 
sample of related individuals is similar to the observed deviation among non-related patients.  
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5.2.3.12 Direction of homozygosity 
Aim: In the previous section, we were able to observe a tendency for our sample to deviate 
toward higher frequencies of homozygote genotypes compared to expected frequencies 
calculated by the HWE test. In this analysis we are investigating whether there is a higher 
tendency in our sample to observe higher frequency of loci homozygous for risk alleles 
compared to loci homozygous for non-risk alleles.  
Analytic Methods: Mean and standard deviations and t-test to assess presence of statistically 
significant difference.    
Variables:  
- Number of all homozygote loci.  
- Number of loci homozygous for risk alleles. 
- Number of loci homozygous for non-risk alleles. 
 
Subjects: 316 patients and their healthy siblings.  
Results: 
Table 5.37: Means and standard deviations of number of homozygote loci:  
 Mean Std. Deviation 
Number of all homozygote loci 14.99 2.821 
Number of loci homozygous for risk alleles 9.05 1.946 
Number of loci homozygous for non-risk alleles 5.94 2.189 
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Table 5.38: T-test to measure difference of means between number of loci identical 
for risk alleles and non-risk alleles: 
 
 
Interpretation: 
    This analysis suggests a deviation toward observing higher frequencies of homozygote 
genotypes for risk alleles compared to homozygote genotypes for non-risk alleles. In this 
sample, we observed a deviation of HWE toward observing higher frequency of homozygote 
genotypes. We can argue that inbreeding in this sample, in addition to increasing overall 
homozygosity, could have contributed to increased frequency of genotypes homozygous for risk 
alleles.  
     Inbreeding does not selectively increase frequency of genotypes homozygote for risk alleles. 
Inbreeding would increase frequency of homozygote genotypes despite the risk status of alleles 
of interest. However, we might argue that the Saudi Arabian population, as explained earlier in 
the background chapter, might have witnessed a thrifty genotype effect leading to higher 
frequencies of risk alleles due to selective forces. If we assume that selection could be 
responsible for passing certain risk alleles for type 2 diabetes to the following generations, we 
can argue that inbreeding of the subsequent generations might have further contributed to 
increased frequency of loci homozygous for selected risk alleles.  
     In this analysis, we combined all patients and healthy siblings. This might seem to violate the 
concept of measuring frequencies of risk genotypes assuming that patients are likely to have 
higher frequencies of risk alleles compared to their healthy siblings. However, we conducted a t-
test to measure the difference in means of risk alleles number and there was no statistical 
difference between patients and healthy subjects. We further examined if there is a systematic 
difference in risk alleles frequencies between patients and healthy siblings of each family and 
we also observed no significant difference between siblings. We must acknowledge that failing 
 t df Sig. (2-
tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
Lower Upper 
Loci homozygous 
for risk alleles 
82.66
5 
315 .000 9.051 8.84 9.27 
Loci homozygous 
for  none- risk 
alleles 
48.22
1 
315 .000 5.937 5.69 6.18 
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to find a significant difference of risk alleles frequencies between siblings is expected hence 
siblings are likely to share half of their alleles including type 2 diabetes risk alleles. 
Additionally, healthy subjects at the time of the interview could be at a risk of developing the 
disease later in their lives.  
 
5.3 Conclusion 
 The study sample might have not been powered sufficiently to detect statistically 
significant cumulative recessive effect of measured SNPs on age at diagnosis and other 
type 2 diabetes risk factors.  
 Individuals with higher inbreeding coefficients are likely to be associated with earlier 
age at diagnosis. This might indicate a possible cumulative recessive effect, which 
could not be detected by measured SNPs.  
 The significant association between inbreeding coefficients and age at diagnosis was 
observed to be influenced by parental history of diabetes. Among patients with positive 
paternal and maternal history of the disease, patients with higher inbreeding coefficients 
were likely to be diagnosed earlier with the disease compared with patients with lower 
inbreeding coefficients. 
 No statistically significant associations were detected between inbreeding coefficients 
and BMI, waist circumference and fasting blood glucose.  
 Siblings are likely to share similar eating habits but are less likely to witness similar 
physical activity levels.  
 Siblings with higher inbreeding coefficients are likely to have similar FBG compared to 
siblings with lower inbreeding coefficients.  
 Measured environmental variables are less likely to have an influence on age at 
diagnosis. 
 Levels of vigorous activity are more likely to influence anthropometric traits compared 
to other levels of physical activities and calorific intake.  
 The HWE test of our sample suggests a deviation toward a higher level of observed 
homozygote genotypes compared to expected frequencies.  
 There was a higher tendency to observe loci homozygote for risk alleles compared to 
loci homozygote for non-risk allele.  
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6 Chapter Six: Discussion 
6.1 Association between consanguinity and type 2 diabetes 
    Synergism between consanguinity and type 2 diabetes has been suggested by several studies. 
The main aim of this study was to explain the mechanism behind this association.  We 
hypothesized that higher levels of consanguinity might be associated with higher aggregation of 
loci homozygous for risk alleles and subsequently higher overall aggregation of risk alleles. 
Furthermore, we aimed to study the possible cumulative recessive effects of measured loci by 
studying associations between the number of loci homozygous for risk alleles and age at 
diagnosis, BMI, waist circumference or FBG. 
       Our investigation was not able to find any recessive effect of measured SNPs on severity or 
risk factors of type 2 diabetes. Associations between the number of loci homozygous for risk 
alleles and variables related to severity or risk factor of the disease were not statistically 
significant (age at diagnosis: β: -0.106, p-value: 0.762; BMI: β: 0.221, p-value: 0.438; waist 
circumference: β: -0.278, p-value: 0.658; FBG: β: 0.448, p-value: 0.652]. If there really is a 
causal association between inbreeding coefficients and severity of type 2 diabetes, then this 
suggests there may be many more type 2 diabetes risk loci all acting with weak recessive effects. 
Inbreeding alone cannot induce an association with diabetes risk if the genetic effect is additive 
only. Although we had selected the 23 SNPs with the strongest marginal effects (detected 
through GWAS) our study lacked power to detect the cumulative evidence of these weak 
recessive effects. However, as we see an association between the inbreeding coefficients and 
age at diagnosis this suggests many more recessively acting loci may contribute to the type 2 
diabetes risk. 
       Additionally, we examined the association between the number of detected risk alleles 
(contributed from homozygote loci for risk alleles or heterozygote loci) and traits related to type 
2 diabetes. However, no significant associations were detected between the overall number of 
risk alleles and other traits. This suggests that our sample and measured SNPs, in addition to not 
having the power to detect recessive effect, were not sufficient to detect any additive effect of 
risk alleles on traits related to type 2 diabetes.      
      Only one association between age at diagnosis and total number of risk alleles became 
marginally significant after accounting for parental history of diabetes and inbreeding 
coefficients (β: -0.399, p-value: 0.052). This might indicate that measured SNPs were not 
sufficient to detect significant genetic effect on age at diagnosis and considering other genetic 
factors such as parental history of the disease and consanguinity history were important 
elements.  
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     Our study suggests that with every increase in the number of inherited risk alleles there is a 
tendency toward earlier diagnosis with type 2 diabetes. These finding are consistent with the 
findings of another study suggesting increased odds of developing type 2 diabetes when 
inheriting six or more risk alleles compared to those who inherit four or fewer risk alleles (OR: 
2.05 95%, CI: 1.50–2.80). Furthermore, the same study also suggested that with every increase 
in the number of inherited risk alleles, there is a reduction in age at diagnosis β= −0.46 (−0.80 to 
−0.11) years, p-value = 0.009 (198).  
       Failure to find an association between the aggregation of risk alleles and risk factors such as 
BMI, waist circumference and FBG might stem from two reasons. Firstly, selected SNPs were 
reported to increase the odds of developing type 2 diabetes, to increase levels of fasting blood 
glucose, or to affect insulin function. However, not being able to find a significant association 
between aggregation of risk alleles and risk factors of the disease might be due to the stronger 
effect of unmeasured alleles which might be more inclined to independently effect those traits 
rather than affecting type 2 diabetes. Secondly, the low number of healthy participants (n = 159) 
did not enable us to detect significant associations.  
     The sample size for the first and third components of the investigation was smaller than the 
planned one. In the first and third questions, achieved powers were 69% and 60% respectively. 
Owing to changing inclusion criteria of patients, the power of the second component of the 
investigation was 81%. Given the achieved sample size of the study, the study would have been 
able to detect correlation coefficients of 0.14 for the first question, and 0.19 for the second and 
third questions, assuming a two-sided type 1 error of 5% and 80% power to detect a true 
correlation. However, the effects detected for all questions were very small compared with the 
assumed effects. Detected effect sizes varied between - 0.036 and 0.06 for the three main 
questions where assumed coefficients varied between 0.12 and 0.2.  
P values and 95% Confidence intervals of detected effects are illustrated as below:  
1st question: Spearman rho:  0.01 p-value 0.856 (95% CI: - 0.104 – 0.117).  
2nd question: Pearson coefficient: 0.024 p-value: 0.762 (95% CI: - 0.212 – 0.160).    
3rd question: BMI: Pearson coefficient: 0.062 p-value: 0.438 (95% CI: - 0.130 –0.243). 
                       WC: Pearson coefficient: - 0.036 p-value:0.658 (95% CI: - 0.207 – 0.128). 
                       FBG: Pearson coefficient: 0.039 p-value:0.652 (95% CI: - 0.156 – 0.220). 
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     We can observe that all the confidence intervals cross the zero value, indicating no detected 
association between measured variables. Additionally, the wide range of the confidence 
intervals is due to the small size of the study sample. Apart from the first and third components 
of the third question, correlation coefficients assumed during estimation of sample size lie 
outside the detected confidence intervals. For example, the assumed effect size for the second 
question was 0.2 and the detected 95% confidence intervals of the study were- 
0.212to0.160.Based on this evidence, a true population value is not likely to be as high as 0.2 
and is likely to be equal to or less than 0.160.Therefore, it might be possible to argue that true 
population correlation coefficients are likely to be smaller than coefficients assumed for sample 
size calculation,and based on that a larger sample size will be needed to detect statistically 
significant smaller effects.  
 
     Although 23 SNPs with the strongest and most replicable associations in different 
populations were chosen, their combined effect was not detectable in this study. It is possible to 
argue that utilization of a larger number of type 2 diabetes risk SNPs with higher frequency in 
the targeted populationmay have resulted in a better detectable combined effect and larger 
sample size would have higher power to detect smaller effect sizes.  
     Most of risk alleles reported to increase the risk of type 2 diabetes have been revealed to 
increase risk of the disease in an additive effect. This might seem to contradict our investigation 
where we utilized 23 of SNPs reported to act in an additive manner to investigate a possible 
recessive effect. Although this study failed to detect statistically significant recessive effects of 
measured SNPs on traits related to type 2 diabetes, there might be explanations behind this 
failure. 
       A recent study by McQuillan et al, published in 2012 revealed evidence of a recessive 
effect on height. This study recruited about 35,000 participants from 21 European populations 
and used genome wide homozygosity to investigate recessive effect on height. Despite observed 
heterogeneity of association between height and genome-wide homozygosity among different 
populations, there was a statistically significant inverse association suggesting a reduction of 
height with increased level of homozygosity.  
      Height is a complex continuous trait affected by genetic and environmental variables.       
However, its polygenic nature is similar to the nature of type 2 diabetes risk traits which our 
study investigated. The concept of the study by McQuillan et al. is similar to ours where 
homozygosity was utilized to assess its effect on continuous traits. However, this study was able 
to find this effect by observing between 295,000 to 318,000 SNPs where in our study only 23 
SNPs incurring a risk of type 2 diabetes were utilized. Type 2 diabetes genetic risk markers, 
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which have been reported by GWAS studies to act additively, only explain about 10% of 
diabetes heritability. This might indicate that there could be a possible recessive effect and 
finding this effect in our study might have required a larger sample and a larger number of SNPs. 
      Although the study by McQuillan et al. was able to find a statistically significant inverse 
association between height and homozygosity, we must acknowledge an important point. This 
study only suggested a significant inverse association with height based on an observed number 
of homozygote loci. However, unlike our study, the observed thousands of homozygote 
genotypes are not necessarily known to have an effect on height. This study did not investigate 
whether there is a possible recessive effect of SNPs, reported by previous GWAS studies, to 
affect human height in an additive nature. This point could imply that this study might have 
investigated the effect of unknown risk markers of human height by combining thousands of 
homozygote genotypes in a single analysis instead of analysing the effect of SNPs individually 
as in commonly used additive models.  This study was able to suggest an inverse association 
between genome-wide homozygosity but could not simply identify which loci are acting in a 
recessive manner to affect height.        
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6.2 Key findings from secondary analysis 
6.2.1 Consanguinity and age at diagnosis  
     Our study provided several items of evidence suggesting a significant effect of inbreeding on 
an increased risk of type 2 diabetes. A Spearman rank correlation coefficient of -0.187 (p value: 
0.012), measuring the association between inbreeding coefficients and age at diagnosis, 
indicates a significant effect of the degree of consanguinity on the risk of developing type 2 
diabetes at a young age. Additionally, our analysis suggests a significant effect of the magnitude 
of consanguinity on correlations of FBG between siblings.  
     Significant negative correlations between age at diagnosis and inbreeding coefficients 
suggest that inbreeding history might increase the chance of developing the disease at a young 
age. Additionally, observing a marginal significant effect of measured detected type 2 diabetes 
risk alleles on reducing at age diagnosis only when controlling for parental history of the disease 
and inbreeding history, might indicate that inbreeding coefficients might have accounted for 
aggregation of unmeasured risk alleles which might have a recessive effect on age at diagnosis.  
     These findings are consistent with other studies suggesting an increased risk of type 2 
diabetes with increased degree of inbreeding (245, 246, 280). However, these studies only 
measured the odds of the disease using consanguinity as binary value. Our study developed 
more in-depth analysis of the association between continuous measurement of consanguinity 
history and other variables related to type 2 diabetes with adjustment for environmental factors.  
 
6.2.2 Dominance effect on correlation of FBG  
    Our study detected significant association of FBG between siblings (r = 0.317 P value 0.040). 
Since we are comparing between full siblings, this correlation could be attributed to correlation 
due to similar inherited alleles (additive effect), correlation due to similar inherited genotypes 
(dominance effect) or because of correlation due to shared environmental factors. However, 
once we measured correlation of FBG between siblings based on a limited range of inbreeding 
coefficients, we noticed an increase in correlation with increased values of inbreeding 
coefficients.  
      An increased correlation of FBG with increased level of inbreeding coefficients might 
indicate a dominance effect. Higher levels of inbreeding might increase the chance of inheriting 
similar alleles at a particular loci. Additionally, even when we controlled for the effect of 
environmental variation between siblings, the effect of inbreeding coefficients on the variation 
of FBG was still significant (β: - 1.8  P-value: 0.039). The negative regression coefficient 
indicates that variance between siblings’ FBG is reduced with increased level of inbreeding 
even when we considering the variance of the environmental effect of siblings. 
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 6.2.3 Impact of inbreeding on genotypes frequencies  
     We made an attempt to compare alleles and genotype frequencies in our sample to 
frequencies reported in other populations. The table in appendix 13 illustrates allelic frequencies 
variations in several populations reported by association studies. By observing allelic 
frequencies of different populations, we can observe a tendency for East Asians populations to 
have almost similar frequencies of major and minor alleles. There is a tendency for allelic 
frequencies in our sample to have allelic frequencies more related to European populations 
compared to East Asians.  
     The aim of constructing this table was to study possible tendency of increase homozygote 
genotypes of our sample compared to other populations. Observing the in appendix 13 is not 
sufficient to conclude whether the genotype frequencies are due to deviations of allelic 
frequencies toward one direction or because of other factors. In our situation, we are interested 
to observe if there is a tendency for genotypes of SNPs of interest to deviate toward 
homozygosity. However, the level of homozygosity under HWE is mainly dependent on the 
magnitude of deviation toward one allele. For example, if allele A has a higher frequency than 
allele B, then we would expect the population of interest to have higher frequency of genotype 
AA compared to BB. Additionally, the frequency of heterozygote genotype AB will be reduced 
compared to the overall level of homozygote genotypes (AA and BB).  
      To decide whether the increased level of homozygosity of any SNP in a population was due 
to deviation toward one allele or due to other forces such as inbreeding, we had to control for 
the relationship between level of homozygosity and allelic frequencies. Figure 6.1 illustrates the 
expected level of homozygosity depending on the difference between allelic frequencies under 
HWE. For example, if alleles A and B have a frequency of 0.5 then under HWE, we would 
expect frequency of genotypes AA, AB, and BB as 0.25, 0.5 and 0.25 respectively. Then we can 
conclude that when there is a zero difference in allelic frequencies we would expect half of the 
population to have homozygote genotypes and the remainder to have heterozygote genotypes.  
      Using this concept, we constructed a line, as observed in figure 6.1, to indicate expected 
level of homozygosity compared to allelic frequencies difference under HWE. It can be clearly 
observed that with an increased difference in allelic frequencies, there will be a tendency to 
deviate toward higher homozygosity. The area below the line indicates that the level of 
homozygosity of a given allelic frequency difference is lower than expected. Similarly, the area 
above the line indicates that for a given allelic frequency difference, the level of homozygosity 
is higher than expected and there might be a force causing an increased level of overall 
homozygote genotypes despite observed allelic frequencies.   
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Figure 6.1: Homozygosity Index: association between difference in allelic frequencies and 
overall level of homozygosity.   
 
      In figure 6.2, we fitted values related to allelic frequency difference and homozygosity 
reported in appendix 13 in the homozygosity index. Each population was given a specific colour. 
Regarding disparity in allelic frequencies, there is a tendency for East Asian populations to 
exhibit a lower difference between allelic frequencies compared to other populations. For 
European populations, there is a spread of allelic frequency difference along the normality line. 
For Saudi Arabian subjects, there is an observed tendency to deviate from the normality line 
indicating higher levels of homozygosity after controlling for the effect of allelic frequency 
difference.  
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     The deviation toward an increased frequency of homozygote genotypes in our sample 
compared to other populations is expected given the increased level of inbreeding with our 
population compared to others. However, once we tried to assess the effect of the degree of 
inbreeding on homozygosity of type 2 diabetes risk alleles of each participants, there was no 
significant association. There was no observed pattern in our sample to indicate that with an 
increased level of inbreeding, the number of homozygote genotypes of risk alleles would 
increase. Lack of association could be attributed by limited number of SNPs to detect an 
association between inbreeding and risk alleles or perhaps due to homogeneous genetic 
background of the Saudi Arabian population. 
   
 
 
Figure 6.2: Homozygosity Index: after adding populations’ frequencies.  
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6.3 Methodological Findings  
6.3.1 Measurement of inbreeding coefficients using tribal and family tree relationships 
     The overall rate of consanguineous marriage in our sample is 63%. The remaining proportion 
of participants did not report mating of related parents. Our method of calculating inbreeding 
coefficients considered mating of individuals from the same tribe or from the same subtribe. 
Therefore, our method is more comprehensive than other methods measuring inbreeding 
coefficients in Saudi subjects which have mainly used categorical values of degree of 
consanguinity.  
      To precisely evaluate the validity of our method to measure inbreeding coefficients, we 
should compare estimated inbreeding coefficients of these individuals to genetically measured 
runs of homozygosity. However, this method of assessing validity was not feasible in this study. 
Nonetheless, we must acknowledge that our method of calculating inbreeding coefficients 
produced 57 different inbreeding coefficients based on 179 pedigrees which enabled us to use 
inbreeding values in a continuous form rather than a categorical one.  
       It is possible to argue that our method measuring inbreeding degree was able to detect 
several associations with variables relating to type 2 diabetes. However, calculated inbreeding 
coefficients failed to correlate with number of homozygote genotypes of selected SNPs. Failing 
to detect an association, though, between estimated inbreeding coefficients and measured 
homozygote genotypes could be attributed to several reasons.  
      By observing the overall distribution of homozygote genotypes in our sample, we observed 
a deviation toward a higher frequency of homozygote genotypes. Even when we compared the 
level of homozygosity of our sample to studies which measured similar SNPs in other 
populations, we noticed several deviations toward higher rate of homozygosity despite allelic 
frequencies. This might indicate that the expected long history of consanguineous marriages in 
our population for many generations has resulted in an increased overall frequency of 
homozygote genotypes.  
     Finally, failure of calculated inbreeding coefficients to correlate with the number of 
homozygote genotypes could be related to the low power of number of selected SNPs to detect 
a significant association. Perhaps, larger number of genome wide random SNPs would have 
resulted in better prediction of overall homozygosity. However, due to the financial limitation of 
this study, we had to opt for genotyping only 23 SNPs.  
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6.3.2 Type 2 diabetes and parental history of the disease  
     A high risk of developing type 2 diabetes in the circumstance of a family history of the 
disease have been documented by several studies. These studies suggest that there is an 
increased risk of developing type 2 diabetes when there is one parent affected. The odds of 
developing the disease is even higher when both parents are affected by type 2 diabetes (13).  
      In this study, we found a significant association between the age at diagnosis and the degree 
of inbreeding. However, once we assess the association in four groups according to parental 
history of diabetes, the association became stronger in the group which reported both parents to 
be affected by type 2 diabetes. This finding might not only suggest a high risk of the disease 
when both parents have a history of the disease but could signify the important effect of 
consanguinity on aggregating a higher number of risk alleles when both parents are affected by 
the disease.  
    We might argue that a higher chance of diagnosis with diabetes is merely influenced by a 
higher tendency of offspring of affected parents to adopt a behavioural attitude. This attitude 
forces them to seek earlier investigation of their blood glucose status compared to those with no 
family history of the disease. This point might be valid but when investigating the association 
between age at diagnosis and inbreeding history, we controlled for the effect of parental history 
of the disease by dividing subjects to four different groups. Therefore, the detected significant 
association between age at diagnosis and inbreeding history in the subjects with both parents 
affected (Spearman’s rank correlation: -0.502 (P-value: 0.003)) is less likely to be biased by a 
tendency of siblings of parents with diabetes to be diagnosed by the disease at earlier age.  
     Our analysis indicated a stronger maternal effect on development of type 2 diabetes at an 
earlier age compared to other categories of parental history (β:-5.538, P value: 0.000).  This 
pattern is supported by several studies suggesting stronger maternal effect of transmission of 
type 2 diabetes to their offspring (13, 280-283). However, other studies did not find a similar 
effect (284, 285). Nonetheless, the maternal effect on transmission of type 2 diabetes to 
offspring might not be purely genetic.  
    A literature review investigated possible causes leading to increased maternal transmission of 
type 2 diabetes. This study suggests that the maternal effect on offspring can be influenced by 
the intrauterine environment. It indicated the higher risk of developing diabetes in siblings who 
were born after maternal development of diabetes compared to those who were born before 
maternal development of diabetes. Despite having shared maternal genetic risk, the difference in 
uterine life between siblings of the same mother might explain part of the variation in the risk of 
developing type 2 diabetes (286). 
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   Apart from the possible uterine effect, there might be a possible link between a maternal 
history of diabetes and the lifestyle of the offspring. The cultural background in Saudi Arabia 
dictates a strong maternal influence on the food intake behaviour of offspring since mothers – 
unlike fathers- are responsible for culinary activities and provision of food for the family. In 
other words, if the mother is exhibiting a certain lifestyle associated with increased food intake, 
the children are likely to exhibit similar behaviour toward higher food intake.        
6. 3.3 Associations between measured phenotypes and environmental factors  
         Our primary aim in utilizing a food frequency questionnaire was to control for the effect of 
one of the environmental variations, in this case variation of calorific intake. We used a food 
frequency questionnaire to collect information about variations in frequency of consumption of 
137 food items with additional open-ended questions to allow for other items to be added during 
interviews. In order to calculate calorific values of each food item, we constructed a database 
based on caloric values provided by a variety of nutritional databases.   
     Physical activity is an important environmental factor modifying the risk of developing type 
2 diabetes and its related risk factors. We utilized a modified version of the EPIC physical 
activity questionnaire. The original EPIC physical activity questionnaire included several 
questions which were not applicable to a Saudi population; therefore, several questions had to 
be removed. The level of physical activity was measured by calculating the number of hours 
spent performing sedentary, moderate and vigorous physical activities per week.  
       Several studies have investigated the repeatability and validity of the EPIC food frequency 
questionnaire and physical activity questionnaires in different populations. The validity of these 
questionnaires was assessed by studying its construct validity against standard clinical 
measurements. These studies found significant correlations between estimated nutrients levels 
from questionnaires and nutrients measured using biochemical markers (287-289). Similarly, a 
study confirmed significant correlations between the level of estimated energy expenditure 
using the EPIC physical activity questionnaire and measured level of heart rates (290).  
     We had to modify the EPIC questionnaires to construct applicable versions of the 
questionnaires for a Saudi Arabian population. Despite the reported validity of the 
questionnaires, we cannot confirm whether modified versions of the questionnaires were valid 
to a Saudi Arabian population. Nonetheless, the association between measured dietary intake 
and physical activity in our sample should have several significant correlations with different 
anthropometric traits.  
    By assessing associations using continuous forms measuring environmental factors, we found 
significant, yet weak, association between increased calorific intake and increased BMI. 
Additionally, the level of vigorous level activities was significantly negatively associated with 
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the level of BMI and waist circumferences. These significant associations indicate that our 
measurement methods might have valid predictive capabilities.  
    Several studies have assessed associations between the level of environmental factors in 
continuous forms and anthropometric traits. A study has measured the level of calorific intake in 
a Greek population and measured its correlation with level of BMI. This study found that with 
every increment of 500 kcal of daily dietary intake, there was an increment of BMI of 0.14 
(291).  This study also found significant inverse association between the level of physical 
activity and BMI. These findings are consistent with our findings.     
      In our sample, the number of hours spent performing moderate activities was not 
significantly correlated with any anthropometric traits. This trend was similarly observed in a 
study conducted in Saudi Arabia measuring the effect of physical activity on the BMI level in a 
population aged between 14 and 19 years. This study was only able to find significant inverse 
effect of vigorous level of physical activity on BMI but not to the total level of physical activity 
(292). This finding is consistent with our finding indicating that measurement of vigorous 
activity is more likely to have a better predictive value of BMI compared to a level of moderate 
activity. 
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6.4 Strength of this study  
     Major strengths of this study include measures taken to reduce observer bias during the 
recruitment of participants and a reduction of measurement bias when answering questionnaires 
or collecting anthropometric data. Another strength issue is related to the handling of data using 
electronic forms of questionnaires. Introducing new concepts relating to pedigree constructions 
enabled a better estimation of inbreeding coefficients. Finally, there are several cultural issues 
related to the Saudi cultural background which could be considered as facilitating factors.  
6.4.1 Participant recruitment and sampling 
         Although we targeted patients and health individuals with a family history of diabetes, the 
design of our study did not select participants on the basis of consanguinity history. This 
enabled us to have a representative sample with a reasonable range of inbreeding coefficients 
leading to the possibility of performing correlations with several phenotypes. Additionally, 
recruiting participants without prior knowledge about their inbreeding history may have reduced 
observer bias. Construction of pedigrees was systematic in all participants regardless of their 
inbreeding history.  
 
6.4.2 Data collection 
6.4.2.1  measurement of consanguinity 
    This study utilized a unique system of constructing extended pedigrees by developing 
concepts related to the mating of individuals from different tribes or subtribes. This technique 
enabled us to detect variability in consanguinity history that could not be detected if the shared 
ancestor could not clearly be identified. Among studies which found significant associations 
between inbreeding and risk of developing type 2 diabetes, this is the only study which utilized 
inbreeding coefficients rather than using a binary or categorical form of consanguinity history.  
6.4.2.2  Electronic forms 
       Our study was mandated using questionnaires to measure environmental variations between 
participants. Instead of using lengthy paper-based questionnaires, we made an effort to convert 
our data collection tool from paper-based to electronic forms. We used Visual Basics 2010 to 
develop electronic questionnaires where we were able to answer questions, enter the answers 
and provide instant results after analysis.  
     This process had a great impact on reducing the time needed to transfer collected data to 
electronic databases. It would have been more time consuming transferring answers from paper-
based questionnaires to electronic databases; this waste of time had been averted in this study. 
Additionally, it reduced the risk of mistakes which might have been caused by manually 
transferring data from paper-based questionnaires to electronic data bases.  
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6.4.3 Reducing measurement bias 
6.4.3.1 Reducing the risk of recall bias    
     This study benefited from several points to tackle issues related to recall bias. From an 
ethical point of view, participants were informed about the main purpose of the study. However, 
they were not given detailed explanations of research questions such as the association between 
age at diagnosis and inbreeding history or the association between consanguinity and other 
anthropometric measures. Participants were blind to these associations in order to avoid having 
recall bias leading to distorted reporting of age at diagnosis or consanguinity history.  
6.4.3.2 Measuring anthropometric variables  
     We managed to measure FBG of the majority of healthy participants. Although many 
subjects did not exhibit a healthy level of FBG, we only related them to being healthy hence 
they were not diagnosed with the disease and were not taking any medications. The main 
purpose of measuring blood glucose was not to avoid misclassification of healthy subjects with 
respect to their glycaemic index. Measuring blood glucose was mainly carried out to detect 
variations between individuals' blood glucose in subjects not taking any medication or not trying 
to impose environmental constrictions to reduce their blood glucose level. Misclassification of 
subjects was not a critical issue in our study hence we performed analysis in different cohorts of 
patients and healthy subjects.  
       All tools used to measure subjects phenotypes were used in a systematic manner by one 
observer. Measurement of environmental variation was systematic in all subjects whether they 
were patients or healthy. We can confidently reject overestimation of environmental risk factors 
in patients when filling food frequency questionnaires because, as the analysis showed, patients 
reported having a lower mean of average caloric intake. In theory, we would expect patients to 
report higher caloric intake of the disease but in reality, recall of food frequency was markedly 
influenced by patients’ tendency to report healthier lifestyle to suggest better glycaemic control.  
      Interviewing all participants to answer questionnaires was an important issue aiding the 
avoidance of several biases. Firstly, interviewing all participants enabled us to recruit illiterate 
individuals. Secondly, we were able to illustrate to all participants how questionnaires are 
answered and give description of food items not recognized by participants. Having all subjects 
interviewed reduced measurement bias that might have been caused by having questionnaires 
filled out by participants during home visits. Thirdly, as we illustrated in the pilot study, we 
were able to ask specific questions relating to the frequency of consumption to avoid 
overestimation of intake.  
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      Measurements of FBG, body weight, height, waist circumference were all collected by one 
observer. We avoided self-report bias by measuring all of these variables. We can ensure that all 
observations were systematically collected as the same measurement tools were utilized for all 
subjects. Additionally, we controlled for possible measurement bias caused by variations in 
successfully genotyped sample by applying cut-off criteria to exclude samples with low 
detected genotypes.  
6.4.4 Cultural factors  
    The advantage of choosing to conduct this study in Saudi Arabia was due to the high 
prevalence of both type 2 diabetes and consanguinity. Additionally, mating usually occurs at a 
young age and families tend to be bigger in comparison to other populations. This increased the 
chance of finding subjects needed for the different components of our study.  
     Logistics factors were important in enhancing the data collection process. Hence the 
investigator comes from the region of Jazan, it was easier for him to commute to PHCs and 
homes of participants in several cities and villages in Jazan. It would have been more difficult 
for a person who did not come from Jazan region to get access to PHCs and houses without the 
assistance of a local individual.  
     Other cultural elements were of great importance. Participants tended to ask the investigator 
about his origin, his education and employment history. Once participants realized that the 
investigator belonged to a known tribe in the Jazan region and was a graduate of Jazan 
University, participants were then more inclined to participate, share their information and give 
samples. In an additional cultural gesture, the investigator always wore national Saudi clothing 
whether at PHCs or during home visits.  
     Driving a car was the only mean of transportation between the cities and villages of Jazan. 
There is no other means of public transportation such as buses, trams or trains between cities 
and villages of Jazan. Being a male is an advantage in Saudi Arabia where females are not 
allowed to drive. It would have been of immense difficulty to collect data for this study if the 
investigator of this study had been a female.  
     Being a medical doctor is another cultural point. Participants were more willing to welcome 
the investigator in their homes once they knew the investigator was a medical doctor. As what 
could have been a sign of health care deprivation, several participants appreciated the visit of a 
medical doctor to their homes and in several situations, shared medical issues with the 
investigator which were not necessarily related to diabetes. Although this might initiate an 
ethical concern, the actions provided by the investigator were merely advisory and no medical 
interventions were applied.   
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6.5 Limitations of this study  
     Major limitations of this study related to the lack of data about to birth weight, the utilization 
of proxy variables, and the risk of misclassification of cases. The food frequency questionnaire 
in our sample could have been subjected to measurement bias. Other limitations were related to 
the possible risk of selection bias caused by an inability to recruit females and a lower 
recruitment rate of Khat chewers. There are several cultural and logistic limitations which 
increased the difficulty of recruitment.  Finally, there could be limitations in interpreting the 
findings of this study due to issues with multiple testing.  
6.5.1 Lack of clinical data 
     The first limitation was related to the possibility of answering questions related to the 
associations between birth weight, inbreeding, and risk of type 2 diabetes. Most healthy subjects 
recruited in our study were above 30 years old despite our aim to recruit younger healthy 
individuals in each family. Due to recent developments in health systems in Jazan area over the 
last few decades, most recruited subjects did not have a record of their birth weight.  
6.5.2 Use of proxy variables 
     Another limitation was related to using age at diagnosis as a proxy for the development of 
type 2 diabetes. It is almost impossible to accurately indicate age at development of type 2 
diabetes in recruited subjects. This uncertainty is mainly caused by the nature of the disease 
where in several occasions patients are asymptomatic or even when they are symptomatic some 
patients might not seek health advice promptly.  
6.5.3 Misclassification of diabetes  
     Although we recruited type 2 diabetes patients based on a diagnosis provided by their 
treating doctors, there might be a chance of misclassification of cases. We managed to avoid 
cases diagnosed as type 1 diabetes depending on medical diagnosis. However, due to the limited 
capability of PHCs in Saudi Arabia to diagnosis MODY cases, there might be a chance of 
misdiagnosing those cases as type 2 diabetes especially younger cases. Nonetheless, several 
SNPs were reported to be shared between MODY and type 2 diabetes.  
6.5.4 Selection bias 
     Selection bias could have been introduced because several participants were less willing to 
participate in the study. Those participants were mainly Khat chewers or cases where healthy 
siblings refused to participate. However, we recruited several Khat chewer cases and their 
samples were successfully genotyped as we illustrated earlier. An inability to recruit females is 
another limitation of this study. The reasons were mainly related to cultural barriers as 
illustrated earlier in the methodology chapter.  
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6.5.5.Measurement bias 
     Despite utilizing validated EPIC questionnaires and showing the predictive validity of 
modified versions of these questionnaires, there are several points that might have introduced 
recall bias or reduced validity of questionnaires. Although these questionnaires ask the 
interviewee about food consumption or physical activity in the last year, this did not reflect true 
environmental variation affecting the incidence of diabetes in recruited subjects. This was 
clearly apparent upon interviewing patients where the assessment of environmental variation 
was strongly affected by their attitude toward management of type 2 diabetes. Subjects who 
were trying to control their glycaemic index were likely to report lower caloric intake compared 
to those not exhibiting a healthy lifestyle. However, the last notion was not systematically 
recorded during data collection and we are only suggesting this association.    
       Another issue is related to the application of a food frequency questionnaire in a Saudi 
population. As a usual procedure conducted to measure intake, an average portion size is usually 
estimated for each food item. Although we tried to propose a fixed portion size which was 
systematically applied to all participants, there is a large possibility of difference between 
estimated portion size and actual portion size consumed by participants.  
     The difficulty in estimating portion size in a Saudi Arabian population stems from the culture 
of serving food. As our analysis indicated, Chicken or Lamb Kabsa is the most frequently 
consumed food item in our sample. The most important ingredient of this food is rice. Kabsa is 
usually severed in one large dish as shown in figure 6.3 where consumers typically gather 
around the dish which is usually placed on the floor. Consumers eat directly from the large dish 
using hands unlike western societies where smaller quantities are usually served in plates. 
Therefore, it is very difficult to precisely estimate the portion size of this food items. Although 
consumers are sharing the same large dish, variations in portion sizes consumed by each 
individual are expected. 
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Figure 6.3: Method of serving popular food in Saudi Arabia.  
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6.5.6 Effect of Khat chewing on data collection  
         Catha Edulis or Khat (as called in Jazan) is a plant with stimulating amphetamine-like 
characteristics (293).Cultivation, transportation, trading, and consumption of Khat are strictly 
unlawful actions in Saudi Arabia. A study conducted in Jazan revealed that 37% of male 
students (aged between 15 and 25) were Khat chewers. (293). There is no study published 
regarding the consumption of Khat in older subjects, but based on the obvious trend of a higher 
tendency to consume Khat with age and based on our observation during data collection, we can 
expect, at least, half of the population in Jazan to be Khat chewers. Appendix 14 includes 
further background information about the pharmacogenetic, the heath impact and the social 
effects of Khat.  
    Even though we were aware of presence of Khat in the Jazan area, we were not perfectly alert 
about its potential effect on our recruitment plan. Although we did not attempt to systematically 
record the number of patients or healthy participants who were Khat chewers, we can 
confidently argue that the percentage of Khat chewers among those who were approached, 
including recruited subjects, was almost higher than 50%. Khat chewing made data collection a 
challenging task and it was one of the factors that rendered the principal investigator unable to 
achieve 100% of the targeted sample size.  
      Due to its social effect, certain individuals were not willing to participate in the study 
because it interfered with their chewing sessions. We advised approached individuals to abstain 
from Khat chewing until the interview had been completed and the buccal swab was taken. 
However, this appeared to reduce the participation rate and thus we had to stop requesting 
approached individuals not to chew Khat. Even though we changed our policy and started 
explaining to the approached individuals it was acceptable to chew Khat during the interviews, 
several individuals refused to participate.  
     In several situations, some approached individuals tended to show an interest in the study 
and agreed to participate giving a specific date for data collection but due to their addiction to 
Khat, they cancelled the appointment or did not respond when the investigator attended their 
address for the agreed data collection session. The cancellation of appointments or not showing 
up during home visits had a significant effect on the recruitment rate. The challenge to recruit 
individuals was aggravated by situations where one of the siblings, either patients or healthy, 
were not available due to Khat chewing sessions. In addition to the effects of unsocial behaviour 
caused by Khat consumption, insomnia and sleeping disturbances caused several approached 
individuals to sleep during agreed appointments.  
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    The reason we were trying to convince approached individuals to refrain from Khat chewing 
before collection sessions was due to our effort to have clean DNA samples. Khat is chewed for 
several hours in one side of the mouth and taking a buccal swab during chewing session was 
very likely to contaminate the swab with Khat. Those who agreed to participate in the study 
while they were chewing Khat were requested to give other convenient appointments to give a 
buccal swab. Usually, those individuals preferred to give buccal swabs just before they go to 
work in the morning. In addition to Khat, other products with less impact interfered with the 
collection of buccal swabs such as chewing tobacco. 
6.5.7 Limitations related to awareness and cultural Conditions  
     Type 2 diabetes patients were more willing to participate than their healthy siblings. In 
addition to the reduced participation caused by Khat consumption, several healthy siblings were 
afraid to participate due to fear of being diagnosed with type 2 diabetes. Although we explained 
the importance of screening for type 2 diabetes, our effort on certain occasions was fruitless. On 
other rare occasions, healthy siblings were willing to give all the needed information and 
measurements except blood glucose because they were afraid of needles.  
    In some approached families, familial ties between siblings were not strong and approached 
patients at PHCs informed us that they could not contact their siblings. Additionally, several 
patients did not have contact details for their siblings. In other families, siblings were having 
disputes and were not even speaking to each other.  These issues interfered with recruitment 
conditions and rendered several approached individuals not suitable for recruitment.  
   Other culturally embraced behavioural concepts appeared to complicate the collection of 
selected information from certain participants. For example, it was rather embarrassing for 
certain participants to be asked about the names of their females siblings. If we had the 
impression that it would be embarrassing to ask about the names of female siblings, we tended 
to neglect asking about names and only asked about age and the health status of female siblings. 
Nonetheless, several participants did not mind revealing the names of their female siblings.  
     Another example is related to asking participants about household activities such as cooking 
and caring for children. According to the Saudi culture, these activities are mainly performed by 
females. Several participants were less interested in answering these questions and one 
participant refused to give answers regarding these questions listed in the physical activity 
questionnaire.  
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6.5.8 Limitations related to safety and logistics 
      The nature of this research mandates meeting hundreds of subjects in person and visiting 
several families in their homes. Visiting this large number of subjects in their houses revealed 
several issues which were not possible to observe during visits to PHCs. For example, we 
arranged to recruit a subject during a home visit; during this home visit, the subject informed us 
about the presence of drug dealers and the presence of illegal immigrants in his neighbourhood. 
This situation illustrates how dangerous data collection can be when meeting individuals from 
risky neighbourhoods.  
    Another incident occurred when a healthy participant was convinced that he had hepatitis B 
infection although, as he informed us, his screening blood tests were negative. We tried to 
assure him that he can always perform other blood tests in order to confirm the disease status. 
However, he insisted on having an abdominal examination performed. Although I tried to 
convince him that his living room was not an appropriate clinical environment and I was not 
entitled to perform a clinical examination for him, he insisted. Therefore, I had to perform an 
abdominal examination in an effort to examine his liver. However, it was merely a 
psychological manoeuvre to calm him down. This incident also signifies how difficult it can be 
to deal with the public in various sensitive matters.   
    In addition to safety issues, other logistic factors made data collection a difficult process. 
Firstly, several participants were living in remote and difficult to access places. We visited 
several houses distributed in different sectors. In certain situations, participants were living in 
deserts, mountains or poorly planned and crowded neighbourhoods. Figure 6.4 is collection of 
pictures of places visited during the data collection.  
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Figure 6.4: Photos of places visited during data collection.  
 
    Another issue was related to the unavailability of competent navigation systems. One of the 
most undeveloped issues in Saudi Arabia is domestic planning where established houses do not 
have clear addresses or even postal codes. To illustrate this issue, I am quoting an actual 
conversation made by a person trying to illustrate the address of his house:  
 ‘In order to get to our house, please proceed through first exit, turn toward the north, keep 
driving until you reach the third traffic signal. Once you reach the third traffic signal, please 
take the first exit to the right. Drive forward until you face a school. Drive alongside the school 
until the fence of the school ends. Once the school’s fence ends, turn right. On your right hand 
you will find the house which is coloured brown’  
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      This quote might seem exaggerated but it is a typical description of a house in Saudi Arabia. 
It was quite difficult in some occasions to find houses of participants and in several situations 
the description was so difficult that some participants had to meet us outside their 
neighbourhood just to show us the way to their houses. Extreme caution had to be taken by the 
investigator to memorize the houses of the participants in case there was a need for a second 
visit to collect buccal swabs or to test FBG.  
6.5.9 Limitations due to multiple testing 
     Setting a significance level at 0.05 means that there is a 5% chance of rejecting the null 
hypothesis when it is true, and accepting the alternative hypothesis when it is false (false 
positive error).  If multiple hypothesis testing is applied to the same sample, there will be a 
higher chance of detecting significant p-values by chance. When assuming a significance level 
of 0.05, performing  100 statistical tests on the same sample we would expect to detectfive 
significant tests by chance (false positive).    
     In multiple testing situations corrective strategies such as the Bonferroni correctionor the 
False Discovery Rate (FDR) are applied, but others have argued that simply accounting for how 
many tests were conducted and why they were done is all that is necessary (294) . By counting 
the number of tests performed, a total of 139 different statistical tests were utilized in this study, 
where 43 tests were statistically significant. In all tests, a significance level was set at 0.05, 
which means that out of the 139 tests conducted, we would expect to find about seven 
statistically significant associations to be false positive.   
 
Bonferroni correction relies on giving a corrected p-value depending on the number of tests 
performed. In this scenario, corrected p-value will be equal to the detected p-value multiplied by 
the number of tests performed (295) (2). For example, if 100 tests were performed where one 
test had a p-value of 0.004, then the corrected p-value would be 0.4. The corrected p-value 
indicates that this test is not statistically significant.  
Bonferroni correction is a stringent test and might result in failure to detect several true 
associations. By applying Bonferroni correction to our calculated p-values, 11 corrected p-
values were below 0.05. The marked reduction in the number of statistically significant tests is 
expected, given the small sample size of this study. Although this test is conservative and 
reduces the increased chance of detecting false positive results, it might have resulted in 
elimination of true associations detected in this study. Bonferroni correction is a simple and a 
popular method, although highly criticized. It has been argued that it increases the chance of 
type 2error by rejecting true alternative hypothesis (294).  
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FDR controls the expected proportion of tests which are false positive among all significant 
results (296). This is a less stringent test and calculated by ordering p-values from largest to 
smallest. The largest p-values will be corrected by multiplying the p-value by the number of 
tests.The following formula is used to correct the remaining p-values according to the order of 
the p-value: p-value * (n/n-[number of rank - 1]) where n is the number of tests performed. For 
example, the corrected p-value for the fourth one will be p-value * (n/n-3). 
Unlike the Bonferroni test, FDR correction is less conservative. By fixing the FDR at 
0.05,applying FDR correction to the study's calculated p-values resulted in 25 corrected p-
values below 0.05. Based on the FDR correction, the association between age at diagnosis and 
inbreeding coefficient became marginally statistically non-significant (corrected p-value:0.06). 
However, the association between inbreeding coefficient and age at diagnosis among patients 
both of whose parents were reported to be affected with type 2 diabetes remained statistically 
significant (corrected p-value: 0.02).Siblings FBG correlations were statistically significant 
when applying different ranges of consanguinity (p-values: 0.04, 0.015, 0.003, 0.001). 
Nonetheless, some of the correlations became statistically non-significant after FDR correction. 
However, after applying the FDR correction, there is a trend of increased significance level with 
increased inbreeding coefficients (0.13, 0.06, 0.02, 0.009) where siblings with higher inbreeding 
coefficients witnessed statistically significant correlations. Finally, all statistically significant 
deviation from WHE remained statistically significant after applying FDR correction. In 
conclusion, although some of the main findings of this study became marginally statistically 
significant, it is possible to argue that the main findings of the thesis are still valid even after 
applying the FDR correction.  
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6.6 Personal Experience  
6.6.1 Learning experience: approaching and data collection 
     Working in the field gives you a chance to observe unexpected events and gain valuable 
experiences. Several points were not targeted objectives upon the start of data collection. 
However, noteworthy aspects of the population in Jazan have to be illustrated with relation to 
type 2 diabetes, orientation about health and their attitude toward medical research.    
   Upon approaching patients and participants, information sheets were provided. We also gave 
approached participants a chance to enquire about the purpose, steps and nature of the research. 
It was a valuable gained experience about how to approach individuals with different age ranges 
and educational backgrounds. Approaching illiterate older subjects was in essence different 
from approaching younger educated subjects. The magnitude and type of questions asked by 
approached participants varied greatly between individuals.  Eventually, we were able to choose 
a suitable approach process for each individual. 
     Data collection was additionally complicated when a second visit had to be done to collect a 
buccal swab or to measure FBG. On several occasions, we had to start working at 4 AM to 
travel to a remote place and measure FBG for a participant or to collect a swab. On one 
occasion, we were frustrated to realize that one of our early-morning trips to collect a buccal 
swab was useless: on arriving at the participant’s house, we were informed about his refusal to 
give the swab despite participating and giving most of the other needed information after 
signing the consent form. Nevertheless, this was quite a valuable lesson when applying research 
methods in the field and the importance of expecting limitations when dealing with hundreds of 
subjects especially when working in a non-clinical settings.    
 
6.6.2 A need to raise awareness  
     Interviewing participants gave us a valuable chance to meet patients and their healthy 
siblings. In almost all home visits, the participants and even the non-participants tended to 
enquire about diabetes, its risk factors and complications. This gave us an indication that 
knowledge about diabetes and its complications seemed to be rather shallow. Although we did 
not attempt to quantify the magnitude of this issue, we think that a public orientation campaign 
is very important and urgently needed to reduce complications among patients of diabetes or to 
reduce the incidence of subjects at risk.  
   Several subjects seemed to be unaware that diabetes is a serious illness and in extreme 
situations, chose to ignore or even reject the idea of being diagnosed with diabetes. Several 
healthy participants refused to participate in the research thinking that their participation could 
result in them being diagnosed with diabetes. This clearly signifies that they are not aware that 
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earlier diagnosis of type 2 diabetes could significantly reduce their risk of developing 
complications related to the disease. We also met several patients who refuse to take their 
medication and maintained a very unhealthy lifestyle or chose Khat chewing as a remedy to 
cure diabetes.  
6.6.3 Administrative capabilities  
     The complexity of this work and the collection of several continuous variables made this 
effort an unforgettable experience. Furthermore, all the work of coordinating appointments, 
conducting visits for families and performing data collection and data entry was conducted by 
one person within a limited time frame. Completing the data collection within the proposed time 
frame was faced with several doubts regarding its success. After all, achieving 90% of the target 
sample size signifies the assertive effort done by the principal investigator.     
       Collecting data appeared to be a challenging and, at certain times, an exhausting task. Data 
collection required substantial organizational skills and immaculate ability to deal with several 
participants in a timely manner. For several weeks, we worked for seven days. In addition, on 
some days we had to work for almost 10 hours due to the time needed to approach participants, 
make appointments, travel to remote areas and spend several hours to carry out the actual data 
collection. For several months, the principal investigator only stopped working for emergencies.  
6.6.4 Emotions behind research  
      Due to visiting almost more than 170 houses, we were exposed to participants from different 
socioeconomic classes. In addition to visiting well-planned neighbourhoods with high living 
standards, we also visited several remote, unplanned and deprived regions with very low living 
standards. This study has a social and emotional perspective since we interviewed participants 
who were in serious need of help. On one occasion, one of the participants was affected by 
diabetic complications affecting his vision and a severe case of diabetic foot impacted on his 
mobility. Due to these complications, he lost his job and was not able to provide for his family. 
It was quite difficult for the investigator to separate between his emotions and the professional 
work of data collection. Although at that time we were not able to provide any significant help, 
we provided advice regarding better control of diabetes and our deepest emotions had to be 
shared with the participant.     
     Despite all difficulties, tragedy and drama witnessed during data collection, there were 
several cheerful and encouraging events. Several families were quite happy to participate. Some 
participants even went further and admitted that they were expecting our visit to their PHC since 
they had heard about our research from neighbouring PHCs.  
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     For a reason, our research was somehow well-known. After few months we felt that this 
unplanned announcement made the recruitment process a success. Potential participants learned 
about the research from their friends and neighbours and when they were approached; it was 
easier for them to understand procedures which had to be taken and the purpose of the research.  
Some families were extremely cooperative and made data collection an enjoyable experience. 
Several educated participants showed their deep appreciation of the research and were very 
interested to learn about the results and recommendations of the study.  
     It was quite normal to have the whole family present during data collection in addition to 
participating siblings. However, this welcoming attitude made it slightly difficult to collect data 
and more time consuming as I had to deal with several individuals in addition to the participants. 
Some families were quite helpful when constructing family pedigrees. One family gifted us a 
book written by one of the participants. The book's subject was about their family tree and a 
description of their ancestors back to 1400 years ago. Some families take pride in their 
genealogy hence they believe their family trees go back to the family of Prophet Muhammad 
(peace be upon him).  
     Other rewarding moments were experienced when we were able to be of assistance on 
several matters. We were able to provide advice to those who were refusing to take their 
medication despite being diagnosed with type 2 diabetes. Several healthy participants were 
having an above normal level of FBG or impaired glucose level. We provided advice to those 
participants regarding the importance of visiting their family doctor and of starting to change 
their lifestyle. On several occasions, we would measure blood glucose for those who were not 
participating in the study such as other siblings, parents, and friends. This had slightly increased 
the cost of glucose testing hence we needed to buy more glucose strips, lancets, and alcohol 
swabs.     
     In addition to measuring FBG for several individuals, adults and even children appeared to 
enjoy having their weight and height measured during home visits. Whenever they saw the 
stadiometer and the scale, they started gathering and requested the investigator to measure their 
heights and weights. Some non-participating individuals went further and asked the investigator 
to calculate their BMI and provide relevant advice. Additionally, participants frequently asked 
the investigator about the results of the food frequency analysis program. Based on the 
frequency provided, I was able to advise the participants about food items they were frequently 
consuming which had high calorific values.  
     The kindness and generosity of the participants was quite an appreciated experience. On 
most visits, beverages such as traditional Arabic coffee and dates were provided as a gesture of 
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greeting. Although our time during home visits was mostly taken up by performing data 
collection, we strived to appreciate their generosity and consume what they served and 
apologized whenever we could not, realizing that it is an offence in our culture not to accept 
what you are served. Several participants insisted on inviting us for another visit whereupon we 
had to apologize due to the limited nature of our time. One participant, and out of generosity, 
went further and provided us with Khat leaves. The principal investigator had to apologize to 
the participant explaining his attitude toward Khat chewing.  
     One final remark has to be mentioned due to its uniqueness to the Muslim society.  The 
Month of Ramadan coincided with the first stage of data collection. During this month, Muslims 
fast during the day time which made it easier for the investigator to measure the participants’ 
FBG. Additionally, the religious behaviour of Muslims during this month is significantly 
different than other months of the year. Subjects in the Jazan region were less likely to chew 
Khat which made the recruitment process during this month notably easier compared to other 
months. Several participants revealed that they had better glycaemic control during this month 
due to fasting and were able to reduce medicational doses.  
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6.7 Reflections  
     Revealing causal relationship between a factor and a phenotype is the essence of 
epidemiology. Complexity and sophistication of the human body has rendered detection of such 
relationships a difficult yet captivating mission. Failing or succeeding to tackle ambiguous and 
uncertain associations is a defining moment for any epidemiological investigation.  
     Determinants of any living creature are a combination between their inner propensity to 
survive and an outer surrounding environment which decides their chance of thriving. Humans, 
as any living creature, have this inner factor which determines most, if not all, of their 
characteristics. The variability of characteristics plays a key role in deciding whether individuals 
are fit to survive when placed in a similar environment.  
     The human genome has been estimated to be composed of more than 3 billion bases (297). 
In many complex illnesses, investigating the effect that a single nucleotide variation would 
produce is almost similar to observing the effect that a drop of water would cause upon falling 
in an ocean. The magnitude of complexity and ambiguousness of factors causing a complex 
disease such as type 2 diabetes is far from being resolved by observing SNPs acting individually 
or even additively.   
       It could be argued that the genetic effect on any trait might begin even before having an egg 
fertilized by a sperm. Similarities or variations between parents’ genomes are solely driven by 
factors affecting their chance of mating. Apart from parents’ ability to pass their genotypes, 
which is basically influenced by their capability to survive selective forces, genetic determinants 
of their offspring are further complicated by the chances of mating of individuals with similar or 
different genomes. This similarity could be driven by a similarity in phenotypes or similarity 
caused by a shared ancestor. 
      Sequencing of the human genome has revealed several nucleotides variations linked to 
variations of phenotypes. Most studies concerned with associating these variations with 
phenotypes assume an additive effect of alleles. However, this concept could be far from 
detecting the true causal pathway. The risk of having a particular trait is not simply caused by 
inheriting a single allele especially when addressing complex illnesses.   
      Apart from assuming an additive effect of alleles, other complex deviations from this model 
might be solely responsible for detecting causal pathways not revealed by additive models. 
Whether inheriting similar alleles at a locus would make a different effect compared to only 
inheriting a single allele or a single allele is dominant enough to cause an effect without having 
a similar copy is difficult to observe in complex phenotypes. Additionally, we could postulate 
whether inheriting a single allele is affecting expression of another allele in an epistatic effect or 
one environmental factor is affecting expression of one allele in an epigenetic effect.   
242 
 
      Once a zygote is formed, a long journey of development begins during uterine life. 
Variations in intrauterine environments have a significant effect on phenotype variations despite 
genomic variations. Intrauterine life is a rather critical developmental stage where a single 
change might start a cascade of events continuing after birth.  The environmental effect further 
continues to explain significant part of variations of complex phenotypes variations.   
     In addition to our study, several studies have signified the association between the non-
random mating of parents and risk of the development of type 2 diabetes in their offspring. 
Furthermore, our study has indicated that this association is augmented when both parents are 
affected by the disease. This might indicate that causal pathways indicated by higher risk posed 
by consanguinity are different than causal pathways in those with less or no degree of 
inbreeding.  
     The complexity of type 2 diabetes as a phenotype does not only stem from its polygenic risk 
or multifactorial environmental factors. The effect of inheriting a similar risk allele has been 
shown to act in different ways. Rs7901695 near TCF7L2 has been reported to increase the risk 
of type 2 diabetes in non-obese individuals (205). This notion suggests that type 2 diabetes is a 
heterogeneous disease where different or even opposing risk factors could result in the very 
same outcome.  
    A strong example suggesting heterogeneity of type 2 diabetes is the effect of intrauterine life 
on the development of type 2 diabetes. Several studies have suggested a significant association 
between low birth weights and a high risk of type 2 diabetes. This association has been partially 
explained by the thrifty genotype theory. However, mothers who are pregnant while affected by 
type 2 diabetes are more likely to have offspring with a high birth weight (Macrosomia) and yet 
their offspring are at a higher risk of developing type 2 diabetes. We can observe two different 
and opposing risk factors (low birth weight versus macrosomia) with similar outcome (type 2 
diabetes).  
    The importance of acknowledging heterogeneity of type 2 diabetes might have several 
consequences. Firstly, based on stratifying individuals according to specific criteria such as 
studying the causes of type 2 diabetes in lean individuals or those with higher inbreeding degree, 
it might be possible to identify pathways leading to development of type 2 diabetes. The second 
reason is related to the prediction and screening of the disease in different cohorts. For example, 
we might argue that those with a high degree of inbreeding and an extensive history of familial 
type 2 diabetes should be subjected to targeted screening and preventive measures compared to 
the general public.   
     Heterogeneity of type 2 diabetes might have an influence on how treated patients respond to 
given treatments. From a pharmacogenetic point of view, one therapeutic agent given to similar 
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type 2 diabetes patients might have a variable range of effects. This variation in response could 
be attributed to variation in environmental factors (such as a change in caloric intake or physical 
activity) or due to genomic variation. Oral glucose lowering agents have already been suggested 
to have different effect in monogenic forms of diabetes. Since type 2 diabetes shares several 
variants with monogenic form, genomic variability could be a contributing factor leading to a 
variable range of responses in type 2 diabetes patients.    
      Although this study managed to find significant associations between inbreeding history and 
several variables related to type 2 diabetes, failure to find significant effects of inbreeding on 
molecular risk factors has limited our ability to confirm a causal molecular risk related to 
inheriting homozygote genotypes of risk alleles. A small number of genotyped SNPs and 
relatively small number of subjects limited by financial and logistic circumstances might be a 
contributing factor leading to the failure in detecting significant effect. Having found significant 
association between inbreeding coefficients and age at diagnosis without finding molecular 
evidence might indicate the need to genotype larger number of risk alleles and patients to detect 
a significant association.  
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7 Chapter Seven: Conclusion 
     This study explored association between consanguinity and risk of developing type 2 
diabetes. Although this study was not able to find statistically significant recessive effects of 
measured SNPs on traits related to severity or risk factors of type 2 diabetes, we were able to 
find a statistically significant association between age at diagnosis and inbreeding coefficients. 
Furthermore, our study suggests a possible genetic effect on FBG by observing increased 
siblings’ correlations with increased level of consanguinity. The effect of consanguinity on age 
at diagnosis and correlations of FBG might give partial explanations of synergism between type 
2 diabetes and consanguinity. Further investigations are required to target subjects with high 
consanguinity, to recruit a larger sample and to genotype a larger number of SNPs to find 
possible recessive effect on traits related to type 2 diabetes. 
     According to our knowledge, this study is the first study to measure several SNPs related to 
type 2 diabetes in a Saudi Arabian population. This issue was clearly apparent when we realised 
that research facilities in Saudi Arabia did not have the means to perform genotyping of this 
study and samples had to be shipped to the UK. Additionally, by comparing between genotype 
frequencies in our sample to frequencies reported in other populations, we were able to suggest 
the possible effect of increased frequency of homozygosite genotypes that could be attributed to 
high levels of consanguinity.  
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7.1 Implication for public health policies 
      Based on this study’s finding, we can suggest that those with affected parents who are 
related should be targeted when implementing secondary preventive measures. However, for 
this suggestion to be considered, further investigations are needed to replicate this association in 
other region of Saudi Arabia. Furthermore, this study was restricted to males due to cultural 
barriers. Nonetheless, we can argue that the incidence of type 2 diabetes is alike between 
genders and similar causal pathways are likely to be the same in males and females.  
      Despite a similar prevalence of type 2 diabetes in males and females, we can argue that 
heritability of type 2 diabetes among Saudi female subjects could be higher than expected. 
Studies which measured physical activity in Saudi males and females reported that females are 
less likely to be physically active than males. This observation indicates the limited range of 
physical activity of women in Saudi Arabia and variability in incidence of type 2 diabetes could 
be attributed to differences in calorific intake and genetic variance.  
     The data collection period was a good chance to interact with hundreds of individuals. This 
interaction gave us several indications which were not among the aims of this study. For 
example, we observed a strong influence of Khat consumption on the behavioural attitude 
toward accepting diabetes as a disease and treatment compliance. We would argue that there 
might be a strong need for the health authority in the Jazan region to start investigating this 
issue and implement relevant educational programs to enhance overall control of the disease. 
      Several suggestions can be given to reduce the burden of type 2 diabetes in Saudi Arabia. 
We can argue that most of participants who were at risk of the disease did not have a good 
knowledge about the causes of type 2 diabetes. Even patients lacked good knowledge about 
better control of the disease and several healthy subjects were reluctant to have their blood 
glucose measured.   
      We sense a strong need for educational public health campaigns with the ability to reach 
individuals with limitations such as illiteracy or being resident in remote villages. Patients in 
Saudi Arabia need to be educated that reliance on religious factors does not interfere with 
utilizing medical and lifestyle interventions to control the disease. Additionally, since many 
health professionals working at PHC in Saudi Arabia are not native Arabic speakers, the quality 
of health service is likely to be compromised leading to poorer health education and reduced 
overall control of type 2 diabetes. This point need to be addressed on a national level where 
trained health professional with good Arabic speaking skills should be engaged in proper health 
education of individuals at risk or suffering  from the disease.  
      A final remark is related to the benefits gained from the food frequency questionnaire 
program. As the program included a database comprising the calorific values of food items, we 
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were able to observe which food items were most commonly consumed by interviewed 
participants and give advice to participants about calorific intake. Several participants were not 
alert to the high calorific value of items they consumed on a daily basis. We could argue that 
using this software might allow health care professionals to comprehensively ask patients about 
their eating habit and decide which food items exactly can be eliminated or a reduction be made 
in the frequency of their consumption.   
 
 
7.2 Implication for future research 
       Finding a statistically significant association between inbreeding coefficients and age at 
diagnosis with a stronger association in patients where both parents are affected, might indicate 
a need for future research in a specific subjects. We would argue the need to target subjects with 
high consanguinity and strong family history in further genetic investigations to find possible 
recessive effects of risk alleles. Similarly, finding higher correlations of FBG in subjects with 
higher levels of consanguinity might indicate a similar approach of targeting healthy individuals 
with high consanguinity would increase the chance of detecting genetic markers with possible 
recessive effect on FBG. 
      We hypothesized a possible intermediate effect of low birth weight on the association 
between consanguinity and type 2 diabetes. However, upon visiting the Directory of Health in 
Jazan, we were informed that the Directory was established in 1990. Therefore, the majority of 
participants did not have a record of birth weight. As a consequence, this study was not able to 
investigate this hypothesis retrospectively.  
        Lack of birth weight records of older generations indicates the importance of investigating 
the effects of consanguinity on a reduction in birth weight and possible subsequent development 
of type 2 diabetes in younger generations. Younger generations in Saudi Arabia are more likely 
to have a record of birth weight compared to older generations. Therefore, young subjects who 
have a record of birth weight, and not necessarily type 2 diabetes patients, could be recruited in 
a prospective study to investigate this hypothesis.  
      There are several other methodological recommendations. Firstly, Khat is less likely to 
interfere with DNA quality and therefore, we would argue that there should be no restriction 
against  taking buccal swabs from subjects who are khat chewers. Secondly, measuring caloric 
intake and physical activity in patients was not beneficial due to bias caused by changing of life 
style. We would recommend measuring these environmental variables in healthy subjects to 
study their effect on traits related to type 2 diabetes. Thirdly, utilizing food frequency 
questionnaires in Saudi Arabia requires further efforts to develop better assessments of portion 
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sizes and to develop a Saudi Nutritional Database which should be available for the public and 
researchers. Finally, based on this study's findings and other relevant publications, we would 
argue that a vigorous activity parameter is best used to measure variation in physical activities 
compared to sedentary or moderate levels of physical activities.  
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Appendix 4: Participants Information sheets 
Investigating the Potential Effect of Consanguinity on Type 2 Diabetes Susceptibility in a 
Saudi Population 
Patients Information Sheet 
You are being invited to take part in a research project. Before you decide it is important for you 
to understand why the research is being done and what it will involve. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether or 
not you wish to take part. Thank you for reading this information. 
What is the project’s purpose? 
I am conducting this research as a partial requirement for my PhD degree at University of 
Sheffield, UK. The purpose of this research is to study genetic and lifestyle risk factors for 
diabetes in a Saudi population. One of the factors we are measuring is marriage between 
relatives. This study will be very helpful in advancing knowledge related to genetic causes of 
diabetes. 
Why have I been chosen? 
We are inviting patients with diabetes and their healthy brothers and sisters to take part in this 
study. To identify genetic and lifestyle risk factors that are associated with diabetes , we need to 
study DNA (the substance which comprises the body's genetic code) and lifestyle of individuals 
with diabetes. A total of 400 participants (150 diabetes patients and 250 healthy brothers or 
sisters of patients) from Jazan region are required to take part in this research.  
Do I have to take part? 
It is up to you to decide whether or not to take part. You will be given this information sheet to 
keep and be asked to sign a consent form once you agree to participate. You can still withdraw 
at any time without it affecting any health care that you are entitled to in any way.  You do not 
have to give a reason. If you consent to participate, it is entirely up to you to decide what 
information to provide.   
What will happen to me if I take part? 
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Figure 1 is a flow chart explaining the research procedure and what you would be expected to 
do. Data and samples will be collected during a visit to your home. You will be interviewed 
once in your home. During the interview, you will be asked about family tree, physical activity 
and how frequently you eat various foods.   The approximate time period of Interview and 
buccal swabs collection will be 1 hour.  The interview and measurement sessions will be with 
the principal investigator (me) for male participants and a female medical practitioner for 
female participants.  
What do I have to do? 
The interviewer will ask questions about your diet and physical exercise. Otherwise, there will 
be no other restriction on lifestyle or general activities.  
You will be asked to give a buccal swab using a designated collection kit. Swabs will be taken 
one hour after eating or drinking and mouth rinsed prior to taking sample. You will be given a 
swab to insert into your mouth and rub firmly against the inside of your cheek for 1 minute. 
Afterwards, the investigator will l place the swab in a designated tube with preservative 
capsules .At the end of data collection, these kits will be sent to a specialist company for  DNA 
extraction and genetic analysis.   
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What are the possible disadvantages and risks of taking part? 
There are no foreseeable disadvantages and risks linked to research participation other than time 
consumption. However, it might be inconvenient for some participants to give buccal swabs. 
Giving your DNA samples for analysis will not impose any risk of identifying other medical or 
genetic conditions as we are looking only at genes which may be involved in diabetes risk. 
Collected swabs will be used to perform a DNA extraction and genetic analysis for one time 
only. This study will not  preserve DNA samples once the analysis has been performed.  
Figure 1:Research Process and Guidelines: 
 
End of Data Collection 
Buccal swabs 
Family background 
Researchers will interview participants to answer questions 
related to family history of diabetes, and whether parents or 
grandparents are related or not.  
 
Home Visit 
Filling questionnaires You will be interviewed in order to complete food frequency 
questionnaire and physical activity questionnaire by researchers. 
Arrangements were made with your Primary Health Care 
Centre to arrange your invitation to the study.  
You will be asked to give a buccal swab using a designated 
collection kit.  
271 
 
What are the possible benefits of taking part? 
Whilst there are no immediate benefits for those people participating in the project, it is hoped 
that this work will be very helpful in designing intervention programs for future prevention of 
diabetes.  
What if something goes wrong? 
If you have any query/complaint you can contact me without hesitation at my given contact 
number. However, if you feel that I could not handle your query/complaint appropriately then 
you can contact my supervisor at (m.d.teare@sheffield.ac.uk).  
Will my taking part in this project be kept confidential? 
All the information that you will provide during the session will be kept strictly confidential 
under my custody. Data will be analysed anonymously and individual name/identity of any 
participant will not be disclosed in any paper/report or publication.Buccal swabs will not be 
labelled by any identifiable data and researchers will only use anonymised codes to link 
between buccal swabs and other collected data.  
What will happen to the results of the research project? 
Results of the study will be submitted to The University of Sheffield in January 2014. Findings 
of the study will be sent to reputable scientific journals for publication. If you are interested in 
knowing the findings of this study, you can contact the principal investigator. 
 
Who is organising and funding the research? 
 
This study is partially sponsored by Saudi Cultural Bureau in London, UK and the remaining 
financial requirements are met by the principal investigator . 
 
Who has ethically reviewed the project? 
 
The Ethics Review Committee of School of Health and Related Research (ScHARR) at 
University of Sheffield, UK and Directory of Health in Jazan region, Saudi Arabia managed the 
ethics review process.  
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Finally …  
 
Participants will be given a copy of the information sheet and a signed consent form to keep. 
 
If you need further information you can contact at given below number. I will be very thankful 
for your cooperation. 
 
Best Wishes 
Dr. Ibrahim Gosadi 
Principal Investigator, postgraduate research student student 
School of Health and Related Research (ScHARR) 
University of Sheffield, Sheffield, UK 
Contact No. +966 562447123 
Email: igosadi@ksu.edu.sa 
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Investigating the Potential Effect of Consanguinity on Type 2 
Diabetes Susceptibility in a Saudi Population 
Healthy Participant Information Sheet 
You are being invited to take part in a research project. Before you decide it is important for you 
to understand why the research is being done and what it will involve. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether or 
not you wish to take part. Thank you for reading this information. 
What is the project’s purpose? 
I am conducting this research as a partial requirement for my PhD degree at University of 
Sheffield, UK. The purpose of this research is to study genetic and lifestyle risk factors for 
diabetes in a Saudi population. One of the factors we are measuring is marriage between 
relatives. This study will be very helpful in advancing knowledge related to genetic causes of 
diabetes. 
Why have I been chosen? 
We are inviting patients with diabetes and their healthy brothers and sisters to take part in this 
study.To identify genetic and lifestyle risk factors that are associated with diabetes , we need to 
study DNA (the substance which comprises the body's genetic code) and lifestyle of individuals 
who have a brother or sister with diabetes. A total of 400 participants (150 diabetes patients and 
250 healthy brothers or sisters of patients) from Jazan region are required to take part in this 
research.  
Do I have to take part? 
It is up to you to decide whether or not to take part. You will be given this information sheet to 
keep and be asked to sign a consent form once you agree to participate. You can still withdraw 
at any time without it affecting any health care that you are entitled to in any way.  You do not 
have to give a reason. If you consent to participate, it is entirely up to you to decide what 
information to provide.   
What will happen to me if I take part? 
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Figure 1 is a flow chart explaining the research procedure and what you would be expected to 
do. Data and samples will be collected during a visit to your home. You will be interviewed 
once in your home. During the interview you will be asked about your family tree, physical 
activity and how frequently you eat various foods. The approximate time period of Interview, 
physical measurements, and buccal swabs collection will be 1 hour.  The interviews and 
measurement sessions will be with the principal investigator (me) for the male participants and 
a female medical practitioner for female participants 
What do I have to do? 
You will be kindly requested not to eat for 8 hours prior to the visit to allow for measurement of 
fasting blood sugar. This measurement will be done using a glucose meter during the home 
visit. The procedure involves pricking a finger to obtain a blood drop. The drop will be applied 
to a glucose meter to provide a reading of the glucose level. 
The interviewer will ask questions about your diet and physical exercise. Otherwise, there will 
be no other restriction on lifestyle or general activities.  
You will be asked to give a buccal swab using a designated collection kit. Swabs will be taken 
one hour after eating or drinking and mouth rinsed prior to taking sample. You will be given a 
swab to insert into your mouth and rub firmly against the inside of your cheek for 1 minute. 
Afterwards, the investigator will place the swab in a designated tube with preservative capsules 
.At the end of data collection, these kits will be sent to a specialist company for  DNA 
extraction and genetic analysis.   
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Physical measurements 
 
Your weight will be measured by an 
electronic scale while wearing light 
clothing. Your height will be measured 
using a stadiometer while standing 
barefoot. Your waist circumference will 
be measured by a measuring tape while 
standing.  
 
Blood sugar 
 
Your fasting blood sugar will be measured 
by a glucose meter. 
 
Buccal swabs 
Family background 
Researchers will interview participants to 
answer questions about family history of 
diabetes, and whether parents or 
grandparents are related or not.  
 
Your birth weight will be retrieved from your medical records 
available at your primary health care centre. 
Home Visit 
Filling questionnaires 
End of home visit Data collection from PHC 
Arrangements were made with your Primary Health Care (PHC) 
Centre to arrange your invitation to the study.  
You will be interviewed in order to 
complete food frequency questionnaire 
and physical activity questionnaire by 
researchers. 
You will be asked to give a buccal swab 
using a designated collection kit. 
End of data collection 
Figure 1:Research Process and Guidelines: 
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What are the possible disadvantages and risks of taking part? 
You might experience discomfort due to 8 hours fasting needed to measure blood sugar. A 
slight pain might be felt while finger pricking needed to obtain blood drop. The process of 
taking glucose reading will be proceeded by investigators wearing new gloves when taking the 
glucose reading of each participant, applying alcohol wipes at the area of finger pricking, using 
a new lancet for each participant. 
Certain healthy participants might exhibit an above normal level of blood sugar. However, this 
measurement of blood glucose is not confirmatory and it does not mean that you have diabetes. 
If a healthy participant appears to have an above normal level of blood sugar, they will be 
advised to seek medical advice from their family physician. However, having an elevated level 
of blood sugar does not interfere with your participation in this study. 
It might be inconvenient for some participants to give buccal swabs. Giving your DNA samples 
for analysis will not impose any risk of identifying other medical or genetic conditions as we are 
looking only at genes which may be involved in diabetes risk. Collected swabs will be used to 
perform a DNA extraction and genetic analysis for one time only. This study will not  preserve 
DNA samples once the analysis has been performed.  
 
What are the possible benefits of taking part? 
Whilst there are no immediate benefits for those people participating in the project, it is hoped 
that this work will be very helpful in designing  intervention programs for the future prevention 
of diabetes.  
What if something goes wrong? 
If you have any query/complaint you can contact me without hesitation at my given contact 
number. However, if you feel that I could not handle your query/complaint appropriately then 
you can contact my supervisor at (m.d.teare@sheffield.ac.uk).  
Will my taking part in this project be kept confidential? 
All the information that you will provide during the session will be kept strictly confidential 
under my custody. Data will be analysed anonymously and the individual name/identity of any 
participant will not be disclosed in any paper/report or publication.Buccal swabs will not be 
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labelled by any identifiable data and researches will only use anonymised codes to link records 
between Buccal swabs and other collected data.  
What will happen to the results of the research project? 
The results of the study will be submitted to The University of Sheffield in January 2014. 
Findings of the study will be sent to reputable scientific journals for publication. If you are 
interested in knowing the findings of this study, you can contact the principal investigator. 
 
 
Who is organising and funding the research? 
 
This study is partially sponsored by Saudi Cultural Bureau in London, UK and the remaining 
financial requirements are met by the principal investigator . 
 
Who has ethically reviewed the project? 
 
Ethics Review Committee of School of Health and Related Research (ScHARR) at University 
of Sheffield, UK and Directory of Health in Jazan region, Saudi Arabia managed the ethics 
review process.  
 
Finally … 
 
Participants will be given a copy of the information sheet and a signed consent form to keep. 
 
If you need further information you can contact at given below number. I will be very thankful 
for your cooperation. 
 
Best Wishes 
Dr.Ibrahim Gosadi 
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Principal Investigator, postgraduate research student 
School of Health and Related Research (ScHARR) 
University of Sheffield, Sheffield, UK 
Contact No. +966 562447123 
Email: igosadi@ksu.edu.sa 
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Appendix 5: Participants consent form 
 
Participants Consent Form 
 
 
Title of Research Project: Investigating the Potential Effect of Consanguinity on Type 2 
Diabetes Susceptibility in a Saudi Population 
 
Name of Researcher:  Dr. Ibrahim Gosadi 
Participant Identification Number for this project: 
                                                                                                                             
initial box 
 
1. I confirm that I have read and understand the information sheet  
 dated 26/04/2012 explaining the above research project 
and I have had the opportunity to ask questions about the project. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason and without there 
being any negative consequences. In addition, should I not wish to 
answer any particular question or questions, I am free to decline.  
      Contact number of lead investigator : 0562447123 
 
3. I understand that my responses will be kept strictly confidential. I 
give permission for members of the research team to have access to 
my anonymised responses. I understand that my name will not be 
linked with the research materials, and I will not be identified or 
identifiable in the report or reports that result from the research.   
 
4. I agree for the data collected from me to be used in the above  research 
project.  
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5. I understand that sections of my medical records may be looked at 
by the principle investigator. I give permission for the Principal 
investigator to access my records. 
 
6. I agree to my DNA samples used for the above research project. 
 
7. I agree to take part in the above research project. 
 
 
 
_____________________ ________________         
____________________ 
Name of Participant Date Signature 
(or legal representative) 
 
 
_________________________ ________________         
____________________ 
Name of person taking consent Date Signature 
(if different from lead researcher) 
To be signed and dated in presence of the participant 
 
 
_________________________ ________________         
____________________ 
 Lead Researcher Date Signature 
To be signed and dated in presence of the participant 
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Appendix 8: Changes made for EPIC- food frequency questionnaire 
Location in the EPIC 
questionnaire 
Food Item(s) Action Taken Reason of action 
Page 3: Meat and 
Fish. 
Pork, Bacon, Ham, 
Corned Beef, Spam, 
Pork Pie, Steak and 
Kidney Pie, Fish Cakes, 
Fish Roe and 
Taramasalta. 
Deletion Not available in Saudi Arabia 
Page 4: Bread and 
Savoury Biscuits 
White bread and rolls Example Addition: 
Tamees 
Popular food in Saudi Arabia. Not 
Available in the UK. 
Page 4: Bread and 
Savoury Biscuits 
Marsa Item  Addition Popular in Saudi Arabia. White or 
brown bread is cut into small 
pieces and mixed with banana, 
honey, and butter. 
Page 4: Bread and 
Savoury Biscuits 
Maasoub Item  Addition Popular in Saudi Arabia. Brown 
bread is cut into small pieces and 
mixed with banana, honey, butter, 
cream, dates and sugar. 
Page 4: Bread and 
Savoury Biscuits 
Asseda Item  Addition Popular food in Saudi Arabia. 
Made from white wheat, butter, 
and sugar. Vegetable oil and  
honey are added upon serving.  
Page 4: Bread and 
Savoury Biscuits 
Haisya Item  Addition Popular food in Saudi Arabia. 
Made from home made whole 
wheat. Meat and gravy are added 
upon convenience. 
Page 4: Bread and 
Savoury Biscuits 
Crispbread Example 
Replacement: Ryvita 
with bread rusk 
(white, brown or 
whole wheat)  
Popular food in Saudi Arabia. 
Page 4: Cereals Porridge, Readybrek Deletion Not available in Saudi Arabia 
Page 5: Dairy 
Products and Fats 
Single or sour cream Replacement with 
Cream 
Sour Creams are not available in 
Saudi Arabia 
Page 5: Dairy 
Products and Fats 
Dairy desserts Deletion Not Available in Saudi Arabia 
Page 5: Dairy Cottage cheese Replacement with Salted cheese is common in Saudi 
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 Products and Fats Salted cheese Arabia unlike the cottage cheese 
Page 5: Dairy 
Products and Fats 
Butter and margarine 
spread on bread and 
vegetables 
Grouped into two 
items, margarine or 
butter on bread. 
Butter and margarine are 
commonly used while cooking. 
Uncommon as a spread on bread 
Page 6:Sweets and 
Snacks 
Sponge puddings Deletion Not available in Saudi Arabia 
Page 6:Sweets and 
Snacks 
Baqlawa, Kenafa, 
Basboosa, Lugmat 
Alghadi, and Mushabak 
Items  Addition Popular Arabic sweets in Saudi 
Arabia. These different items 
share similar ingredients including 
wheat, butter, cream, and sugar.  
Page 6: Soups, 
Sauces, and Spreads 
Sauces, eg. White sauce, 
cheese sauce, and gravy. 
Marmite, Bovril 
Deletion Not available in Saudi Arabia.  
Page 7:Drinks Arabic Coffee Item Addition Popular in Saudi Arabia. 
Page 7:Drinks Wine, Beer, Liqueurs, 
And Sprites 
Deletion Not available in Saudi Arabia. 
Page 7:Fruits Guava, Dates, Hard 
Melon, Fig, and 
Pomegranate.  
Items Addition Popular fruits in Saudi Arabia. 
Page 8:Vegetables Brussels sprout, Leeks, 
Beansprouts, 
Watercress, Beetroot, 
Tofu, Soya met and TVP 
Deletion Not available in Saudi Arabia. 
Page 8:Vegetables Green onion, and Baqel. Items Addition Popular vegetables in Saudi 
Arabia usually eaten uncooked.  
Page 9: Milk Milk types: Channel 
Islands: Gold, and Soya 
Deletion Not available in Saudi Arabia 
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Appendix 9: Changes made for EPIC- physical activity questionnaire 
Location in the EPIC 
questionnaire 
Activity Action 
Taken 
Reason of action 
Page 3: Getting about-
Apart from going to work. 
Using public transport Deletion Public Transport is not 
available in Saudi Arabia 
Page 3: Getting about-
Apart from going to work. 
Using Cycle Deletion Cycling is not a common 
activity among adults in 
Saudi Arabia  
Page 8: Travel to and 
from work 
Using public transport Deletion Public Transport is not 
available in Saudi Arabia 
Page 8: Travel to and 
from work 
Using Cycle Deletion Cycling is not a common 
activity among adults in 
Saudi Arabia  
Page 10:Recreation 
activities 
Mowing the lawn, 
Cycling for Pleasure, 
Dancing, Squash, 
Golf, Cricket, 
Rowing, Musical 
instrument playing or 
singing, Martial arts, 
Boxing, and 
Wrestling 
Deletion These activities are never 
or rarely performed in 
Saudi Arabia.  
Page 10:Recreation 
activities 
Sailing, Wind 
Surfing,  Boating 
Replacement  
with fishing 
Fishing is a common 
recreational activity in 
Saudi Arabia which 
mostly mandates boating  
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Appendix 10: Nutritional Database 
6+ 
per 
day 
4-5 
per 
day 
2-3 
per 
day 
Onc
e a 
day 
5-6 
per 
week 
2-4 
per 
week 
Once 
a 
week 
1-3 
per 
mont
h 
Never or 
less than 
once/mont
h 
Food Item Portion size in 
grams 
Source 
6 4.5 2.5 1 0.79 0.43 0.14 0.07 0    
6660 4995 2775 111
0 
876.9 477.3 155.
4 
77.7 0 Lamb Kabsa 400g Ingredients:200 g of stewed lamb, and 200 g of 
long grain rice cooked, 40 g of oil 
5160 3870 2150 860 679.4 369.8 120.
4 
60.2 0 Chicken Kabsa 400g  Ingredients:200 gm of chicken stew and 200 g of 
rice, and cookig oil 
3972 2979 1655 662 522.9
8 
284.6
6 
92.6
8 
46.3
4 
0 Fried Chicken 200g Chicken, broiler, back, meat and skin, batter 
dipped, frie, CNF 
3516 2637 1465 586 462.9
4 
251.9
8 
82.0
4 
41.0
2 
0 Grilled Chicken, 
Mandi or Hanith 
200g Chicken breast tenders, cooked in conventional 
oven, CNF 
3792 2844 1580 632 499.2
8 
271.7
6 
88.4
8 
44.2
4 
0 Grilled Lamb, 
Mandi, Hanith 
200g wait of serving has been adjusted to resemble 
chicken, Lamb, New Zealand, loin, lean and fat, 
6mm (1/4") trim, broiled / CNF 
1068 801 445 178 140.6
2 
76.54 24.9
2 
12.4
6 
0 Lamb Liver 90g Lamb, liver, pan-fried, USDA  
3420 2565 1425 570 450.3 245.1 79.8 39.9 0 Chicken Stew 200g Chicken, stewing, meat and skin, stewed, CNF 
4872 3654 2030 812 641.4
8 
349.1
6 
113.
68 
56.8
4 
0 Lamb Stew or 
Borma 
200g http://recipes.sparkpeople.com/recipe-
calories.asp?recipe=367697  
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1194 895.5 497.
5 
199 157.2
1 
85.57 27.8
6 
13.9
3 
0 Mogalgal, Lamb 100g http://recipes.sparkpeople.com/recipe-
calories.asp?recipe=198278     items included, 
lamb, anion , oil, and herbs  
4302 3226.
5 
1792
.5 
717 566.4
3 
308.3
1 
100.
38 
50.1
9 
0 Hysia 300g 200 gm of lamb stew and 100g of brown bread 
1860 1395 775 310 244.9 133.3 43.4 21.7 0 Fried Fish 200g http://recipes.sparkpeople.com/recipe-
calories.asp?recipe=189697  
1878 1408.
5 
782.
5 
313 247.2
7 
134.5
9 
43.8
2 
21.9
1 
0 Fish Stew 200g raw sea bass, 30 kcals from oil, anion and herbs, 
tomatos http://recipes.sparkpeople.com/recipe-
calories.asp?recipe=1339055  
1488 1116 620 248 195.9
2 
106.6
4 
34.7
2 
17.3
6 
0 Grilled Fish 200g Sea bass, grilled, mixed herbs , amount doubled, 
CNF 
840 630 350 140 110.6 60.2 19.6 9.8 0 Tuna 75g Tuna, white, canned with oil, drained, unsalted, 
CNF 
798 598.5 332.
5 
133 105.0
7 
57.19 18.6
2 
9.31 0 Grilled Shrimp 135g Shrimp, mixed species, boiled or steamed , CNF 
2382 1786.
5 
992.
5 
397 313.6
3 
170.7
1 
55.5
8 
27.7
9 
0 Fried Shrimp 135g USDA   
http://ndb.nal.usda.gov/ndb/foods/show/7629  
1650 1237.
5 
687.
5 
275 217.2
5 
118.2
5 
38.5 19.2
5 
0 whitebread 100 g Nutrient data for 18413, Bread, pita, white, 
unenriched, USDA  
2904 2178 1210 484 382.3
6 
208.1
2 
67.7
6 
33.8
8 
0 Zalba, germish, 100g Ingredients:  wheat and oil calories 
6972 5229 2905 116917.9499.6162.81.30 Marsa 150g Ingredients :100g of wheat, 5ml oil, butter, 
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2 8 6 68 4 honey, and two banana 
9150 6862.
5 
3812
.5 
152
5 
1204.
75 
655.7
5 
213.
5 
106.
75 
0 Maasoub 150g 100g wheat, 40 oil, butter, two banana, 5 dates, 
and 100 g cream 
6312 4734 2630 105
2 
831.0
8 
452.3
6 
147.
28 
73.6
4 
0 Asseda 150g Ingredients: wheat, butter and honey 
2418 1813.
5 
1007
.5 
403 318.3
7 
173.2
9 
56.4
2 
28.2
1 
0 Pastries ready 
made 
100g Danish pastry, cinnamon CNF  
2178 1633.
5 
907.
5 
363 286.7
7 
156.0
9 
50.8
2 
25.4
1 
 Spinach pie 150 Ingredients: wheat and spinach 
3312 2484 1380 552 436.0
8 
237.3
6 
77.2
8 
38.6
4 
 Cheese Pie 150 Ingredients: Wheat and cheese 
2598 1948.
5 
1082
.5 
433 342.0
7 
186.1
9 
60.6
2 
30.3
1 
 Labnah Pie 150 Ingredients: wheat and labnah 
4008 3006 1670 668 527.7
2 
287.2
4 
93.5
2 
46.7
6 
 Ush Albulbul 150 Ingredients: cheese, labnah, honey,  
3054 2290.
5 
1272
.5 
509 402.1
1 
218.8
7 
71.2
6 
35.6
3 
 Labnah with 
Honey 
150 Ingredients: wheat, labnah, honey 
3390 2542.
5 
1412
.5 
565 446.3
5 
242.9
5 
79.1 39.5
5 
 Meat Pie 150 Ingredients: wheat  and meat 
3474 2605.
5 
1447
.5 
579 457.4
1 
248.9
7 
81.0
6 
40.5
3 
 Banana Pie 175 Ingredients: banana, egg, wheat, oil for usual 
cook 
3048 2286 1270 508 401.3
2 
218.4
4 
71.1
2 
35.5
6 
 Chicken Pie 150 Ingredients: chicken and wheat 
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3000 2250 1250 500 395 215 70 35  Zaatar pie 150 Ingredients: Zaater and wheat 
1992 1494 830 332 262.2
8 
142.7
6 
46.4
8 
23.2
4 
0 Pizza one slice 139g Fast foods, pizza, cheese and vegetables, regular 
crust ,CNF 
162 121.5 67.5 27 21.33 11.61 3.78 1.89 0 green salad 100 Ingredients: tomato, cucumber, and onion , CNF 
228 171 95 38 30.02 16.34 5.32 2.66 0 cucumber with 
laban 
100g  Ingredients:50 g of yogurt and 50g os cucumber  
150 112.5 62.5 25 19.75 10.75 3.5 1.75 0 Jargeer 100g Arugula, raw, CNF 
12 9 5 2 1.58 0.86 0.28 0.14 0 Baqel one, 17g Radish, white icicle, raw, CNF 
192 144 80 32 25.28 13.76 4.48 2.24 0 Green onion 100g Onion, spring (green) or scallion (includes tops 
and bulb), raw ,CNF 
996 747 415 166 131.1
4 
71.38 23.2
4 
11.6
2 
0 Hummus 100g Hummus, commercial ,CNF 
2466 1849.
5 
1027 411 324.6
9 
176.7
3 
57.5
4 
28.7
7 
0 Fatoush 100 http://recipes.sparkpeople.com/recipe-
calories.asp?recipe=72323  
1287 965.2
5 
536.
2 
214 169.4
5 
92.23
5 
30.0
3 
15.0
1 
0 stuffed vine 
leaves 
105  http://www.food.com/recipe/dolma-stuffed-
grape-leaves-198071 
1710 1282.
5 
712.
5 
285 225.1
5 
122.5
5 
39.9 19.9
5 
0 Baba Ganoush 100 http://caloriecount.about.com/calories-sabra-
babaganoush-i163033 
1649 1237.
0 
687.
2 
274
. 
217.1
7 
118.2
0 
38.4
8 
19.2
4 
 taboulah 100g 40 g of bulgar, parsley, etc 
http://recipes.sparkpeople.com/recipe-
calories.asp?recipe=357 
468 351 195 78 61.62 33.54 10.9
2 
5.46 0 Coleslaw 100g Coleslaw (cabbage salad), with dressing, 
homemade, CNF 
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618 463.5 257.
5 
103 81.37 44.29 14.4
2 
7.21 0 Vegetarian Stew 100 Ingredients: tomato, potato, carrot, anion, and oil 
918.
6 
688.9
5 
382.
7 
153
. 
120.9
4 
65.83
3 
21.4
3 
10.7
1 
0 Fuol 112  http://www.food.com/recipe/fool-madamas-
134366 
2508 1881 1045 418 330.2
2 
179.7
4 
58.5
2 
29.2
6 
0  lentils stew 100g Lentils, raw anion, oil and tomato ,CNF 
1938 1453.
5 
807.
5 
323 255.1
7 
138.8
9 
45.2
2 
22.6
1 
0 Hulbah 100g Spices, fenugreek seed, anion, oil and tomato, 
CNF 
858 643.5 357.
5 
143 112.9
7 
61.49 20.0
2 
10.0
1 
0 Peas stew 100g Peas, green, raw, anion, oil and tomato, CNF 
576 432 240 96 75.84 41.28 13.4
4 
6.72 0 Beans stew 100g Beans, snap, green, anion, oil and tomatoraw, 
USDA 
510 382.5 212.
5 
85 67.15 36.55 11.9 5.95 0 Khousa stew small, 118g Squash, summer, zucchini, includes skin, raw 
anion, oil and tomato, USDA 
576 432 240 96 75.84 41.28 13.4
4 
6.72 0 Bhamia stew 100g Okra (gumbo), raw , anion, oil and tomato, CNF 
588 441 245 98 77.42 42.14 13.7
2 
6.86 0 Eggplant stew 100g Eggplant (aubergine, brinjal), raw, anion, oil and 
tomato, CNF 
480 360 200 80 63.2 34.4 11.2 5.6 0 Mloukiah stew 100g This Reading was provided by inspecting a 
product which contains this plant 
2292 1719 955 382 301.7
8 
164.2
6 
53.4
8 
26.7
4 
0 Djer stew 100g Beans, kidney, all types, raw, anion, oil and 
tomato, CNF 
630 472.5 262.105 82.95 45.15 14.7 7.35 0 Qawar stew 100g http://pankaj3625.hubpages.com/hub/How-To-
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5 Count-Calories-In-Your-Vegetables 
1914 1435.
5 
797.
5 
319 252.0
1 
137.1
7 
44.6
6 
22.3
3 
0 French Fried 100g Fast foods, side dish, potato, french-fried in 
vegetable oil, CNF 
2124 1593 885 354 279.6
6 
152.2
2 
49.5
6 
24.7
8 
0 mashed potatoes 100g CNF 
660 495 275 110 86.9 47.3 15.4 7.7 0 Flafel 100g http://low-cholesterol.food.com/recipe/easy-
falafel-317819 
2460 1845 1025 410 323.9 176.3 57.4 28.7  Flafel Sandwitch 170g Ingredients: bread 100g, Flafel 50g, cheese 20g  
2724 2043 1135 454 358.6
6 
195.2
2 
63.5
6 
31.7
8 
 Liver Sandwitch 170g Ingredients: bread 100g, liver 50g, cheese 20g 
3348 2511 1395 558 440.8
2 
239.9
4 
78.1
2 
39.0
6 
 Lamb Sandwitch 170g Ingredients: bread, lamb 50g and cheese 20g 
2706 2029.
5 
1127 451 356.2
9 
193.9
3 
63.1
4 
31.5
7 
 Fried Egg 
Sandwitch 
170g Ingredients: bread, fried egg 50g and cheese 20g 
2550 1912.
5 
1062
.5 
425 335.7
5 
182.7
5 
59.5 29.7
5 
 Boiled Egg 
Sandwitch 
170g Ingredients: bread, boiled egg 50g and cheese 
20g 
3084 2313 1285 514 406.0
6 
221.0
2 
71.9
6 
35.9
8 
 Fries Sandwitch 170g Ingredients: bread, chips  50g and cheese 20g 
2928 2196 1220 488 385.5
2 
209.8
4 
68.3
2 
34.1
6 
 Tuna sandwitch 170g Ingredients: bread, tuna  50g and cheese 20g 
3006 2254.
5 
1252
.5 
501 395.7
9 
215.4
3 
70.1
4 
35.0
7 
 chicken 
Sandwitch or 
shaorwma 
170g Ingredients: bread, chicken  50g and cheese 20g 
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2622 1966.
5 
1092
. 
437 345.2
3 
187.9
1 
61.1
8 
30.5
9 
 Jam Sandwich 170g Ingredients: bread, jam  50g and cheese 20g 
1170 877.5 487.
5 
195 154.0
5 
83.85 27.3 13.6
5 
0 rice 150g Grains, rice, white, long-grain, regular, cooked, 
CNF 
948 711 395 158 124.8
2 
67.94 22.1
2 
11.0
6 
0 pasta, eg. 
Spaghetti, 
macaroni, noodles 
100g Pasta, spaghetti, enriched, cooked ,CNF 
2082 1561.
5 
867.
5 
347 274.1
3 
149.2
1 
48.5
8 
24.2
9 
0 Bashamil,  100g Ingredients:100 g of lamb fried, 100g of pasta, 
one egg, 100 ml of milk and 100 ml of cheese, 
3204 2403 1335 534 421.8
6 
229.6
2 
74.7
6 
37.3
8 
0 sambosa, cheese 100g Ingredients: 100g wheat, frying oil, and 50g of 
cheese 
2910 2182.
5 
1212 485 383.1
5 
208.5
5 
67.9 33.9
5 
0 Oatmeal soup 100g Ingredients: aot, tomato paste 40g, onion 40g, oil 
42 31.5 17.5 7 5.53 3.01 0.98 0.49 0 Pickles  65 g Pickles, cucumber, sour, CNF 
252 189 105 42 33.18 18.06 5.88 2.94 0 Jam, (teaspoon) 15 ml , 19g Jam type spread, Double Fruit, CNF 
384 288 160 64 50.56 27.52 8.96 4.48 0 honey 21g, 15ml honey, USDA  
3564 2673 1485 594 469.2
6 
255.4
2 
83.1
6 
41.5
8 
0 Peanuts or other 
nuts 
100g Nuts, mixed nuts, dry roasted with peanuts, CNF 
36 27 15 6 4.74 2.58 0.84 0.42 0 Tomato ketchup 
(teaspoon) 
6 g, packet ketchup, CNF 
570 427.5 237.
5 
95 75.05 40.85 13.3 6.65 0 Peanut butter  15 ml Peanut butter, smooth type, fat and sugar added, 
CNF 
240 180 100 40 31.6 17.2 5.6 2.8  Olive 10 pieces Olive, ripe, canned, small to extra large, CNF 
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396 297 165 66 52.14 28.38 9.24 4.62 0 full fat milk 100 ml Milk, fluid, whole, producer, 3.7% M.F. CNF 
258 193.5 107.
5 
43 33.97 18.49 6.02 3.01 0 low fat milk 100ml Milk, fluid, partly skimmed, 1% M.F.CNF 
360 270 150 60 47.4 25.8 8.4 4.2 0 Full fat laban 100ml http://www.livestrong.com/thedailyplate/nutrition
-calories/food/generic/fresh-laban-almarai/ 
300 225 125 50 39.5 21.5 7 3.5 0 Low fat Laban 100ml http://tracker.dailyburn.com/nutrition/almarai_al
marai_vetal_laban_low_fat_calories  
771 578.2
5 
321.
25 
128
.5 
101.5
15 
55.25
5 
17.9
9 
8.99
5 
0 Cream  50g Cream, whipped, cream topping, pressurized, 
USDA 
366 274.5 152.
5 
61 48.19 26.23 8.54 4.27 0 Full fat yogurt 100g Yogurt, plain, whole milk, USDA 
378 283.5 157.
5 
63 49.77 27.09 8.82 4.41 0 Low fat yogurt 100gm Yogurt, plain, low fat, 12 grams protein per 8 
ounce, USDA 
1794 1345.
5 
747.
5 
299 236.2
1 
128.5
7 
41.8
6 
20.9
3 
0 Cheese 100 ml Cheese spread, cream cheese base, CNF 
1002 751.5 417.
5 
167 131.9
3 
71.81 23.3
8 
11.6
9 
0 Salted cheese 100ml Cheese, feta, CNF 
1158 868.5 482.
5 
193 152.4
7 
82.99 27.0
2 
13.5
1 
0 fried egg 100g Egg, chicken, whole, fried, CNF 
846 634.5 352.
5 
141 111.3
9 
60.63 19.7
4 
9.87 0 Eggs boiled 100g Egg, chicken, whole, boiled in shell, hard-
cooked, CNF 
348 261 145 58 45.82 24.94 8.12 4.06 0 mayonnaise 15ml Salad dressing, mayonnaise type, commercial, 
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regular , CNF 
2190 1642.
5 
912.
5 
365 288.3
5 
156.9
5 
51.1 25.5
5 
0 Sweet biscuits 
plain 
100g Biscuit, plain/buttermilk, commercial , CNF 
2538 1903.
5 
1057
.5 
423 334.1
7 
181.8
9 
59.2
2 
29.6
1 
0 Cakes ready made 100g Cake, white, dry mix, pudding-type, unenriched. 
USDA 
3756 2817 1565 626 494.5
4 
269.1
8 
87.6
4 
43.8
2 
0 Trumba 100g Ingredients: 100 wheat, one egg, 35 g butter, 
frying oil, sugar 
2670 2002.
5 
1112
.5 
445 351.5
5 
191.3
5 
62.3 31.1
5 
0 Baqlawa 100g http://www.food.com/recipe/baklava-143885 
2664 1998 1110 444 350.7
6 
190.9
2 
62.1
6 
31.0
8 
0 Kunafa 100g http://www.food.com/recipe/konafa-342899 
2508 1881 1045 418 330.2
2 
179.7
4 
58.5
2 
29.2
6 
0 Basboosa 100g http://www.food.com/recipe/basboosa-easy-
semolina-cake-254309 
1584 1188 660 264 208.5
6 
113.5
2 
36.9
6 
18.4
8 
0 Lugmat alqadi 150g  http://www.food.com/recipe/luqaimaat-arab-
donuts-309634 
2778 2083.
5 
1157
.5 
463 365.7
7 
199.0
9 
64.8
2 
32.4
1 
0 Mushabak 100g Ingredients:from wheat, frying oil, cornstarch, 
and yogurt 
1242 931.5 517.
5 
207 163.5
3 
89.01 28.9
8 
14.4
9 
0 Milk puddings eg. 
Rice, custard, 
trifle  
100g Dessert, pudding, all flavours except chocolate, 
instant, dry mix, prepared with 2% milk, CNF  
1248 936 520 208 164.3
2 
89.44 29.1
2 
14.5
6 
0 Ice cream 100g Dessert, frozen, ice cream, vanilla, 11% M.F. , 
CNF 
3210 2407.1337535 422.6230.074.9 37.40 Chocolates, single 100g Candies, bars / chips, milk chocolate, plain, CNF 
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5 .5 5 5 5 or squares 
1488 1116 620 248 195.9
2 
106.6
4 
34.7
2 
17.3
6 
0 Chocolate snack 
bars eg. Snickers 
45g Candies, bars, Twix, chocolate fudge cookie, 
CNF 
402 301.5 167.
5 
67 52.93 28.81 9.38 4.69 0 Sweets, toffees, 
mints 
12g , piece Candies, toffee, homemade, CNF 
96 72 40 16 12.64 6.88 2.24 1.12 0 Sugar added to 
tea, coffee, 
cereals 
5ml spoon CNF 
1458 1093.
5 
607.
5 
243 191.9
7 
104.4
9 
34.0
2 
17.0
1 
0 Crisps or other 
packet snacks 
small bag 45g Snacks, potato chips, plain, salted, USDA 
6 4.5 2.5 1 0.79 0.43 0.14 0.07 0 Tea (cup) 100g CNF 
27.6 20.7 11.5 4.6 3.634 1.978 0.64
4 
0.32
2 
0 Arabic Coffee 62  http://www.food.com/recipe/arabic-qahwa-
189733 
192 144 80 32 25.28 13.76 4.48 2.24 0 Adani Tea 100g http://www.food.com/recipe/yemeni-chai-chai-
adani-199390 
12 9 5 2 1.58 0.86 0.28 0.14 0 Coffee, instant or 
ground (cup) 
one teaspoon , 5ml, 
1g 
Coffee, instant, regular, powder ,CNF 
96 72 40 16 12.64 6.88 2.24 1.12 0 Coffee whitener, 
eg. Coffee-male 
(teaspoon) 
one packet , 3g Coffee whitener (non dairy), powdered ,CNF 
126 94.5 52.5 21 16.59 9.03 2.94 1.47  ADDED MILK 15ml Milk, evaporated, whole, canned, undiluted, 7.8% 
M.F.CNF 
594 445.5 247.99 78.21 42.57 13.86.93 0 Cocoa, hot 100ml Hot chocolate, cocoa, homemade, prepared with 
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5 6 chocolate (cup) whole milk,CNF 
6 4.5 2.5 1 0.79 0.43 0.14 0.07 0 Diet soft drinks 
(glass) 
355ml CNF 
846 634.5 352.
5 
141 111.3
9 
60.63 19.7
4 
9.87 0 sweetened soft 
drinks 
355 , can Carbonated drinks, cola,CNF  
282 211.5 117.
5 
47 37.13 20.21 6.58 3.29 0 Pure fruit juice 
(100%) eg. 
Organe 
100ml Orange juice, raw,CNF 
570 427.5 237.
5 
95 75.05 40.85 13.3 6.65 0 Apples  1 fruit CNF 
618 463.5 257.
5 
103 81.37 44.29 14.4
2 
7.21 0 Pears  1 fruit CNF 
516 387 215 86 67.94 36.98 12.0
4 
6.02 0 Oranges   1 fruit CNF 
246 184.5 102.
5 
41 32.39 17.63 5.74 2.87 0 Grapefruit   1 fruit CNF 
630 472.5 262.
5 
105 82.95 45.15 14.7 7.35 0 Bananas   1 fruit CNF 
408 306 170 68 53.72 29.24 9.52 4.76 0 Grapes  (medium serving) Grape, red or green (European type, such as 
Thompson seedless), adherent skin, raw, CNF 
180 135 75 30 23.7 12.9 4.2 2.1 0 Melon  (water melon or had 
melon) (1 slice) 
watermelon, raw, CNF 
288 216 120 48 37.92 20.64 6.72 3.36 0 apricots 3 fruits 103 g apricot,raw, CNF 
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306 229.5 127.
5 
51 40.29 21.93 7.14 3.57 0 Peaches, small fruit, 130 b peaches, raw, USDA 
180 135 75 30 23.7 12.9 4.2 2.1 0  plums,  (1 fruit) one fruit, 66g plums, USDA 
60 45 25 10 7.9 4.3 1.4 0.7 0  
raspberries(mediu
m serving) 
10 fruits, 19 g raspberries ,raw, CNF 
96 72 40 16 12.64 6.88 2.24 1.12 0 Strawberries, five fruits medium , 
60g 
strawberries, raw, USDA 
276 207 115 46 36.34 19.78 6.44 3.22 0 Kiwi 1 medium fruit 76 g Kiwi fruit, raw, CNF 
366 274.5 152.
5 
61 48.19 26.23 8.54 4.27 0 Guava one, 90 g Guava, common, raw, CNF 
1404 1053 585 234 184.8
6 
100.6
2 
32.7
6 
16.3
8 
0 Dates 10 fruits Date, domestic, natural and dry, CNF 
384 288 160 64 50.56 27.52 8.96 4.48 0 Pomegranate half a fruit, 77g pomegranate, raw ,CNF 
222 166.5 92.5 37 29.23 15.91 5.18 2.59 0 Fig  one medium, 50 g fig, raw, CNF 
270 202.5 112.
5 
45 35.55 19.35 6.3 3.15 0 Pineapple one slice 90 g pineapple, raw, CNF 
312 234 130 52 41.08 22.36 7.28 3.64 0 Cherry 10 fruits, 82g Cherry, sweet, raw, CNF 
270 202.5 112.
5 
45 35.55 19.35 6.3 3.15 0 Tangerine one medium, 84g Tangerine (mandarin), raw, CNF 
177 132.7
5 
73.7
5 
29.
5 
23.30
5 
12.68
5 
4.13 2.06
5 
0 Papaya half small fruit, 76 Papaya, raw, CNF 
774 580.5 322.129 101.955.47 18.09.03 0 Dried fruit, eg. small box, 43g Raisins, seedless, USDA 
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5 1 6 Raising, prunes 
(medium serving)  
150 112.5 62.5 25 19.75 10.75 3.5 1.75 0 Cabbage 100g Cabbage, raw, CNF 
2610 1957.
5 
1087
.5 
435 343.6
5 
187.0
5 
60.9 30.4
5 
 cheese Sandwich 140g Ingredients: bread 100g, cheese 40g  
1188 891 495 198 156.4
2 
85.14 27.7
2 
13.8
6 
0 stewed Shrimp 225 Ingredients: 135g Shrimp, mixed species, oil, 
tomato onion 
3324 2493 1385 554 437.6
6 
238.2
2 
77.5
6 
38.7
8 
0 mixed pie 200 Ingredients: wheat, spinach, cheese, meat, egg 
1308 981 545 218 172.2
2 
93.74 30.5
2 
15.2
6 
0 shakshookah 190 Ingredients: fried egg, tomato, onion 
3834 2875.
5 
1597
.5 
639 504.8
1 
274.7
7 
89.4
6 
44.7
3 
 mixed sandwitch 270g Ingredients: Bread 100g, Falafel 50g, cheese 
20g , boiled egg 50g, fries 50g 
3072 2304 1280 512 404.4
8 
220.1
6 
71.6
8 
35.8
4 
 egg pastry 175g Ingredients:100 g wheat, 25 mozzarella, 50g 
boiled egg 
3210 2407.
5 
1337
.5 
535 422.6
5 
230.0
5 
74.9 37.4
5 
 tuna pastry 175g Ingredients:100 g wheat, 25 mozzarella, 50g tuna 
3738 2803.
5 
1557
.5 
623 492.1
7 
267.8
9 
87.2
2 
43.6
1 
 chicken burger 228g Fast foods, sandwiches and burgers, chicken fillet 
sandwich with cheese, CNF 
3030 2272.
5 
1262
.5 
505 398.9
5 
217.1
5 
70.7 35.3
5 
 taheniah 100g Ingredients: 80 g of tahini seed and 50ml of sugar 
2478 1858.
5 
1032
.5 
413 326.2
7 
177.5
9 
57.8
2 
28.9
1 
 cheese and may 
sand 
120g Ingredients:100 g bread, 20g cheddar, 15ml mayo 
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2976 2232 1240 496 391.8
4 
213.2
8 
69.4
4 
34.7
2 
 hashi kabsa 440g Ingredients: camel meat 250g, rice 150g, onion 
40, 
http://www.myfitnesspal.com/food/calories/gener
ic-camel-meat-26858616 
2544 1908 1060 424 334.9
6 
182.3
2 
59.3
6 
29.6
8 
 hashi stew  Ingredients: Camel meat 250g, potato 50g, 
http://www.myfitnesspal.com/food/calories/gener
ic-camel-meat-26858616 
810 607.5 337.
5 
135 106.6
5 
58.05 18.9 9.45  mango 1 fruit/ 207g Mango, raw, CNF 
2220 1665 925 370 292.3 159.1 51.8 25.9  peanut butter sand 120g Ingredients: 100g of bread, and 15ml peanut 
butter 
2280 1710 950 380 300.2 163.4 53.2 26.6  bread and banana 200g Ingredients:100 g of bread, 100 g of banana 
2472 1854 1030 412 325.4
8 
177.1
6 
57.6
8 
28.8
4 
0 shakshookah sand 170g Ingredients: 100g bread, 50g shakshookah, 20g 
cheese 
3012 2259 1255 502 396.5
8 
215.8
6 
70.2
8 
35.1
4 
0 shrimp sand 170g Ingredients: bread and 50g fried shrimp, 20g 
cheese 
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 Caloric of ingredients (CNF and USDA) 
538 butter, for marsa, 75g 
362 calories in wheat 100g 
122 kcal in sunflower oil 15ml for frying 
40 kcal in sunflower oil 5ml for usual cooking 
138 zaatar 50g 
160 mozzeralla 50 
71 labnah 50g 
203 lamb 50g 
146 chicken 50g 
327 sugar 100ml 
9 tomato 50g  
16 onion 40g 
11.5 spinach 50g 
275 bread 100g 
55 flafel 50g 
80 cheese cheddar 20g 
99 liver 50g 
203 lamb 50g 
96 fried egg 50g 
70 boiled egg 50g 
159 Fries 50g 
93 tuna 50g 
381 corn starch 100g 
365 oat 100g 
82 jam two table spoons 
150g Seeds, sesame butter, tahini, roasted and toasted kernels 100g 
245 camel meat 250g 
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Appendix 11: Custom Declaration Form 
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Appendix 12: Shipment Cover Letter 
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 Appendix 13: allelic and genotype frequencies in different 
populations 
No SNP N Frq 22* Frq21* 
 
Frq11
* 
Frq 
Risk 
alleles 
Frq 
Other 
Alleles 
Population (ref) 
1 rs10946398 2917 0.33 0.49 0.18 0.58 0.42 Han Chinese 
(171) 
334 0.56 0.36 0.08 0.74 0.26 Saudi Arabian 
2 rs10811661 2922 0.28 0.51 0.21 0.53 0.47 Han Chinese 
(171) 
501 0.29 0.52 0.19 0.55 0.45 Korean (179) 
4678 0.74 0.24 0.02 0.86 0.14 Finnish (177) 
338 0.66 0.3 0.04 0.81 0.19 Saudi Arabian 
3 rs1111875 501 0.08 0.45 0.47 0.30 0.70 Korean (179) 
4748 0.29 0.48 0.23 0.53 0.47 Finnish (177) 
332 0.67 0.25 0.08 0.79 0.21 Saudi Arabian 
4 rs13266634 4739 0.40 0.45 0.15 0.63 0.37 Finnish (177) 
16137 0.12 0.42 0.46 0.33 0.67 European (178) 
2396 0.21 0.49 0.30 0.45 0.55 Chinese (178) 
2033 0.003 0.057 0.94 0.03 0.97 African (178) 
330 0.77 0.20 0.02 0.87 0.13 Saudi Arabian 
5 rs7754840 2932 0.18 0.49 0.33 0.42 0.58 Han Chinese 
(171) 
500 0.14 0.52 0.35 0.40 0.60 Korean (179) 
4644 0.14 0.47 0.39 0.37 0.63 Finnish (177) 
339 0.08 0.36 0.56 0.25 0.75 Saudi Arabian 
6 rs560887 2225 0.10 0.42 0.48 0.31 0.69 Dutch (198) 
335 0.59 0.34 0.07 0.76 0.24 Saudi Arabian 
7 rs2191349 1779 0.31 0.49 0.20 0.56 0.44 European (298) 
328 0.39 0.39 0.22 0.59 0.41 Saudi Arabian 
8 rs10830963 2295 0.55 0.39 0.06 0.75 0.25 Dutch (198) 
2238 0.18 0.49 0.33 0.42 0.58 Chinese (187) 
328 0.07 0.31 0.62 0.21 0.79 Saudi Arabian 
9 rs7034200 1781 0.24 0.50 0.26 0.49 0.51 European (298) 
329 0.4 0.46 0.14 0.63 0.37 Saudi Arabian 
10 rs174550 1758 0.46 0.45 0.09 0.69 0.31 European (298) 
324 0.69 0.28 0.03 0.83 0.17 Saudi Arabian 
11 rs11708067 1778 0.62 0.33 0.05 0.79 0.21 European (298) 
333 0.77 0.21 0.02 0.88 0.12 Saudi Arabian 
12 rs4607517 1727 0.04 0.29 0.67 0.19 0.81 European (298) 
330 0.09 0.31 0.6 0.17 0.83 Saudi Arabian 
13 rs7903146 4733 0.04 0.33 0.63 0.20 0.80 Finnish (177) 
931 0.16 0.50 0.34 0.41 0.59 Moroccan (170) 
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*22 indicates homozygote risk alleles, 21 indicates heterozygote alleles,  
and 11 indicates homozygote non risk alleles. 
1561 0.11 0.41 0.48 0.31 0.69 Austrian (170) 
334 0.15 0.44 0.41 0.33 0.67 Saudi Arabian 
14 rs1799884 2208 0.69 0.28 0.03 0.83 0.17 Dutch (198) 
339 0.11 0.33 0.56 0.26 0.74 Saudi Arabian 
15 rs5219 4658 0.23 0.50 0.27 0.48 0.52 Finnish (177) 
335 0.07 0.28 0.65 0.21 0.79 Saudi Arabian 
16 rs7756992 2910 0.27 0.50 0.23 0.52 0.48 Han Chinese 
(171) 
16158 0.54 0.39 0.07 0.73 0.27 European (178) 
2391 0.27 0.47 0.26 0.51 0.49 Chinese (178) 
1886 0.16 0.45 0.39 0.38 0.62 African (178) 
336 0.07 0.4 0.53 0.26 0.74 Saudi Arabian 
17 rs780094 1759 0.32 0.49 0.19 0.57 0.43 European (298) 
333 0.42 0.39 0.19 0.62 0.38 Saudi Arabian 
18 rs2237897 4842 0.43 0.46 0.11 0.66 0.34 Japanese (184) 
3168 0.45 0.43 0.12 0.67 0.33 Singaporean 
(184) 
9479 0.93 0.07 0.00 0.96 0.04 Dane (184) 
336 0.95 0.02 0.03 0.98 0.02 Saudi Arabian 
19 rs2237895 4714 0.15 0.47 0.38 0.39 0.61 Japanese (184) 
3378 0.13 0.46 0.41 0.36 0.64 Singaporean 
(184) 
8181 0.18 0.50 0.32 0.43 0.57 Dane (184) 
2995 0.19 0.47 0.34 0.43 0.57 Indian (185) 
332 0.27 0.45 0.28 0.49 0.51 Saudi Arabian 
20 rs1387153 3870 0.16 0.51 0.33 0.42 0.58 Chinese (299) 
330 0.09 0.41 0.5 0.3 0.7 Saudi Arabian 
21 rs231362 120 0.58 0.35 0.07 0.76 0.24 Indian (185) 
327 0.37 0.46 0.17 0.58 0.42 Saudi Arabian 
22 rs7957197 120 0.74 0.23 0.03 0.85 0.15 European (300) 
334 0.75 0.21 0.03 0.86 0.14 Saudi Arabian 
23 rs757210 120 0.15 0.57 0.28 0.44 0.56 European (301) 
327 0.27 0.43 0.29 0.49 0.51 Saudi Arabian 
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Appendix 14: Introduction to Khat 
What is Khat? 
         Catha edulis or Khat (as called in Jazan) is a plant with stimulating amphetamine-like 
characteristics (293).  The act of (Takzeen), or chewing leaves of Khat, is performed in order to 
achieve the stimulant effect of this plant. Tender and fresh leaves are usually picked and chewed. 
Chewed leaves are not swallowed and kept in one side of the mouth for several hours.  
          This habit of Khat chewing is more prevalent in Eastern African countries and in the 
south western areas of the Arabic peninsula (302). However, it is also consumed by immigrants 
to European countries, including the UK. Although its importation is banned in several western 
countries, it is allowed to be imported and consumed in the UK (303).  
           Cultivation, transportation, trading, and consumption of Khat are strictly unlawful 
actions in Saudi Arabia. The legal action has also been supported by religious restrictions 
prohibiting the consumption of Khat. Those who are arrested performing activities related to 
Khat trading or consumption can face imprisonment. Despite all governmental restrictions, 
chewing Khat is widely spread social behaviour in Jazan area.   
          Khat is cultivated in regions with high altitudes (1500-2000 meters above sea level) (304). 
This quality makes mountains in Jazan and borders of Yemen a suitable natural habitat for the 
tree of Khat. In order for stimulant effect to be maximized, Khat leaves always have to be fresh. 
Leaves are usually consumed within few days of harvesting if not on the same day. Khat leaves 
are usually kept fresh by wrapping it with a wit clothes or banana leaves. Additionally, the 
commercial value of the leaves are correlated with its freshness (305) (Figure 1).   
 
       
 
 
 
 
 
   A typical session of Khat chewing usually starts in the evening. Chewers usually consume a 
large meal before the chewing session hence once they start chewing Khat, they will no longer 
have the appetite to eat any food. Chewing sessions usually done in groups and those who chew 
Figure 1: Khat Leaves. * 
*This photo was taken by a friend who is a Khat 
chewer. This photo has no Copy of Right.   
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Khat are more likely to be tobacco or water-pipe smokers (305, 306).  Khat chewing session can 
last up to six hours (306). In some extreme sessions, chewing can last overnight and some 
individuals might attend their jobs without nocturnal sleeping.     
 
Khat in Jazan: 
     A study conducted in Jazan revealed that 37% of male students (aged between 15 and 25) 
were Khat chewers. The percentage of female Khat chewers in the same population was greatly 
smaller (3.7%). There is also a tendency for older subjects to chew Khat more than younger 
ones. Percentage of those who chew Khat under the age of 15 was 17.4% compared to 24.2% in 
those who are older than 20 (293). This study was restricted to high school and university 
students. Although there is no study published regarding consumption of Khat in older 
population, based on the obvious trend of higher tendency to consume Khat with older age and 
based on our observation during data collection, we can expect that percentage of adult subjects 
who are Khat chewer to be around 50% if not more.   
 
Pharmacological effect of Khat: 
    The effective substance in Khat is called Cathinone. It has a stimulating effect of the 
sympathatic nervous system leading to an increase in blood pressure and tachycardia. It also has 
psychological and euphorigenic action (307).  This psychological action gives Khat an addictive 
property hence it gives the chewer a temporary sensation of activeness and happiness.  
 
The effect of Khat chewing on health: 
 
    Although Khat chewing is associated with activeness and euphoria during the session, several 
drawbacks have been reported especially after the chewing session. A study suggested in 
increase in mood disturbances and depression in Khat chewers compared to non chewers (308).  
The depressive effect of Khat was reported to increase toward the end of the chewing session 
(305). Another study indicated that anxiety and insomnia were more prevalent in chewers than 
non chewers (309).   
       
     The strongest effect of Khat is achieved when fresh leaves are chewed. The concentration of 
Cathinone in Khat leaves depends on where the tree was cultivated and on the freshness of 
leaves (305). Storing the leaves for longer durations causes the effect of Cathinone to be 
reduced when compared to fresh ones. This effect interferes with storing Khat leaves for longer 
terms and therefore, Khat chewers will always be on a continuous quest to find fresh Khat. 
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Certain individuals exhibit daily consumption of Khat. For those individuals, finding fresh Khat 
is another cause of anxiety giving that Khat is banned and has to be smuggled in Jazan region.   
 
     Consumption of Khat can induce several adverse effects on several systems. Hence Khat is 
kept in the mouth for several hours, it can be associated with periodontal diseases. In addition, it 
has been claimed that it might be associated with gastrointestinal illnesses such as oesophagitis 
and gastritis (293). During chewing sessions, chewers are less likely to consume food which 
might end in anorexia and malnutrition.  
 
Khat and diabetes:  
     During Data collection, several type 2 diabetes patients claimed that they were chewing Khat 
due to its effect on blood glucose. They were believing that Khat chewing is likely to reduce 
blood glucose and thus leading to better control of glucose level. In few extreme occasions, 
certain patients admitted stopping taking medications prescribed by their doctors and favoured 
to use Khat as a remedy.  
    Although Khat might have an impact on blood glucose, it is likely to be temporal due to the 
anorexic effect of Khat leading to lack of appetite and consequently temporal reduction of blood 
glucose level during or toward the end of chewing session. This effect is likely to be reversed 
once the effect of Cathinone is reduced after cessation of Khat chewing.  Two studies have 
suggested that Khat’s effect on level of blood glucose is not significant and thus unlikely to 
reduce it (310, 311).   
Socioeconomic effect of Khat consumption:  
     Although Khat consumption leads to a sensation of activeness and euphoria, it is chewed 
while individuals are resting to allow proper chewing. Chewers tend to exhibit lack of physical 
activities for several hours in every session. Khat consumption has to be done in private and 
secluded areas hence it is banned in Jazan area. Therefore, Khat chewers are almost never 
engaged in public or social actions while they are chewing. Psychological effect of Khat might 
aggravate the social isolation where in best situations, chewers tend only to meet closed circle of 
relatives and friends during chewing sessions.  
     In addition to its adverse effect on social behaviour, Khat consumption can have adverse 
effect on economical status of chewers. While Khat consumption causes insomnia, it leads to 
disturbance in sleeping time and therefore, affects level of responsiveness and activity during 
work hours. If we assume that half of the adult workers are Khat chewers, we can confidently 
argue that the quality of work provided by chewers is very likely to be incompetent affecting the 
overall economic potentials of a whole society.   
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     The cost of Khat varies between countries. The cost of Khat required for one session in the 
UK is approximately 5 to 10 pounds. Hence it is banned in Jazan area, the cost of same amount 
of is approximately between 20 and 50 pounds depending on the freshness and type of Khat 
leaves. Although expenditure on Khat varies between magnitudes of addiction, in extreme 
situations, certain individuals tend to spend up to £1000 on monthly basis. Giving the elevated 
cost of Khat, its consumption poses a financial burden on families if more than one member is 
Khat chewer.  
 
